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Abstract 
The insertion sequence ISYlOO is a member of the IS630/Tcl/mariner superfamily of 
transposable elements and was first found in the cyanobacterium Synechocystis sp. 
PCC6803. ISYlOO is active in E. coli, transposing into TA dinucleotides like other 
members of the IS630/Tc1lmariner superfamily (Urasaki, et al., 2002). 
An in vivo transposition assay was set up in this study, confirming the TA target 
preference of ISYlOO and showing that 30 bp from each end of ISYlOO is sufficient for 
efficient transposition. Single mutations in the proposed catalytic residues (D136, D218 
and E253) in the C-terminal domain inactivated ISYlOO transposase in vivo. 
Adding 6 histidines to the C-terminus of the transposase did not change its 
transposition activity in vivo. His-tagged transposase was purified and catalysed efficient 
transposition in vitro. Purified transposase was the only protein required for transposition. 
The in vitro system was used to study the different steps in the transposition reaction. 
Purified His-tagged transposase bound the transposon ends, protecting approximately 26 
bp from cleavage by DNase I at each end. Two helix-turn-helix DNA binding motifs 
linked by an 'AT-hook' -like sequence were predicted in the N-terminal domain ofISYlOO 
transposase. Deletion derivatives containing just these helix-turn-helix motifs bound 
efficiently to the transposon ends. 
Analysis of in vivo cleavage products suggested that ISYlOO transposase cleaves 
exactly at the transposon ends to produce 3' OH ends and two nucleotides inside ISYlOO 
on the other strand to produce 5' phosphates (Urasaki et al., 2002). In this study, 
supercoiled plasmid containing ISYlOO ends, and synthetic linear transposon ends were 
tested for cleavage by transposase in vitro. Cleavage products were observed and the 
cleavage sites were mapped. Supercoiled plasmid substrates were cleaved in vitro exactly 
as found in vivo by Urasaki et al. (2002). However, linear DNA fragments containing 
single ISYlOO ends were cleaved mainly one nucleotide inside the transposon end to 
produce a 3' OH and one nucleotide outside the transposon end to produce a 5' phosphate. 
Changes in the flanking TA dinucleotides at either one end or both ends of ISYlOO, 
reduced the efficiency of transposition in vivo. These changes also reduced the efficiency 
of cleavage in vitro. Changes at only one end inhibited cleavage at both ends implying 
communication between the two transposon ends. 
Synthetic pre-cut transposon ends were tested in an in vitro integration assay, and 
transposase catalysed the insertion of transposon 3' -OH ends into a target plasmid. 
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Transposase mediated efficient integration of a mini-ISYlOO, pre-excised by transposase 
or restriction enzyme, into T A targets in vitro, confirming that excised transposon 
fragments are intermediates in the reaction. 
Target sequences of ISYlOO from published data and this study were analyzed, 
yielding the consensus target sequence ADWTAWHT (W = A or T, D = not C and H = not 
G), in which the central TA is the duplicated target dinucleotide. 
Transposase was fused with the DNA-binding domain of Zif268, separated by 
different-length linkers. Transposition activities of these chimeric proteins were tested in 
vivo with a series of target plasmids carrying TA target sequences adjacent to a Zif268 
binding site. Results with chimeric transposases showed reduced transposition frequencies. 
However, when the Zif268 DNA-binding domain was linked to ISYlOO transposase via the 
DNA-binding domain of Tn3 resolvase, transposition occurred into TA dinucleotides to 
one side of the Zif268 binding site with elevated frequency. This could be developed into a 
genetic tool for target-specific integration. 
iii 
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Chapter I 
Introduction 
1.1 Introduction 
Transposons are defined mobile genetic elements that can jump, or transpose, from one site 
to another in DNA. This transposition is a fOlm of genetic recombination and is catalysed 
by specialised enzymes called transposases. Genetic transposition was first observed in 
maize by Barbara McClintock half century ago (McClintock, 1951; Comfort, 2001). Since 
then, transposons have been identified widespread in nature, and are found in virtually all 
organisms. Large-scale sequencing results have revealed that a large fraction of DNA in 
many eukaryotic genomes consists of transposable elements and their remnants. For 
example, about 40% of both human and mouse genomes are derived from transposable 
elements (Lander et al., 2001; Waterston et al., 2002). Transposition leads to a variety of 
genomic rearrangements such as insertions, deletions and translocations (for examples see 
Craig et al., 2002), is important in the spread of antibiotic resistance between bacte11a 
(reviewed in Gomez-Lus, 1998), and has contributed to the evolution of the genomic DNA 
of species from all three kingdom (Bennett, 2004; Kazazian, 2004). 
1.2 Transposition in brief 
1.2.1 Class I transposons 
Based on whether transposition occurs via an RNA intermediate, transposons have been 
categorised into two classes (reviewed in Finnegan, 1992). Class I transposons (or 
retrotransposons) move via an RNA intelmediate and can be further divided into long 
terminal repeat (LTR) and non-LTR retrotransposons. To perform transposition, LTR 
retrotransposons, including retroviruses and retrovirus-like transposons, are first 
transcribed into a RNA copy from the integrated DNA copy. This RNA is then reverse-
transcribed into a full length linear double strand eDNA in a process involving template 
switching between the LTRs (reviewed in Wilhelm and Wilhelm, 2001). Finally the eDNA 
copy of the retrovirus is integrated into genomic DNA in a reaction catalysed by the 
integrase protein (IN) (reviewed in Lewinsld and Bushman, 2005; Craigie, 2002). 
Non-LTR retrotransposons do not have long terminal repeats but usually have a 3' 
poly(A) tail or a similar sequence, so are also called poly(A) retrotransposons. Based on 
their length, non-LTR retrotransposons can be further divided into long and short 
interspersed nuclear elements (LINEs and SINEs) (reviewed in Deininger and Batzer, 
2002). SINEs are nonautonomous forms of LINEs and depend on proteins encoded by the 
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LINEs for their transposition. To transpose, an mRNA copy is first transcribed from the 
DNA of the integrated element and translated to generate functional proteins with 
endonuclease and reverse transcriptase activities. Endonuclease cleaves the target DNA 
revealing a poly(T) stretch which base pairs with the poly(A) sequence of the LINE or 
SINE RNA. Target site primed reverse transcription then synthesizes the first cDNA 
strand. The RNA is degraded, the second strand is synthesized and DNA joining and repair 
completes the integration of the non-LTR element into a new location in the genome 
(reviewed in Ostertag and Kazazian, 2001). 
1.2.2 Class II transposons 
In contrast to class I transposons, class II transposable elements transpose directly at the 
DNA level and can be found in all species from Archaea and Eubactelia to Eukarya. 
According to their mechanisms of transposition, class II transposons can be subdivided 
into two categories, non-replicative transposons and replicative transposons. During 
transposition, non-replicative transposons are cut on both strands at both ends to produce a 
fully excised element which then inserts into a new target site (Figure 1.1). This 
mechanism has also been called cut-and-paste transposition. Replicative transposons are 
cut on only one strand at each transposon end. The transposition products can then be 
processed by DNA replication into a cointegrate molecule containing donor and target 
replicons separated by two copies of the transposon. The cointegrate molecule can then be 
resolved by site-specific recombination into the original donor plasmid and the target 
plasmid with a new transposon insertion (Figure 1.1). 
One type of class II transposons common in bacteria are called "insertion sequences" 
(IS). IS are short DNA mobile elements with a simple genetic structure and no selectable 
phenotype (Figure 1.2). A number of eukaryotic class II transposons (such as mariner and 
Tel) have a similar organisation and structure to these simple bacterial insertion 
sequences. 
In bacteria, two ISs can mobilise a segment of DNA (often canymg phenotypic 
markers) in between them, forming a composite transposons (Figure 1.2). Two examples 
of this are TnlO, formed by two copies of IS 10 flanking a tetracycline resistance gene, and 
Tn5, formed by two copies of IS50 flanking a kanamycin resistance gene. Other bacterial 
transposons, such as Tn7 and Tn3, have more complex genetic structures. These may 
contain multiple genes required for transposition as well as antibiotic resistance genes, all 
flanked by transposon end sequences which are recognised by the transposase proteins. 
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Figure 1.1 Replicative and non-replicative transposition. Left: non-replicative (cut-
and-paste) transposition, in which the transposon is fully excised from the donor molecule 
and then inserted into a new target. Right: replicative transposition, in which the h'ansposon 
is cleaved only at its 3' ends. Integration of these 3' ends into a target molecule produces 
two replication fork-like structures. Replication produces a cointegrate which can be 
resolved by site-specific recombination into donor and target molecules, each carrying a 
single copy of the transposon. The diagram is coloured as follows: transposon, thick black 
lines; donor replicon, blue; target rep licon, green; target site, red; newly replicated DNA, 
grey. 
A) 
IRL Transposase IRR 
--------------.~ ~ 
B) 
ISL ISR 
~ ~~ Transposon marker ~ ~~ 
or 
~ ~~ Transposon marker ~~ ~ 
Figure 1.2 Structure of typical insertion sequences and composite 
transposons. A) Insertion sequences contain single open reading frames 
encoding the transposase (shown as arrow) flanked by the terminal inverted 
repeats IRL and IRR (shown as black triangles). B) Composite transposons 
contain transposon marker genes flanked by two insertion sequences, which 
can be in direct or inverted repeat. 
1.2.3 Examples of class II transposons 
A large number of class II transposons have been studied in great detail, facilitated by in 
vitro systems that recreate the full transposition reaction with purified proteins and DNA 
substrates. Some examples are briefly introduced below. 
The bacterial composite transposon Tn5 jumps in a cut-and-paste reaction that 
requires only the transposase protein. Transposase binds to the IRs at both ends of the 
transposon, brings the ends together, cuts both strands at both ends and inserts the 
transposon at a new location (Goryshin and Reznikoff, 1998). TnlO transposes by a similar 
mechanism, but requires the host protein IHF (Integration Host Factor) for efficient 
transposition (Chalmers et at., 1998). 
The bacterial transposon Tn7 carries at least three antibiotic resistance genes in 
between transposon ends containing multiple binding sites for the transposase protein 
TnsB (Arciszewska and Craig, 1991). Transposition also requires the other transposon-
encoded proteins TnsA, TnsC and either TnsD or TnsE. TnsA and TnsB cooperate to 
excise the transposon from its original location, and TnsB catalyses insertion at a new 
location (Sarnovsky et al., 1996). TnsC, D and E are involved in directing Tn7 to its new 
target (Bainton et at., 1993; Peters and Craig, 2001). 
Tel and Tc3 from Caenorhabditis etegans, Mos1 from Drosophila mauritiana and 
other mariner elements, which are found widespread in eukaryotes (reviewed in Plasterk et 
at., 1999), as well as Hermes from the hAT superfamily jump by cut-and-paste mechanisms 
(Zhou et at., 2004), and have also been studied in vitro. 
IS911, an insertion sequence first isolated from Shigella dysenteriae, uses a different 
strategy to produce the linear excised transposon via a circular intermediate. This linear 
excised transposon then inserts at new locations in DNA much like other class II 
transposons (Polard and Chandler, 1995; Polard et at., 1996; Ton-Hoang et at., 1999). 
The best studied elements that jump by a replicati ve mechanism are Tn3 and Mu. Mu 
is a transposon that has adopted the lifestyle of a bacte110phage by acquisition of genes 
required for the lytic and lysogenic phases of the bacteriophage lifecycle, and uses 
transposition to replicate its DNA in the lytic phase (reviewed in Chacon as and Harshey, 
2002). Tn3 was one of the earliest transposons to be discovered because of its ability to 
confer resistance to ampicillin (reviewed in Grindley, 2002). Transposition of Tn3 
produces a cointegrate molecule that is resolved by the well studied Tn3 resolvase protein 
(reviewed in Grindley, 2002). 
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Retroviral integration reactions, for instance that catalysed by mv integrase, are 
closely related to the transposition reaction catalysed by the transposases of class II 
transposons mentioned above, and have also been well studied (reviewed in Craigie, 2001). 
1.2.4 Transposons as genetics tools 
Transposons have been widely used as genetic tools. They are most commonly used to 
create tagged mutations in the study of model organisms ranging from bacteria to fungi, 
insects and mammalian cells in tissue culture. Transposons are potent mutagens, and 
transposition occurs at random or semi-random sites. Methods have been developed to 
isolate large numbers of independent transposition events. Transposition may take place in 
vivo in the target organism, or may be carried out in vitro into isolated target DNA. 
Once a transposon tagged mutant has been selected, the known transposon sequence 
can be used to isolate the flanking DNA and identify the gene of interest. Transposons can 
also be used as mobile primer sites for sequencing projects or PCR-based strategies 
(reviewed in Hayes, 2003). Transposons can also be used to deliver single copy integrated 
transgenes to a wide variety of organisms. Any DNA can be inserted into the genome, so 
long as it is flanked by transposon end sequences and the transposase protein is supplied, 
usuall y in trans. 
In Drosophila melanogaster, the P-element transposon has been developed as a 
genetic tool for about 20 years (Rubin and Spradling 1982; Spradling and Rubin 1982). P 
elements are the method of choice for producing transgenic D. melanogaster and 
transposon-based systems are being developed for other important insects such as 
mosquitoes. More recently transposons from the Tel/mariner family and hAT 
superfamilies have been used or are being developed as genetic tools in vertebrate 
organisms (reviewed in Miskey et al., 2005). The purposes of using transposon in 
multicellular organisms are similar to those in microorganisms, including characterization 
of functional genes identified by genome sequencing projects, transgenesis and insertional 
mutagenesis (Adelman et al., 2002; Carlson et al., 2003; reviewed in Hamer et al., 2001). 
New applications such as transposon-based RNAi for generating gene knockdowns in 
mammalian cells have also been developed (Heggestad et al., 2004). 
1.3 Mechanism of transposition 
The transposons described in section 1.2.3 are those that have been most intensively 
studied, and whose mechanisms of transposition are understood best. The following 
5 
discussion of transposition mechanisms is therefore based largely on results from these 
elements. 
1.3.1 Strand cleavage and transfer reactions in transposition 
Transposases use two basic chemical steps in their transposition reactions: DNA strand 
cleavage or hydrolysis to produce a 5' phosphate and a 3' OH, and transesterification 
reactions to join this 3' OH terminus to another DNA strand (see section 1.3.2). For many 
transposons, including Tn5 and Tnl0, both cleavage and strand transfer reactions are 
catalysed by a single active site in the transposase protein (Bolland and Kleckner, 1996; 
Davies et al., 1999; Kennedy et al., 2000). 
Non-replicative transposons use a variety of strategies to cleave the transferred and 
non-transferred strands of the transposon ends. Double strand cleavages at Tn5 and TnlO 
ends occur via hairpin intermediates (Bhasin et al., 1999; Kennedy et al., 1998). One 
strand at each end, the transferred strand, is first cleaved in a hydrolysis reaction that 
liberates the transposon 3' OH end (Bolland and Kleckner, 1995). This then attacks the 
opposite strand, and becomes covalently joined to it forming a hairpin structure at the 
transposon end (Figure 1.3A; Bhasin et al., 1999; Kennedy et al., 1998). The hairpin is 
opened by transposase in another hydrolysis reaction to produce transposon 3' OH and 5' 
phosphate ends (Figure 1.3A). 
The eukaryotic transposon Hennes from the hAT family also jumps via a hairpin 
intermediate. However, in contrast to Tn5 and Tn 10, the hairpin is on the sequences 
flanking the transposon rather than on the transposon ends. The donor molecule is first 
cleaved one nucleotide outside the transposon on the non-transferred strand. The liberated 
3' OH attacks the opposite strand, forming a hairpin structure on the transposon flanking 
sequences, and a double-stranded break is produced at the transposon ends (Zhou et al., 
2004). This same mechanism is also used during V(D)J recombination (reviewed in 
Oettinger, 1999). 
Elements such as IS911 and IS21 are excised from the donor site via a circular DNA 
intermediate (reviewed in Berger and Haas, 2001). Hydrolysis first occurs on the 
transferred strand at just one end (Polard and Chandler, 1995). The liberated transposon 3' 
OH attacks the same strand at the other transposon end, forming a covalently closed single 
stranded circle. Replication yields a double stranded circular transposon, with the two ends 
joined together. Transposase then cleaves both strands at the junction between the two 
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Figure 1.3 Different transposons use different transposition pathways. A) Double 
strand cleavage at IS I 0 and IS50 ends takes place via a hairpin intermediate. B) Pathway 
ofIS911 excision. Transposition occurs via a circular intermediate. C) Retroviral integrases 
cleave two nucleotides from the 3' ends of the full length cDNA. D) The 3' ends ofTn7 
are cleaved by TnsB, while the 5' ends are cleaved by TnsA. E) After excision, the 
transposon 3' ends liberated in steps A-D are inserted into staggered positions on the target 
DNA. Gaps and unpaired strands are repaired by host machinery to produce the target 
duplication (grey). F) For Mu and Tn3 only the transferred-strands are cleaved, producing 
3' OH ends which are h·ansferred to the target DNA. The strand transfer product is replicated 
to form a cointegrate. The diagram is coloured as follows : Transposon DNA, thick black 
lines; flanking donor DNA, blue; target DNA, green. Phosphates are shown as circles with 
a ' P , or where known the preferred phosphorothioate stereoisomer Sp or Rp. The exposed 
3' OH groups involved in subsequent reactions are shown as small open circles. Positions 
of strand cleavage are indicated by short arrows. Nucleophilic attack on the DNA 
phosphodiester bond by water or 3' hydroxyls are also indicated by arrows. (Adapted from 
Haren et af.) 1999; Turlan and Chandler, 2000). 
ends, forming a linear excised transposon which can be inserted into a new target site 
(Figure 1.3B; Polard and Chandler, 1995; Polard et al., 1996; Ton-Hoang et al., 1999). 
Full-length double stranded retroviral cDNAs are only a few bp longer than the 
integrated form of the virus. The extra base pairs are cleaved from the cDNA 3' ends by 
the integrase protein in a reaction similar to the strand cleavage reactions catalysed by 
transposases (Figure 1.3C). 
Unlike other transposons, excision of Tn7 from the donor DNA is carried out by a 
heteromultimeric complex of two proteins, TnsB and TnsA. The active site in TnsB 
cleaves the transferred strands and catalyses strand transfer reactions, while TnsA cleaves 
the non-tranferred strands of Tn7 (Figure 1.3D; Sarnovsky et al., 1996). While TnsB is 
homologous to other transposase proteins, TnsA is structurally related to type II restriction 
endonucleases (Hickman et al., 2000). 
Once the transposon has been cleaved at the 3' ends, either with or without cleavage 
of the other strand, the transposon 3' OH termini are transferred to phosphates on opposite 
strands of the target DNA (Figure 1.3E). This yields a transposition product with nicks that 
can be repaired by the host repair machinery. The two ends of the transposon are usually 
transferred to staggered positions on the target DNA, resulting after repair in a short direct 
target repeat flanking the transposon insel1ion. The length of this target repeat is 
characteristic of a given transposon. 
1.3.2 Chemistry of the strand-cleavage and transfer reactions 
The two different types of chemical reaction catalysed by transposase, strand cleavage and 
strand transfer, share a similar mechanism and are usually catalysed by a single active site 
in the transposase protein. In the DNA cleavage reaction, a water molecule acts as a 
nucleophile to attack a phosphate at the cleavage site, generating a 5' phosphate and a 
3'OH at the cleaved ends. In the strand transfer reaction, a 3' OH (generated by a previous 
cleavage reaction) acts as a nucleophile to attack a DNA phosphate. The attacking 3' end 
becomes covalently linked to the target phosphate displacing the original target 3' end. For 
Mu transposase and HIV integrase, it has been shown that both DNA cleavage and strand 
transfer occur by a one-step in-line substitution mechanism (Engelman et al., 1991; 
Mizuuchi and Adzuma, 1991). A nucleophile attacks the activated phosphate from one side 
and a 3' OH leaves the phosphate on the other side of the phosphate. Evidence for this one 
step mechanism came from the inversion of chirality observed on phosphorothioate-
containing substrates (Figure 1.4; Mizuuchi et al., 1999). This contrasts with the 
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Figure 1.4 The chemistry of strand cleavage and transfer. A) Strand cleavage. 
B) Strand transfer and disintegration. The transposon DNA is represented as a 
bold line. Only one of the relevant DNA strands is shown. Nucleophilic attack 
(curved arrows) is carried out either by H20 (A), or a 3' hydroxyl from the exposed 
transposon end for strand transfer, or from the exposed 3' hydroxyl in the target 
DNA for disintegration (B). The phosphodiester bond that undergoes cleavage 
in these reactions is shown as a chiral form, in which a non-bridging oxygen is 
represented as 0*. The hydrolysis (A) and transesterification (B) reactions shown 
here result in an inversion of chirality. The corresponding steps involving double-
strand donor and target DNA together with their polarity are presented on the 
right of this figure for clarity. (Adapted from Haren et al., 1999). 
conservation of chirality seen in the two-step transesterification reaction mechanisms 
adopted by site-specific recombinases, which cut and rejoin via covalent protein-DNA 
intermediates (reviewed in Hallet and ShelTatt, 1997). 
1.3.3 An N-terminal DNA-binding domain 
Transposition of class II transposons is initiated by the transposase specifically bound to 
the transposon ends. The N-terminal domains of many different transposases have been 
shown to bind specifically to sequences found at both transposon ends (Colloms et al., 
1994; Schukkink and Plasterk, 1990; Tavakoli et al., 1997; Weinreich et al., 1994; Zhang 
et al., 2001). Helix-tum-helix DNA-binding motifs have been recognised by sequence 
homology in the N-terminal domains of several different transposases (Nagy et a!., 2004; 
Pietrokovski and Henikoff, 1997; Ton-Hoang et al., 2004) and in two cases the presence of 
these helix-tum-helix DNA-binding domains has been verified by X-ray crystallography 
(Clubb et al., 1994; Watkins et al., 2004). 
In bacterial transposons, the N-terminal DNA-binding domain may fold as it is 
translated and bind to the transposon end before the C-terminal catalytic domain of the 
transposase has been synthesised. This property could account for the cis preference of 
some transposons, where transposase acts preferentially on the transposon copy encoding it 
(Derbyshire and Grindley, 1996; Morisato et al., 1983; Zhou and Reznikoff, 1997). 
1.3.4 A conserved catalytic DDE domain 
A conserved catalytic domain has been recognised by sequence homology in a large 
variety of DNA transposases as well as the retroviral integrases (reviewed in Haren et al., 
1999). This domain contains three highly conserved acidic residues, two aspartates and a 
glutamate, which are essential for catalytic activity (Junop and Haniford, 1997; Kulkosky 
et al., 1992). Most of the sequence similarity clusters around these three acidic residues 
(Figure 1.5). This transposase catalytic domain has been termed the DDE domain, and 
proteins that contain it are refelTed to as DDE transposases. X-ray crystal structures have 
been solved for several different DDE domains, all of which share a structural fold related 
to that of RNase H (Bolland and Kleckner, 1996; Lins et a!., 2000; Richardson et al., 2006; 
Steiniger-White et al., 2004; reviewed in Rice and Baker, 2001). The three acidic residues 
coordinate a pair of divalent metal ions (Mg++ or Mn++), which are thought to catalyse the 
strand cleavage and transfer reactions by stabilising the pentavalent phosphorous 
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HIV (IN) 54 VDCSPGIWQLDCTHLEGKVIL (51) 106 GRWPVKTIHTDNGSNFTGATV (35) 142 PYNPQSQGVVESMNKELKKII 
ASV (IN) 54 GLGPLQIWQTDFTLEPRMAPR (56) 111 VLGRPKAIKTDNGSCFTSKST (35) 147 PGNSQGQAMVERANRLLKDKI 
Mu(MuA) 259 HLDAMQWINGDGYLHNVFVRW ( 66) 326 GIPEDFHITIDNTRGAANKWL (55) 382 GKGWGQAKPVERAFGVGGLEE 
Tn3 690 IWGGGEVASADGMRFVTPVRT (75) 766 TGLNPTEIMTDTAGASDLVFG (129) 896 RRILTQLNRGESRHAVARAIC 
Tn7(TnsA) 18 KEGRGQGHGKDYIPWLTVQEV (85) 104 IRGVDQVMSTDFLVDCKDGPF (34) 139 DERTLEKLELERRYWQQKQIP 
Tn7(TnsB) 263 ALGPGSRYEIDATIADIYLVD (87) 351 CVGLPDVLLADRGELMSHQVE (34) 386 PRRGDAKGIVESTFRTLQAEF 
IS3 124 ASGPNQKWVGDITYLRTGEGW (59) 184 KCPENVIVHTDRGGQYCSTDY (35) 220 RGCCYDNACAESFFHTLKVEC 
IS911 (IS3) 217 VTEPNQVWCGDVTYIWTGKRW (59) 277 GKPVGVMFHSDQGSHYTSRQF (35) 313 RGNCWDNSPMERFFRSLKNEW 
IS30 227 NRRSLGHWEGDLVSGTKNSHI (55) 283 PSELRKSLTWDRGMELARHLE (33) 317 PQSPWQRGTNENTNGLIRQYF 
IS256 157 SEKNYPYLMTDVLYIKVREEN (65) 223 GLQGTELVISDAHKGLVSAIR (107) 331 HNRLKSTNLIERLNQEVRRRE 
Tn552 156 SSRPNEIWQADHTLLDIFILD (73) 230 VCGIPEKFYTDHGSDFTSHHM (35) 266 VGVPRGRGKIERFFQTVNQTF 
IS903 111 TRGEIAHLVIDSTGLKVFGEG (71) 183 THRKIRAASADGAYDTRLCHD (65) 249 TTDYNRRSIAETAMYRVKQLF 
...q- >-[ IS4 123 HWCGLTLLAIDGVFWRTPDTP (75) 199 QTGDNTLTLMDKGYYSLGLLN (104 ) 304 GDLYSHRWEIELGYREIKQTM 
CI) E IS10 87 SGNTMPIVLVDWSDIREQKRL (63) 151 PSNTTPLIVSDAGFKVPWYKS (130) 282 VNIYSKRMQIEETFRDLKSPA 
- ~ IS50 109 EELGKLGSIQDKSRGWWVHSV (68 ) 178 SMMSNVIAVCDREADIHAYLQ (137) 316 IDIYTHRWRIEEFHKAWKTGA 
ISY100 126 LYGSQAIVYIDESGFEAIQAC (81) 208 SLDIPSILIMDNAPIHRKTAI (34) 243 PKYSPDLNDIEHDFSALKRAR 
IS630 171 CSAEHPVFYEDEVDIHLNPKI (79) 251 RRAKTITLIVDNYIIHKSRET (35) 287 PVYSPWVNHVERLWQALHDTI 
IS870 173 PPAHAIVLSVDEKSQIQALDR (82) 256 PKSKAVHVILDNYATHKQPKV (35) 292 PTSCSWLNAVEGFFAKLTRRR 
>- ISRm2011-2 141 GIDPARLVFIDETWTKTNMAP (79) 221 ELKAGDIVILDNLGSHKGQEI (34) 256 PKYSPDLNPIEKLFAKIKHWL 
E ISPsy1 166 PPDRALVLCVDEKSQIQALNR (82) 249 PADVPIHLIMDNYATHKNDKV (35) 285 PTSASWMNLVERFFSTLSEKW 
CO ISRso5 169 PPENALVLCVDEKSQCQALER (82) 252 PADLDVHCIVDNYSSHKHPKV (35) 288 PTYSSWLNQVERFFAIITDKA 
-
ISPpu1 163 PPDKALVLCCDEKSQVQALER (82) 246 PKHLQLHLIVDNYATHKHPKV (35) 282 PTSSSWMNMVERFFRDITVYL 0 
C0 IS1066 166 PPQNALVLSVDEKPSIQALER (83) 250 PADRQIHVILDNLSTHKKNED (33) 284 PTSASWLNQVEIWFGIFQRKT (0 ISRJ1 167 PPAKAIVLCVDEKPSIQALER (82) 250 FPNRKLHVILDNLNTHKKNED (33) 284 PTSAPWLNQVEVWFSILQGQS CI) 
IS642 14 NEEIDHLLFQDESMIRDYQAL (78) 93 YPTGKIVMVLDNARIHHAKLI (36) 130 PPYSPELNLIEGLWKWLKSDV 
IS1471 166 RAEGAEIHWGDETALVNTDVR (78) 245 DAGKKVFLILDNLRVHHSKLV (36) 282 PSYSPQLNPEERLNADLKQEI 
IS14999 178 DDPDQVVFAADEVRVEHEAEV (78) 257 YPDKKITIVWDNARWHRSKKL (38) 296 PPYAPDHNPIEKVWNEAKAAI 
IS895 186 ETGKLRVLLTDECHLMWGDLS (78 ) 265 SPDQRLLIFWDGASYHRSKEI ( 43) 309 APNCPVQNPIEDIWLQAKTWV 
~ [Tel 77 RQEWAKHIWSDESKFNLFGSD (89) 167 NVGRGFVFQQDNDPKHTSLHV (34) 202 PSQSPDLNPIEHLWEELERRL £ >- Tc3 134 GTNWSKVVFSDEKKFNLDGPD (86) 221 YSRKNFRFQQDNATIHVSNST (34) 256 PARSPDLNPIENLWGILVRIV 
'--co·- Mos1 146 KSFLHRIVTGDEKWIFFVSPK (92) 239 KRQHRVIFLHDNAPSHTARAV (34) 274 AAYSPDLAPSDYHLFASMGHA 
::2! § Bari-1 144 LDFWFNILWTDESAFQYQGSY (88 ) 233 FPTTEWILQQDNAPCHKGRIP (34) 268 PPQSPDLNIIENVWAFIKNQR 
--o Impala 139 GIDWRRVKWSDECMVRRGQGM (85) 225 FLQSGDIFMHDNASVHTARIV (34) 260 PPYSPDLNPIENLWALMKAEI 
~ Soymar1 153 FQSMYNIIHIDEKWFYMTKKS (123) 277 ELGSTIFIQQDNARTHINPDD (39) 317 PPNSPDFNVLDLGFFSAIQSL 
D D E 
Figure 1.5 Alignment of DDE domains from a selection of transposases. Conserved DDE residues are shown 
in bold. The positions of the first residue in each segment in the proteins are indicated and the distances between 
the catalytic acidic residues are shown in brackets. 
intermediate, activating the nucleophile and stabilising the negative charge on the 3' OR 
leaving group (Figure 1.6; reviewed in Yang et al., 2006). 
Not all DNA transposases fall into the DDE family (reviewed in Mahillon and 
Chandler, 1998). Some elements that have been classified as insertion sequences use 
enzymes that share homology and mechanistic similarities with enzymes involved in 
rolling circle replication, or site-specific recombinases. The mechanism of transposition of 
these elements may be more similar to site-specific excision and integration carried out by 
bacteriophage such as A (Lenich and Glasgow, 1994; Serre et al., 1995). Transposases of 
some other insertion sequences have active sites that have yet to be identified. 
1.4 Insertion sequences and the IS630/Tcl/mariner superfamily 
The work described in this thesis concerns an insertion sequence belonging to the 
IS630/Telimariner family of transposons. The sections below give a brief introduction to 
bacterial insertion sequences and then go on to describe the properties of the 
IS630/Tel/mariner family in more detail. 
Insertion sequences are small genetically compact DNA transposons found in 
bacteria (reviewed in Mahillon and Chandler, 1998). They are one of the major causes of 
mutation in bacteria and were first discovered for their ability to cause polar mutations 
blocking transcription of downstream genes in operons (Fiandt et al., 1972). They also 
provide repeated sequences in bacterial genomes that allow DNA rearrangements by 
homologous recombination (for example see Parkhill et al., 2003). 
In general, ISs have short terminal inverted repeats marking the transposon ends, 
flanking a single gene that encodes a functional transposase (Figure 1.2). The IR upstream 
of the transposase gene is referred to as IRL and the one downstream of the transposase 
gene is IRR. 
So far, more than 500 different IS elements have been found, and they are classified 
into various families or groups based on their structures and the degree of homology 
between their nucleotide and protein sequences (http://www-is.biotoul.fr). One family of 
ISs is the prokaryotic IS630 family, closely related to the eukaryotic Tellmariner family of 
transposons. Together these elements form the IS630/Tel/mariner superfamily (Doak et 
al., 1994). 
More than 50 different IS630 family insertion sequences have been identified in 
eubacteria and archaebacteria (http://www-is.biotoul.fr). Members of the bacterial IS630 
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Figure 1.6 Coordination of divalent metal ions by the DDE catalytic residues. A) 
Proposed mechanism of two-me tal-ion catalysis by DDE transposases (Steitz and Steitz, 
1993; reviewed in Yang et ai., 2006). The two metal ions are coordinated by carbonyl 
oxygens of the three acidic residues. A non-bridging oxygen on the scissile phosphate is 
directly between the two metal ions. One metal ion assists nucleophilic attack by a 3' OH 
or a water molecule and the other stabilises the negative charge on the 3' OH leaving 
group. B) Clystal structure of the active site ofTn5 transposase, showing the coordination 
ofMn++by the DDE residues (From Steiniger-White, et aI., 2004). 
family of ISs include IS630 from Shigella sonnei (Matsutani et aI., 1987), ISRm2011-2 
from Rhizobium meliloti (Selbitschka et al., 1995) and IS1066 from Pseudomonas sp. 
strain P51 (van der Meer et al., 1991) (See Table 1.1, Figure 1.7). 
The eukaryotic transposon Mos} mariner was first discovered in D. mauritiana 20 
years ago (Hartl, 2001; Jacobson et al., 1986). Members of the mariner family have now 
been found in a wide diversity of species including insects, other arthropods, fish and 
humans (Feschotte and Wessler, 2002; Oosumi et al., 1995; Robertson, 1993; Robertson 
and Lampe, 1995; Wicker et al., 2005). Most members of the mariner family are inactive 
mutants, relics of past active transposons that have been inactivated by mutation. 
Two active mariner elements, Mos} and Himarl have been isolated in different 
ways. The Mos} element was discovered as an active transposon in D. mauritiana 
(Jacobson et al., 1986), whereas Himar} was reconstructed from the consensus sequence 
of multiple inactive transposon copies in the hom fly Haematobia irritans (Lampe et al., 
1996; Robertson and Lampe, 1995). 
The first members of the Tel family to be isolated were found in the nematode C. 
elegans. Tel itself was discovered as an active transposon in C. elegans, at about the same 
time that mariner was discovered in the fruit fly (Emmons et al., 1983). Another naturally 
active Tel family member, Tc3 was found later, also in C. elegans. Other Tel-like 
elements, such as Sleeping Beauty (SB) were reconstructed from inactive elements found in 
the genomes of fish or other organisms (Ivics et al., 1997). 
1.4.1 Structural analysis of the IS630/Tc1/mariner superfamily 
Generally, members from this superfamily have a typical IS structure (Figure 1.2). All 
elements are 900-2400 bp in length and, apart from a few exceptions, carry a single ORF 
encoding the transposase protein. A distinguishing feature of this family is that all 
members integrate into the sequence TA, and insertions are flanked by T A on both sides. 
The presence of the palindromic sequence TA at both the original target site and flanking 
the new inseltion makes the position of the transposon ends and the length of the target 
duplication ambiguous. The TA target site might be duplicated during transposition, or one 
nucleotide at each end might be part of the transposon. Results obtained with Tc3, IS630 
and Mos} mariner, either by changing the sequences flanking the donor transposon, or by 
precise mapping of the excised transposon ends, showed that the T A is a target duplication 
and is not part of the transposon (Dawson and Finnegan, 2003; Tenzen et al., 1990; van 
Luenen et al., 1994). 
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Table 1.1 Transposable elements of IS630/Tcl/mariner superfamily 
A) IS630 family 
Name Origin Accession No. Length Nucleotide Protein (bp) 
IS14999 COlynebacteriul1l AB186419 BAD89377 1149 glutamiculIl ATCC 14999 
IS1471 Burkholderia cepacia U67938 AAB38861 1113 
IS642 Bacillus halodurans C-125 APOO1515 BAB06239 1142 
IS630 Shigella sonnei X05955 CAA29389 1153 
IS630-SJ)nl Streptococcus pneu/lloniae AF026471 AADI0186 895 
IS870 Agrobacterium vitis 2657 Z18270 CAA79150 1146 
IS895* Anabaena sp. PCC7120 M67475 AAA98138 1192 AAA98139 
ISArl AgrobacteriulIl rhizogenes K03313 - 1146 A4 
ISPpul Pseudomonas putida AJ245436 CAB54057 1164 
ISPpu2 Pseudomonas putida AJ233397 CAB69082 1131 
ISPpu3 Pseudomonas putida AJ233397 - 1135 
ISPsyl Pseudomonas syringae Pl'. AF169828 AAD50908 2009 glycinea 
ISRfl Rhizobium fredii (Sinorhizobium fredii) M73698 - 1136 (ISRfrl) USDA257 
ISRso5 Ralstollia solanacea/'ll/JI NC 003295 CAD16890 1167 
ISRmlO SinorhizobiulIl meliloti AF143444 AAD37358 1047 BE31CC 
ISRmlO-1 Sinorhizobiwll //leliloti 2011 AJ242573 CAB43594 1042 
ISRm2011- Rh izobium lIleliloti 2011 U22370 AAC43490 1053 2** 
ISTcSa Synechocystis sp. PCC 6803 U38915 AAB72124 947 
ISY100 Synechocysis sp. PCC 6803 BAOOO022 BAA16620 947 
IS 1066 Pseudomonas sp. P51 U15298 - 1137 
ISRjl Bradyrhizobilllll japoniculIl X02581 CAA26419 1122 USDA 110 
B) Tel/mariner family 
Name Origin Accession No. Length Nucleotide Protein (bp) 
Tel Caellorhabditis elegans X01005 CAA25498 1610 
Tc3 Caellorhabditis elegalls AF025458 P34257 2335 
Impala Fusarium oxysporulllJ sp. AF282722 AAB33090.2 1281 
me/ollis 
Baril Drosophila melanogaster X67681 CAA47913 1728 
Mariner Drosophila mauritiana M14653 AAA28678 1286 
SoymarJ Glycine max AF078934 AAC28384 3491 
Mos} Drosophila mallritiana X78906 - 1293 
Minos Drosophila hyde; X61695 S26856 1775 
*: Contains two ORFs 
**: Putative transposase from frame-shifting translation. 
Mos1 Soymar1 
N~::::'------ 151471 
ISRm10- IS630 
ISPsy1 
Figure 1.7 Phylogenetic analysis ofthe IS630/Tcl/maril1er superfamily oftransposases. 
The tree was generated by the program clustalX 1.83 based on amino acid sequences of 
a selection of the transposases shown in Table 1.1. 
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Figure 1.8 Proposed mechanism of transposition of IS630/Tcl/maril1er superfamily. 
The cut-and-paste transposition model is based on studies of the Tc3 element. Tc3 is first 
excised from the donor molecule by double-stranded cleavage at the ends of the inverted 
repeats. These transposase-mediated cleavages cut the Tc3 element exactly at 31 ends, and 
two nucleotides inside the transposon at the 5' ends. The excised Tc3 inserts into staggered 
positions on a TA dinucleotide target site by transposase-mediated nucleophilic attack of 
transposon 3' OH ends. Host processing results in a TA target duplication flanking the 
transposon and a footprint at the donor site. (Adapted from Plasterk et aT., 1999). 
The transposase genes of the bacterial IS630 family elements take up almost the 
entire length of the transposon and extend into the right invelted repeat. A few elements 
contain frame shift mutations and premature stop codons; these could simply be 
inactivating mutations in the transposase. Alternatively they might be involved in the 
regulation of transposase expression, as has been found for other bacterial ISs (reviewed in 
Mahillon and Chandler, 1998). The eukaryotic transposase genes, such as those from Tel 
and Tc3 contain introns, accounting in part for the greater length of these elements. 
The transposase proteins encoded by IS630/Tcllmariner family elements have an N-
terminal DNA-binding domain that specifically recognises the transposon ends (IRs) and a 
C-terminal catalytic domain with homology to other DDE transposases (reviewed in 
Plasterk et al., 1999). The distance between the last two acidic residues in the catalytic 
domain is 35 for the prokaryotic IS630 family, and 34 for the Tel and mariner families. 
The last acidic residue in the triad is D in the mariner elements giving them a DD(34)D 
motif (Capy et al., 1997; Doak et al., 1994). In recent years, other transposons have been 
identified in this family with catalytic domains classified as DD(37)E motifs (Shao and Tu, 
2001; Turcotte and Bureau, 2002). 
The length of terminal inverted repeats in members of the IS630/Telimariner family 
ranges from 8 bp to greater than 400 bp. The family can be divided into three groups based 
on the inverted repeat length (Tu and Shao, 2002). Transposons in the first group, 
including Tel (54 bp IRs), Mas} (28 bp IRs) and IS630-like elements (8-29 bp IRs) have 
terminal inverted repeats shorter than 100 bp, with single transposase binding sites at the 
transposon termini. The second group of transposons, represented by Sleeping Beauty and 
Minos, have 200-250 bp long terminal inverted repeats and two binding sites in each 
inverted repeat. The third group, for example Tc3 with 462 bp IRs, carry long IRs (> 400 
bp) that extend inward significantly beyond the second target binding site (reviewed in 
Plasterk et al., 1999). However, inverted repeat length does not necessarily correlate with 
transposase sequence. For instance, not all Tc3-like transposons have inverted repeats as 
long as Tc3. Some have IRs in the second class, for example Tc3-CbIIa and Tc3-CbIIb 
from C. briggsae, while MsqTc3 from A. aegypti contains ShOlt (36 bp) terminal inverted 
repeats (Shao et al., 2001; Tu and Shao, 2002). While extra transposase binding sites are 
impOltant for transposition of Sleeping Beauty (Cui et al., 2002), they are not required for 
transposition of Tc3 (Fischer et al., 1999). It is not clear how these long, often almost 
perfect inverted repeats arise in Tc3, nor what if any is their function in transposition. 
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1.4.2 Cut-and-paste transposition of IS630/Tcl/mariner superfamily 
The mechanism of cut-and-paste transposition in this family was first elucidated by studies 
on Tc3 transposition (Figure 1.8; van Luenen et al., 1994). 
Transposition of Tc3 contains several defined steps. Transposition is initiated by the 
binding of the Tc3 transposase to the ends of the inverted repeats (van Luenen et al., 
1993). The N-terminal domain of Tc3 transposase binds specifically to Tc3 ends (Colloms 
et al., 1994). The structure of this domain bound to DNA has been solved by X-ray 
crystallography and contains two paired-like helix-turn-helix DNA-binding domains (van 
Pouderoyen et al., 1997; Watldns et al., 2004). The second step of transposition is double-
strand cleavage at the Tc3 ends, to excise Tc3 from the donor site. The excised element 
was produced upon induction of transposase in C. elegans and contains the complete 
transposon sequence at the 3' ends but lacks the tenninal 2 nucleotides at the 5' ends. The 
third step is presumed to be target capture by the excised transposon transposase complex, 
followed by integration of the excised transposon into the target site. The whole process is 
mediated by Tc3 transposase, and the three acidic residues in the DDE motif are essential 
for the catalytic activity of transposase (van Luenen et al., 1994). Finally, it is thought that 
after transposition, the cellular machinery repairs the gap at each end of the newly inserted 
transposon, and so produces a full length Tc3 flanked by a duplicated T A sequence. As a 
result of transposon excision, two nucleotides from each transposon end remain behind in 
the donor site as a two nucleotide protruding 3' single stranded tail. This is frequently 
repaired producing a 'footprint' T ACATA sequence, in which the two TA dinucleotides 
are from the duplication during the original transposition event (van Luenen et al., 1994). 
Later in vitro transposition studies on Tel (Vos et al., 1996) and the mariner element 
Himar} (Lampe et al., 1996) have shown that they all work by a similar mechanism to 
Tc3. Furthermore, the transposon encoded transposase protein is the only protein required 
for transposition. Similar mechanisms have since been confirmed for other members of the 
family, such as Sleeping Beauty, Frog Prince and Mas} (Dawson and Finnegan, 2003; Ivies 
et al., 1997; Miskey et al., 2003). 
Mas} is now one of the best studied members of the Tel/mariner family. 
Transposition has been reconstituted in vitro with purified transposase (Tosi and Beverley, 
2000). The two strands of the transposon are cleaved with a defined order. The two ends of 
the transposon are brought together in a paired end complex only after cleavage of the non-
transferred strands, and the transferred strands are cleaved in this complex. A 3' OH from 
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the first strand cleavage is not required for second strand cleavage and cleavage does not 
occur via a hairpin intermediate (Dawson and Finnegan, 2003). More recently, a crystal 
structure has been solved for the catalytic domain of Mas} transposase, showing the two 
catalytic divalent metal ions, and their coordination by the three conserved acidic residues 
in the DD(34)D motif (Richardson et al., 2006). 
Studies on the bacterial IS630 family are less far advanced than those on the 
eukaryotic Tel/mariner family. At the start of this project, no in vitro transposition 
systems had been established, so that most of our knowledge came from in vivo 
transposition studies and bioinformatics. The first prokaryote member to be discovered was 
IS630, isolated from Shigella sonnei (Matsutani et al., 1987). Transposition of IS630 can 
take place in E. coli when the transposase protein is appropriately expressed (Ten zen et al., 
1990). IS630 does not mediate cointegration between different replicons, suggesting non-
replicative transposition. IS630 preferentially inserts into TA dinucleotides in the 
tetranucleotide 5' -CTAG-3', and inserts are flanked by TA at both ends (Tenzen et al., 
1990; Tenzen and Ohtsubo, 1991). When the TA sequences were changed at both ends of 
IS630, the new sequences were not calTied with the transposon upon transposition. Thus 
the TAs are a target duplication and not part of the transposon (Tenzen et al., 1990). 
The next best studied bacterial IS630 family element comes from the cyanobacterium 
Synechocystis sp. strain PCC6803, and was originally named IS1987 (Cassier-Chauvat et 
al., 1997). It has also been called ISTcSa, indicating that it is a Tel-like IS from 
Synechocystis (http://www-is.biotoul.fr).However.this element is refelTed to as ISYlOO by 
the Synechocystis genome sequencing project (http://www.kazusa.or.jp/cyano) and by 
Urasaki et al. (2002) who were the first to study its transposition in E. coli. The name 
ISYlOO will be used throughout the rest of this thesis. Urasaki et al. (2002) demonstrated 
that ISYlOO undergoes double strand cleavage at the transposon ends, and transposes to 
new TA targets in E. coli on induction of the ISYlOO-encoded transposase. 
1.5 Advantages of using IS630/Tcl/mariner superfamily as genetic tools 
Transposons from IS630/Tel/mariner superfamily hold great promise and have many 
advantageous traits for use as genetic tools. To date, several transposons of the 
IS630/Tel/mariner family have been used in genome mapping (Akerley et ai., 2002; 
Wong and Mekalanos, 2000) and producing transgenic organisms (Adelman et al., 2002; 
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Akerley et al., 1998; Dupuy et al., 2005; Matsuoka et al., 2004; Rubin et al., 1999). Some 
of the advantages of these elements are outlined below. 
1.5.1 No host co-factors are required for transposition 
Many transposases require host factors to perform transposition. For example, TnlO needs 
IHF, a site-specific DNA binding protein, to assemble the transpososome (Morisato and 
Kleckner, 1987). In the replicative bacteriophage Mu transposition pathway, accessory 
proteins HU and IHF help in the fOlmation of a stable three-site synapse (Maxwell et al., 
1987). This requirement for host-specific proteins makes it difficult to use these 
transposons outside their natural hosts. Other transposons, such as Tn7 and Tn3 require 
multiple transposon-encoded proteins for transposition, again making it more difficult to 
set up transposition system in heterologous hosts. In vitro transposition studies on 
members of the IS630/Telimariner superfamily have demonstrated that transposase is the 
only protein required to perform transposition (Lampe et al., 1996; Tosi and Beverley, 
2000; Vos et al., 1996). It is therefore easy to set up transposition systems in a wide range 
of host species - from bacteria to Xenopus and from flies to mice - with transposons from 
these families (reviewed in Plasterk et al., 1999). 
1.5.2 The transposon ends required to bring about transposition are relatively 
small 
Apart from transposase, the only other requirement for a transposition system is the 
inverted repeats flanking the trans gene to be mobilised. IRs of IS630/Telimariner 
superfamily are often short and the length of DNA required for efficient transposition can 
be smaller than the inverted repeat size. For instance, only 26 bp out of the 54 bp Tel IRs 
are required for the transposition in vitro (V os et al., 1996). The terminal 100 bp of the 462 
bp Tc3 IRs are sufficient to maintain transposition at wild-type level (Fischer et al., 1999). 
In other cases, for instance Sleeping Beauty, longer sequences are needed at both ends. 
This requirement for relatively short transposon-derived sequences may allow larger 
payloads to be carried by artificial transposons. For example, GFP and phleomycin 
resistance reporter genes have been introduced into mini-Mos} elements to make detection 
of transposition easier (Goyard et al., 2001). 
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1.5.3 Efficient and detectable transposition 
Many wild-type transposases from other families show low levels of transposition activity. 
To be useful as a genetics tool, high levels of transposition activity are often required. In 
some cases this has been achieved by the selection of hyperactive transposase mutants 
(Goryshin and Reznikoff, 1998; Lampe et al., 1999; Pledger and Coates, 2005). The large 
number of inactive remnant copies of transposons from the IS630/Tel/mariner family is a 
treasure-trove for construction of new and hyperactive transposase valiants. Good 
examples are provided by SB and Himarl, which were reconstructed from the inactive 
remains of once active transposons (Ivics et al., 1997; Lampe et al., 1996). 
1.5.4 Broad heterologous host range 
IS630/Tel/mariner transposons have been found in a wide range of species and there is 
evidence for horizontal transfer between species, indicating a broad host range. The fact 
that transposons of this family can horizontally transfer to a broad spectrum of species 
broadens their potential use as genetic tools. In the laboratory, many genetic transformation 
experiments using Tel/mariner transposons have been canied out in heterologous species 
(reviewed in Plasterk et al., 1999). For example, Masl has been used as a transformation 
vector for D. melanagaster (Lidholm et al., 1993), Leishmania (Gueiros-Filho and 
Beverley, 1997), the yellow fever mosquito Aedes aegypti (Coates et al., 1998), zebrafish 
(Fadool et al., 1998) and chicken (Sherman et al., 1998) with varying degrees of success. 
As for other transposons, there are some challenges for using members from this 
superfamily as gene delivery tools. One is that their insertion occurs at essentially random 
sites in the genome. Insertions may therefore knock out, or inappropriately activate 
important host genes. Also, insertion into heterochromatin can lead to poor expression. It 
would therefore be useful to be able to control the precise location of transposon 
integration in the host genome. 
1.6 Project aims 
The project described here is on the transposition of ISYlOO. The aims of this project were 
i) To characterise and determine the mechanism of transposition of the bacterial insertion 
sequence ISYlOO in vivo and in vitro. 
ii) To investigate the potential of ISYlOO as a site-specific integration vector for gene 
delivery applications. 
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Chapter II 
Materials and Methods 
2.1 Bacterial strains 
The derivatives of E. coli K-12 or E. coli B used are listed in Table 2.1. 
Table 2.1 Bacterial Strains 
Strain Genotype Source 
E. coli B F dcm ompT hsdS(rB mB ) gal 
BL21 <DE3> Novagen 
A(DE3) 
BL21 <DE3> pLysS 
E. coli B F dcm ompT hsdS(rB-mB-) gal 
A(DE3) [pLysS Cml 
Novagen 
F <D80dlacZ~M15 ~(lacZYA-argF)U169 
DH5a: recA1 endA1 hsdR17(rK-, mK+) phoA supE44 Invitrogen 
thi-1 gyrA96 relA1 
F thr-1 araC14 leuB6 ~(gpt-proA62) lacY1 
DS941 
tsx-33 glnV44 galK2 hisG4 rfbC1 mgl-51 
D. J. Sherratt 
rpoS396 rpsL31(StrR) kdgK51 xylA5 mtl-1 
argE3 thi-1 recF143 lacZ~M15 lacfI 
thr-1 araC14 leuB6 ~(gpt-proA62) lacY1 tsx-
DS964 
33 glnV44 galK2 hisG4 1jbC1 mgl-51 recA13 
D. J. Sherratt 
rpoS396 rpsL31(StrR ) kdgK51 xy1A5 mt1-1 
argE3 thi-1 A + lysogen 
ara-141euB6fhuA31lacY1 tsx-78 glnV44 
GM2163 
ga1K2 galT22 mer A dcm-6, hisG4, rfbD1, 
NEB 
R(zgb21O::Tn10)Tel rpsL136 dam13::Tn9 
xy1A-5 n1f1-1 thi-1 mcrB1 hsdR2 
F mer A ~(mrr-hsdRMS-mcrBC) <D80 
TOP 10 1acZ~M15 ~lacX74 recA1 araD139 ~(ara- Invitrogen 
1eu)7697 galU galK rpsL (StrR) endA1 nupG 
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Table 2.2 Oligonucleotides 
Name Sequence Purpose 
AcuI-TA-L Top 5'-AATTCCTGAAGCTAAGAGCGCAGTATAGTCATTTCAATTAACGATGAGAGAATTTG-3' pXF153 
AcuI-TA-L Bot 5'-GATCCAAATTCTCTCATCGTTAATTGAAATGACTATACTGCGCTCTTAGCTTCAGG-3' pXF153 
AcuI-TA-R Top 5'-AGCTTCTGAAGCTAAGAGCGCAGTATAGTAGTTTCAAATAAAGCTGAGACGCTAAG-3' pXF153 
AcuI-TA-R Bot 5'-GATCCTTAGCGTCTCAGCTTTATTTGAAACTACTATACTGCGCTCTTAGCTTCAGA-3' pXF153 
• BseRI-TG Top 5'-AATTCGAGGAGGATATCTGTACATCTAGA-3' TG-ISYlOO 
BseRI-TG Bot 5'-AGCTTCTAGATGTACAGATATCCTCCTCG-3' TG-ISYlOO 
BseRI-TC Top 5'-AATTCGAGGAGGATATCTCTAGATCTAGA-3' TC-ISYlOO 
BseRI-TC Bot 5'-AGCTTCTAGATCTAGAGATATCCTCCTCG-3' TC-ISYlOO I ! 
BseRI-TT Top 5'-AATTCGAGGAGGATATCTTTAAATCTAGA-3' TT-ISYlOO I 
BseRI-TT Bot 5'-AGCTTCTAGATTTAAAGATATCCTCCTCG-3' TT-ISYlOO 
BseRI-AA Top 5'-AATTCGAGGAGGATATCAATATTTCTAGA-3' AA-ISYlOO i 
BseRI-AA Bot 5'-AGCTTCTAGAAATATTGATATCCTCCTCG-3' AA-ISYlOO 
BseRI -CA Top 5'-AATTCGAGGAGGATATCCATATGTCTAGA-3' CA-ISYlOO 
BseRI-CA Bot 5'-AGCTTCTAGACATATGGATATCCTCCTCG-3' CA-ISYlOO 
BseRI-TA Top 5'-AATTCGAGGAGGATATCTATATATCTAGA-3' TA-ISYlOO 
BseRI-TA Bot 5'-AGCTTCTAGATATATAGATATCCTCCTCG-3' TA-ISYlOO 
YIRR58 Top 
5'-ACGAATTCCTGAAGAGGAGGATCAGCTATAGTAGTTTCAAATAAAGCTGAGACGCTAA- IRR-58 3 ' 
YIRR58 Bot 5'-TTAGCGTCTCAGCTTTATTTGAAACTACTATAGCTGATCCTCCTCTTCAGGAATTCGT- IRR-58 3 ' 
YIRL58 Top 5'-ACGAATTCCTGAAGAGGAGGATCAGCTATAGTCATTTCAATTAACGATGAGAGAATTT- IRL-58 3 ' 
YIRL58 Bot 5'-AAATTCTCTCATCGTTAATTGAAATGACTATAGCTGATCCTCCTCTTCAGGAATTCGT- IRL-58 3 ' 
5'-
YIRL79 Top TAGTTTCTAAAGTAAAAATTAAGAGGTATAGTCATTTCAATTAACGATGAGAGAATTTAATGT IRL-79 
AAAATTATGGAGTGTA-3' 
5'-
YIRL79 Bot TACACTCCATAATTTTACATTAAATTCTCTCATCGTTAATTGAAATGACTATACCTCTTAATT IRL-79 
TTTACTTTAGAAACTA-3' 
5'-
YIRR79 Top CTCATCCGTATAATGCTTTCTCGTATTATAGTAGTTTCAAATAAAGCTGAGACGCTAAACGCC IRR-79 
ACAGTAAGAACGGATA-3' 
5'-
YIRR79 Bot TATCCGTTCTTACTGTGGCGTTTAGCGTCTCAGCTTTATTTGAAACTACTATAATACGAGAAA IRR-79 
GCATTATACGGATGAG-3' 
YIRL-52/51-Top 5'-ATAGTCATTTCAATTAACGATGAGAGAATTTAATGTAAAATTATGGAGTGTA-3' Integration assay 
YIRL-49/51-Top 5'-GTCATTTCAATTAACGATGAGAGAATTTAATGTAAAATTATGGAGTGTA-3' Integration assay 
YIRL-51151-Bot 5 '-TACACTCCATAATTTTACATTAAATTCTCTCATCGTTAATTGAAATGACTA-3 , Inte£fation assay 
YIRL-50/51-Bot 5'-TACACTCCATAATTTTACATTAAATTCTCTCATCGTTAATTGAAATGACT-3' Integration assay 
RI-Z1-TANN Top 5'-AATTCGCGTGGGCGTTAGATATCTAAGTAAATACGTATGTATGTATATAGAA-3' TA array (Z+l) 
RI-Z1-TANN Bot 5'-AGCTTTCTATATACATACATACGTATTTACTTAGATATCTAACGCCCACGCG-3' TA array (Z+l) 
RI-Z2-TANN Top 5'-AATTCGCGTGGGCGTCTAGATATCTAAGTAAATACGTATGTATGTATATAGAA-3' TA array (Z+2) 
RI-Z2-TANN Bot 5'-AGCTTTCTATATACATACATACGTATTTACTTAGATATCTAGACGCCCACGCG-3' TA array (Z+2) 
RI-Z3-TANN Top 5'-AATTCGCGTGGGCGTCATAGATATCTAAGTAAATACGTATGTATGTATATAGAA-3' TA array (Z+3) 
RI-Z3-TANN Bot 5'-AGCTTTCTATATACATACATACGTATTTACTTAGATATCTATGACGCCCACGCG-3' TA array (Z+3) 
RI-Z4-TANN Top 5'-AATTCGCGTGGGCGTCAGTAGATATCTAAGTAAATACGTATGTATGTATATAGAA-3' TA array (Z+4) 
RI-Z4-TANN Bot 5'-AGCTTTCTATATACATACATACGTATTTACTTAGATATCTACTGACGCCCACGCG-3' T A array (Z+4) 
RI-rZ1-TANN Top 5'-AATTCACGCCCACGCTAGATATCTAAGTAAATACGTATGTATGTATATAGAA-3' TA array (Z-l) 
RI-rZ1-TANN Bot 5'-AGCTTTCTATATACATACATACGTATTTACTTAGATATCTAGCGTGGGCGTG-3' TA array (Z-l) 
RI-rZ2-TANN Top 5'-AATTCACGCCCACGCCTAGATATCTAAGTAAATACGTATGTATGTATATAGAA-3' TA array (Z-2) 
RI-rZ2-TANN Bot 5'-AGCTTTCTATATACATACATACGTATTTACTTAGATATCTAGGCGTGGGCGTG-3' TA array (Z-2) 
RI-rZ3-TANN Top 5'-AATTCACGCCCACGCCATAGATATCTAAGTAAATACGTATGTATGTATATAGAA-3' TA array (Z-3) 
RI-rZ3-TANN Bot 5'-AGCTTTCTATATACATACATACGTATTTACTTAGATATCTATGGCGTGGGCGTG-3' TA array (Z-3) 
RI-rZ4-TANN Top 5'-AATTCACGCCCACGCCAGTAGATATCTAAGTAAATACGTATGTATGTATATAGAA-3' TA array (Z-4) 
RI-rZ4-TANN Bot 5'-AGCTTTCTATATACATACATACGTATTTACTTAGATATCTACTGGCGTGGGCGTG-3' T A array (Z-4) 
-------------------
Table 2.3 Primers 
N arne of primer Sequence Purpose 
6803 Top 5'-ggggaattcATATGTCCGGACTTCGCTATAGTTTCTAAAG-3' pXF106 
6803 Bot 5'-cccggatccATGGTCTAGATGTCCTCATCCGTATAATGC-3' pXF106 
ylOO-51 Top 5'-gggctcgaGGATCCTACACTCCATAATTTTAC-3' ISYlOO-51 
ylOO-51 Bot 5'-cccagatctGGATCCTCCGTTCTTACTGTGGC-3' ISYlOO-51 
• ylOO-30 Top 5'-gggctcgaGGATCCAAATTCTCTCATCGTTAATTG-3' ISYlOO-30 . 
ylOO-30 Bot 5'-cccagatctGGATCCTTAGCGTCTCAGCTTTATTTG-3' ISYlOO-30 
TnplOO Top 5'-ggaattccatATGGCTTACAGTTTAGA-3' Tnp I 
TnplOO Bot 5'-cccgcatgcggatccCTAAACGCCACAGTAAGAACGGAT-3' Wild-type Tnp 
TnplOO Chis 5'-cccggatccCTAGTGGTGGTGGTGGTGGTGAACGCCACAGTAAGAACGGAT-3' Tnp-His6 
EagI-BamID 5'-AAGGATCCGGTACCCTAACGGCCGTAAACGCCACAGTAAGAACGG-3' Z-transposase 
AgeI-Hi6-BamHI 5'-GAACCGGTCACCACCACCACCACCACTAGGGATCCTCTAGAG-3' Truncated Tnp 
ISYlOON37 5'-GAACCGGTTCTGTATATCGAGGCTTTTCC-3' Tnpl-37 
ISYlOON38 5'-GAACCGGTCCATCTGTATATCGAGGCTTTTCC-3' Tnpl-38 
ISYlOON46 5'-GAACCGGTTGGGCTTAAATCTACTCTATTTAACC-3' Tnpl-46 
ISYlOON77 5'-GAACCGGTGGCTCTGTCTATCAATCTTGC-3' Tnpl_77 
ISYlOON95 5'-GAACCGGTTTTCATTTTCTTTAATGCG-3' Tnpl-95 
ISYlOON57 5'-GAACCGGTGTCTAATTTCCTATGGCGACGC-3' Tnpl-57 
ISYlOON68 5'-GAACCGGTATTTTCTTCTACGTCTTTTTTTAG-3' Tnpl-68 
ISYlOONllO 5'-GAACCGGTCCGGTTTCTTTCTCGATAACG-3' Tnpl-110 
ISYlOO D136A-Top 5'-GTCAAGCTATAGTTTACATAGCAGAATCTGGATTCGAAGCAATCC-3' TnpD136A 
ISYlOOD 136A-Bot 5'-GGATTGCTTCGAATCCAGATTCTGCTATGTAAACTATAGCTTGAC-3' Tnp D136A 
ISYlOO D218A-Top 5'-GACATTCCATCAATATTAATAATGGCCAATGCTCCTATTCATCGTAAAACTG-3' Tnp D218A 
ISYlOO D218A-Bot 5'-CAGTTTTACGATGAATAGGAGCATTGGCCATTATTAATATTGATGGAATGTC-3' TnpD218A 
ISYlOO E253A-Top 5'-CTCCTGATTTAAATGATATTGCGCATGACTTTAGTGCCTTG-3' TnpE253A 
ISYlOO E253A-Bot 5'-CAAGGCACTAAAGTCATGCGCAATATCATTTAAATCAGGAG-3' TnpE253A 
ISYlOO K260A-Top 5'-GCATGACTTTAGTGCCTTGGCTCGAGCTAGAATGTACGCTC-3' TnpK260A 
ISYlOO K260A-Bot 5'-GAGCGTACATTCTAGCTCGAGCCAAGGCACTAAAGTCATGC-3' Tnp K260A 
ISYlOO R261A-Top 5'-GAGCATGACTTTAGTGCCTTGAAGGCAGCTAGAATGTACGCTCCTATTG-3' Tnp R261A 
ISYlOO R261A-Bot 5'-CAATAGGAGCGTACATTCTAGCTGCCTTCAAGGCACTAAAGTCATGCTC-3' Tnp R261A 
ISYlOO KR260AA- 5'-GATATTGAGCATGACTTTAGTGCCTTGGCTGCAGCTAGAATGTACGCTCCTATTGACAC- Tnp K260A, R261A Top 3 ' 
ISYlOO KR260AA- 5'-GTGTCAATAGGAGCGTACATTCTAGCTGCAGCCAAGGCACTAAAGTCATGCTCAATATC- Tnp K260A, R261A Bot 3 ' 
Kan-L 5'-AAGACGTTTCCCGTTGAATATGG-3' Sequencing 
Kan-R 5'-ATTGCAGTTTCATTTGATGCTCG-3' Sequencing 
polyG 5'-cccccatccatatgaagcttGGGGGGGGGGGG-3' Mapping cleavage 
site 
nest-polyG 5'-cccccatccatatgaagcttG-3' Mapping cleavage 
site 
Uni-Mlul 5'-TCAGGACGCGTCAGCGGGTGTTG-3' Mapping cleavage 
site 
Rev-CIal 5'-TGAGCATCGATTTTTGTGATGCTC-3' Mapping cleavage 
site 
Uni 103 5'-GCTATTACGCCAGCTGGCGAAAG-3' PCR and sequencing 
Uni 203 5'-AAATACCGCACAGATGCGTAAGG-3' PCR and sequencing 
Rev 108 5'-CATTAGGCACCCCAGGCTTTACAC-3' PCR and sequencing 
Rev 308 5'-CCTTTGAGTGAGCTGATACCGCTC-3' PCR and sequencing 
pCB 104-sphCTop 5'-ctgttccgctgggcGtgccaggacaacttc-3' Remove one Sphl site 
on pCB 104 
pCB 104-sphCBot 5'-gaagttgtcctggcaCgcccagcggaacag-3' Remove one Sphl site 
on pCB 104 
Table 2.4 Plasmid list 
Plasmid Description ( antibiotic resistance) Source/ 
Reference 
pUC18 general purpose, pBR322 derived vector (Amp) Yanisch-Perron 
etaZ., 1985 
pUC19 general purpose, pBR322 derived vector (Amp) Y anisch-Perron 
etaZ., 1985 
pUC4K Kanamycin resistance cassette, pBR322 derived vector Vieira and 
(Amp, Kan) Messing, 1982 
pCB104 ~-dv derived vector with pUC18 polylinker (Cm) Boyd and 
Sherratt, 1995 
pH2 pIC20 containing a 2.6 kb TA-rich sequence from Aleksenko and 
Aspergillus niduZans (Amp) Clutterbuck, 
1996 
pTrc99a IExpression plasmid, carries a strong hybrid trp/lac Amann et aZ., 
IPromoter (AmJD 1988 
pKET3a IPET3a derived expression vector (Kan) Studier et aZ., 
1990; 
S.J.Rowland 
unpublished 
pXF80 IPCB104 derived, one SphI site was eliminated (Cm) Chapter III 
pXF106 IPUC18 containing ISYlOOa (Amp) Chapter III 
pXF101 IExpression vector pKET3a + ISYlOO transposase Chapter IV 
gene (Kan) 
pXF102 iExpression vector pKET3a + C-tenninal His6-tagged Chapter IV 
~SY100 transposase gene (Kan) 
pXF104 Expression vector pTrc99a + ISYlOO transposase gene Chapter III & 
(Amp) ChaJ2ter IV 
pXF105 IExpression vector pTrc99a + C-terminal His6-tagged Chapter III & 
~SYlOO transposase gene (Amp) Chapter IV 
pXF109 pUC18 + ISYlOO-51-Kan (Amp) Chapter III & 
Chapter IV 
pXF113 pXF75 + ISYlOO-51-Kan. (Kan, Cm) Chapter III 
pXF114 pXF75 + ISYlOO-30-Kan. (Kan, Cm) Chapter III 
pXF115 iPXF113 + inducible wild-type transposase gene Chapter III 
(Kan, Cm) 
pXF116 IPXF114 + inducible wild-type transposase gene Chapter III 
(Kan, Cm) 
pXF117 iPXF113 + inducible Tnp-His6 transposase gene Chapter III 
(Kan, Cm) 
pXF118 IPXF114 + inducible Tnp-His6 transposase gene Chapter III 
(Kan, Cm) 
pXF119 pUC18 + 51 bp ISYlOO IRL (Amp) Chapter III & 
Chapter IV 
pXF120 pUC18 + 30 bp ISYlOO IRL (Amp) Chapter III 
pXF121 pUC18 + 49 bp ISYlOO IRR (Amp) Chapter III & 
Chapter IV 
pXF122 pUC18 + 30 bp ISYlOO IRR (Amp) Chapter III 
pAN2 esolvase-Zif268 fusion plasmid Akopian et al. , 
2003 
pAN14 resolvase-(GSG)3-Zif268 fusion plasmid Akopian et al. , 
2003 
pAN15 esolvase-(GSG)4-Zif268 fusion plasmid Akopian et al., 
2003 
pXF123 pUC18 + wild-type transposase gene with Kpnl-Eagl- Chapter V 
BamHI polylinker upstream of the stop codon. (Amp) 
pXF124 pXF123 + Kpnl-Eagl fragment from pANI5, Tnp- Chapter V 
(GSG)4-Zif268 DBD (Amp) 
pXF125 pXF123 + Kpnl-Eagl fragment from pANI4, Tnp- Chapter V 
(GSG)3-Zif268 DBD (Amp) 
pXF127 pXF123 + Kpnl-Eagl fragment from pAN2, Tnp-Tn3 Chapter V 
DBD-Zif268 DBD (Amp) 
pXFI28-132 pTrc99a + His6-tagged Tnpl-37, Tnpl-38, Tnpl-46, Tnpl-7 Chapter IV 
and Tnpl-95 (Amp) 
pXF163, pTrc99a + transposase deri vati yes from pXF123- Chapter V 
pXF133-134, pXF125 and pXF127. (Amp) 
pXF136 
pXF141-145 pKET3a + His6-tagged Tnpl-37, Tnpl-38, Tnpl-46, Tnpl-77 Chapter IV 
and Tnpl-95 (Kan) 
pXF147 pUC18 + 30 bp ISYlOO IRL (Amp) Chapter III 
pXF149 pUC18 + 30 bp ISYlOO IRR (Amp) Chapter III 
pXF153 pUC18 + ISYlOO-30-Kan (Amp, Kan) Chapter III 
pXF164- pXF114 + Tnp-Zif268 expression cassettes from Chapter V 
166,168 pXF163, pXF133,pXF134 and pXF136 (Kan, Cm) 
pXFI69-174 Expression vector pTrc99a + transposase mutants Chapter III 
D136A, D218A, E253A, K260A, R261A or KR260AA 
(Amp) 
pXF195 pUC19 + ISYlOO-30-Kan (Amp) Chapter III 
pXF198 pUC-based plasmid + mini-ISYlOO with 30 bp IRR at Chapter III 
both ends (Amp) 
pXF199 pUC-based plasmid + mini-ISYlOO with 30 bp IRL at Chapter III 
both ends (Amp) 
pXF200-207 pUC18 + Z+1 to Z+4 and Z-1 to Z-4 target (TANN)9 Chapter V 
array sequences (Amp) 
pXF208-213 pUC18 + HindlII -B seRI -EcoRI polylinkers with Chapter III 
different dinucleotides flanking BseRI cut sites. (Amp) 
pXF214-219 pXF208-pXF213 + ISYlOO-30-Kan (Amp,Kan) Chapter III, IV 
pXF220 pUC18 + mini-ISYlOO with 30 bp IRR at both ends Chapter III, IV 
(Kan, Amp) 
pXF226 pUC18 + mini-ISYlOO with 30 bp IRL at both ends Chapter III, IV 
(Kan, Amp) 
pZ+ 1 to pZ+4, IPH2 + Z+ 1 to Z+4 and Z-l to Z-4 target sequences. Chapter V 
pZ-1 to pZ-4 (Amp) 
pXF240-242 IPTrc99a-based expression plasmids for His6-tagged Chapter III 
!fnpl-57, Tnpl-68 and Tnpl-110 (Amp) 
pXF243-245 pKET3a-based expression plasmids for His6-tagged Chapter IV 
!fnpl-57, Tnpl-68 and Tnpl-110 (Kan) 
pXF246-251 IPXF114 + inducible mutated transposase gene for Chapter III 
iD136A, D218A, E253A, K260A, R261A and 
~260AA (Kan, Cm) 
pXF252-257 pXFl16-like plasmids. Contain ISYlOO-30-Kan Chapter III 
iflanked by dinucleotides TA, TO, TC, TT, AA and CA 
at both ends. (Kan, Cm) 
pXF258 pXF116-like plasmid. mini-ISYlOO has 30 bp IRR a Chapter III 
both ends (Kan, Cm) 
pXF259 pXF116-like plasmid. mini-ISYlOO has 30 bp IRL a Chapter III 
Iboth ends (Kan, Cm) 
pXF262-264 IPUC18 + mini-ISYlOO with 30 bp IRR at both ends. Chapter III, IV 
IIRRs at right end are flanked by T A and left IRRs are 
iflanked by TT, AA and CA. (Amp) 
pXF265 pXF116-like plasmid. TO at IRL, TA at IRR of the Chapter III 
~SYlOO-30-Kan. (Kan, Cm) 
pXF266 pXF116-like plasmid. TC at IRL, TA at IRR 0 Chapter III 
~SYlOO-30-Kan. (Kan, Cm) 
pXF267-269 pXF116-like plasmids. Mini-ISYlOO has two 30 bp Chapter III 
IIRR at both ends. IRRs at right end are flanked by TA 
and left IRRs are flanked by dinucleotides TT, AA and 
CA. (Kan, Cm) 
2.2 Oligonucleotides 
Oligonucleotides used for constmction of plasmids and in vitro transposition assays are 
listed in Table 2.2. They were synthesized by MWG Biotech. 
2.3 Primers 
Non-commercial primers used for sequencing and primers for PCR or PCR-based site-
directed mutagenesis are listed in Table 2.3. They were synthesized by MWG Biotech. 
Commercial primers for sequencing were supplied by MWG Biotech. 
2.4 Plasmids 
The main plasmids used are listed in Table 2.4. 
2.5 Chemicals and buffer solutions 
2.5.1 Chemicals 
Sources of general chemicals are listed below. 
Chemical Source 
General chemicals, Biochemicals, 
Organic solvents 
Media 
Agarose 
37:1 or 19:1 acrylamide: 
bisacrylamide solutions 
Radiochemicals 
2.5.2 Buffer solutions 
Sigma-Aldrich, Bio-Rad, VWR, New 
England Biolabs, Promega and Invitrogen 
Difco,Oxoid 
BRLlInvitrogen, Cambrex Bio Science 
Rocldand 
VWR Acrylogel, Sigma 
Amersham Pharmacia Biotech 
All solutions were made using deionised or double distilled water. All solutions for protein 
purification were made using double distilled water. Standard solutions are listed below 
and will be shown as their abbreviations in the following text. All percentages represent 
w/v measurements unless otherwise stated. 
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Acrylamide gel elution 
0.5 M ammonium acetate, 1 mM EDTA (pH 8.0) 
buffer 
Agarose gel loading dye 
30% glycerol, 3 mM Tris, 0.3 mM EDT A, 0.5% SDS 
and 0.25% bromophenol blue. Proteinase K was added 
(5x) 
to 0.2 mg/ml if necessary. 
Alkaline agarose gel loading 300 mM NaOH, 6 mM EDTA, 18% Ficoll (Type 400, 
buffer (6x) Ph armaci a) , 0.15% bromocresol green, 0.25% xylene 
cyanol 
Alkaline gel electrophoresis 
500mMNaOH,lOmMEDTA 
buffer (lOx) 
Ammonium persulphate 10% ammonium persulphate in water made fresh 
(APS) before each use. 
Buffer A for purification of 50 mM Tris, 14.3 mM (3-mercaptoethanol, 1 M NaCI, 
ISY100 transposase 0.2% triton X-lOO 
Commercial enzyme buffers As supplied with enzymes 
DolyI 
50 mM glucose, 25 mM Tlis-HCI (pH 8.0), 10 mM 
EDTA 
Doly II 0.2 M NaOH, 1 % SDS 
Doly III 3 M potassium acetate, 2 M acetic acid 
Formamide loading buffer 
20 mM EDTA (30 mM EDTA for footprinting assays), 
0.1 % Xylene cyanol, 0.1 % bromophenol blue in 99% 
(2x) 
deionised formamide 
L-Broth (Luria broth) 
1 % Bacto tryptone, 0.5% Bacto yeast extract, 0.5% 
NaCI, adjust to pH 7.5 with NaOH. 
Neutralizing solution for 
1 M Tris-HCI (pH 7.6), 1.5 M NaCI 
alkaline agarose gels 
Single colony gel loading 2.5% Ficoll, 1.25% SDS, 0.1 % Bromophenol Blue, Ix 
buffer TAE 
SDS-PAGE loading buffer 
62.5 mM Tris-HCI (pH 6.8), 25% glycerol, 2% SDS 
(w/v) , 0.1% Bromophenol blue (w/v) and 0.5% (3-
(2x) 
mercaptoethanol 
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SDS-PAGE running buffer 
(lOx) 0.25 M Tris, 1.92 M Glycine and 0.1 % SDS 
50% methanol, 10% acetic acid, 0.1 % Coomassie 
SDS-PAGE staining buffer 
brilliant blue 
SDS-PAGE destaining 
buffer 
10% methanol, 10% acetic acid 
2% Bacto tryptone, 0.5% Bacto yeast extract, 10 mM 
SOC NaCl, 2.5 mM KCl, 10 mM MgCh, 10 mM MgS04, 
20 mM glucose. 
TAE (50x) 
2 M Tris base, 1 M acetic acid, 0.05 M EDTA (pH 8.0) 
and 1 M sodium acetate 
TBE (5x) 0.445 M Tris base, 0.445 M boric acid, 10 mM EDTA 
TIE (lOx) 0.89 M Tris base, 5 mM EDTA, 0.29 M taurine. 
TE 10 mM Tris-HCl (pH 8.0), 1 mM EDTA (pH 8.0) 
1110 TE 1 mM Tris-HCl (pH 8.0),0.1 mM EDTA (pH 8.0) 
Tris-tricine gel buffer (3x) 3.0 M Tris-HCI (pH 8.45), 0.3% SDS 
Tricine gel cathode buffer 
0.5 M Tris base, 0.5 M Tricine, 0.5% SDS (5x) 
Tricine gel anode buffer 
(5x) 
1.0 M Tris-HCl (pH 8.9) 
Tris-tricine gel loading 100 mM Tris-HCl (pH6.8), 4% SDS, 10% glycerol, 
buffer (2x) 5% B-mercaptoethanol 
2.6 Kits 
QIAprep Spin Miniprep Kit, QIAquick Gel Extraction Kit, MinElute Gel Extraction Kit 
and QIAquick PCR Purification Kit were obtained from Qiagen. The TOPO TA cloning kit 
was supplied by Invitrogen. 
2.7 Bacterial growth media 
E. coli strains were routinely grown in liquid L-Broth or on solid L-Broth agar (L-Broth 
with 15 gIL agar). Media for bacterial growth were sterilised at 121°C, 15 pounds/inch2 for 
15 minutes. 
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2.8 Bacterial growth conditions 
Bacteria in L-Broth normally grew with shaking at 37°C. For expression of transposase, 
cells were grown with shaldng at 30°C. Bacteria on LB Agar plates were incubated at 37°C 
overnight. For long term storage of bacterial strains, 1 ml of overnight culture was added to 
0.7 ml of 40% glycerol, 2% peptone solution and kept at -70°C. 
2.9 Competent E. coli cells 
2.9.1 Commercial chemical competent cells 
Commercial chemical competent cells were obtained from Invitrogen Ltd. Commercial 
competent cells were transformed following protocols provided by the manufacturer. 
2.9.2 CaCl2 competent cells 
A single colony of E. coli was inoculated into 20 ml L-Broth with appropriate antibiotics 
and incubated at 37°C with shaldng overnight. 200 J.tl of this overnight culture was used to 
inoculate 20 ml fresh L-Broth containing appropriate antibiotics. This was incubated in a 
shaldng incubator at 37°C and 200 rpm for 90 minutes. The cells were harvested by 
centrifugation at 6,400 g for 1 minute, the supernatant was discarded and the cell pellet 
was resuspended with 10 ml precooled 50 mM CaCb. This was incubated on ice for 1 hour 
and the cells were again centrifuged at 6,400 g for 1 minute, and resuspended in 1 ml 
precooled 50 mM CaCh This yielded 1 ml competent cells, which were stored on ice until 
use for transformation as described in section 2.10.1. 
2.9.3 Electrocompetent cells 
Electrocompetent cells for the electroporation were prepared according to the protocol 
provided by Bio-Rad Laboratories Ltd. (Hertfordshire, UK). Bliefly, 500 ml of cells grown 
shaldng at 37°C to an OD600 at 0.5-0.7 was kept on ice for about 20 minutes and then was 
centrifuged at 4,000 g for 15 minutes at 4°C. The cell pellet was washed at least three 
times with cold sterile 10% glycerol. Cells were resuspended in a final volume of 1-2 ml of 
ice-cold sterile 10% glycerol to give 1-3 x 1010 cells per ml and were transformed as 
described in section 2.10.2. 
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2.10 Transformation 
2.10.1 Transformation of CaClz competent cells 
Plasmid DNA or ligation product was transformed into 50-100 III of CaCh chemically 
competent cells. The DNA sample and competent cells were mixed gently in an eppendorf 
tube and the mixture was incubated on ice for 30 minutes. The cells were heat-shocked at 
42°C for 90 seconds, and then were incubated on ice for a further 5 minutes. 200 III of L-
Broth was added and the cells were incubated at 37°C for 1 hour to allow expression of the 
antibiotic resistance genes carried on the plasmid. Aliquots of the culture were spread onto 
selective L-Broth agar plates. 
2.10.2 Electroporation 
DNA samples were treated as follows before use in electroporation: For plasmid DNA 
purified using the QIAprep Spin Miniprep Kit, 1/10 TE instead of buffer EB was used to 
elute DNA from the spin column in the last step. Ligation or in vitro transposition reaction 
products were precipitated with ethanol after the addition of 1 Ilg of yeast tRNA. The DNA 
pellet was then resuspended in 10 III of 1/10 TE. 1-2 III of this DNA was added to 40 III of 
electrocompetent cells in a 0.2 cm cuvette (Bio-Rad) and left on ice for 5 minutes. The 
cells were then pulsed at 2.5 kV using a Gene Pulser (Bio-Rad) set on E2 following the 
manufacturer's instructions. 1 ml of SOC was added to the cuvette immediately and mixed 
gently. The culture was then transferred into a 15 ml centrifuge tube and was incubated in 
a shaking incubator (200 rpm) at 37°C for 1 hour. Aliquots of the culture were spread onto 
selective L-Broth agar plates. 
2.11 Antibiotics 
Antibiotics used were supplied by Sigma and are listed below. 
Antibiotic (abbreviation) 
Ampicillin (Amp) 
Kanamycin (Kan) 
Chloramphenicol (Cm) 
Stock solution 
100 mg/ml in H20 
25 mg/ml in H20 
25 mg/ml in ethanol 
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Working concentration 
lOOl1g/ml 
25 I1g/ml 
25l1g/ml 
2.12 Preparation of DNA 
2.12.1 Large-scale preparation of plasmid DNA 
Plasmid DNA was prepared following a modified version of the method of Birnboim and 
Doly (1979).200 ml of overnight culture was centrifuged at 4,000 g (5 minutes at 4°C) and 
the cell pellet was resuspended in 4 ml of Doly I buffer on ice. 8 ml of freshly made Doly 
II buffer was added and mixed in by inverting the tube gently. The tube was held on ice for 
4 minutes to allow full lysis. The mixture was neutralised by the addition of 6 ml of cold 
Doly III, and then mixed gently. The samples were centrifuged at 39,200 g, 4°C for 30 
minutes. The supernatant was transferred into new tubes and plasmid DNA was 
precipitated by adding 12 ml of isopropanol at room temperature for 15 minutes. The 
precipitated DNA was recovered by centrifugation at 39,200 g, 20°C for 30 minutes. The 
DNA pellets were washed with 2 ml of 70% of ethanol to remove the remaining salts and 
then were resuspended in 2 ml of TE buffer and incubated for 1 hour at 37°C. The 
insoluble debris was removed by centrifugation (17,400 g, 5 minutes, 4°C) and the soluble 
plasmid DNA solution was ready for CsCI equilibrium density gradient centrifugation. 
Ethidium bromide CsCl equilibrium density gradient centrifugation 
DNA in TE (2 ml) was transferred into a Beckman quick-seal ultra-centrifuge tube (16 x 
76 mm). 4.324 ml of CsCI solution (5 g CsCI plus 3 ml H 20) and 0.27 ml of an ethidium 
bromide solution (10 mg/ml) were then added. The tubes were filled with liquid paraffin 
and then sealed. The CsCI density gradient was achieved by centrifugation in a Beckman 
Ti70 fixed angle rotor at 45,000 rpm for 16 hours at 18°C (with no brake). The supercoiled 
plasmid DNA was visualised on a long-wave UV source (365 nm) and was recovered by 
piercing the tube immediately below the desired band with a 21 G hypodermic needle 
attached to a 1 ml syringe. About 0.5 ml of sample was recovered and the ethidium 
bromide was removed by extraction with water-saturated n-butanol. CsCI was removed 
from samples by dialysis against 400 volumes of TE three times at 4°C. The DNA samples 
were stored at -20°C. 
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2.12.2 Small-scale preparation of plasmid DNA 
Plasmid DNA was purified from 3 ml of culture using the QIAprep Spin Miniprep Kit 
(Qiagen) following the manufacturer's instruction. The purified plasmid DNA was 
normally eluted from the column with 50 III of the supplied EB buffer or 30 III of 1110 TE 
for use in electroporation. 
2.13 Restriction enzyme digestion of DNA 
Restliction enzyme digestions were camed out according to the suppliers' instructions. 
Partial digestions were accomplished by reducing the enzyme concentration andlor 
reducing the reaction time. 
2.14 Electrophoresis 
2.14.1 Agarose gel electrophoresis 
Native agarose gels (1.0% or 1.2%) were prepared by mixing appropriate amounts of 
agarose and T AE buffer and dissolving by heating in a microwave oven. The solution was 
allowed to cool to ~ 60°C and poured into a gel former with an appropriate comb. After the 
gel was set, the comb was removed and the gel was run at 40 V for 16 hours or 100 V for 4 
hours in a gel tank containing Ix TAE buffer just covering the gel sUlface. The gel was 
stained and then visualized as described in section 2.15.1. 
Alkaline agarose gel electrophoresis was performed to separate single stranded DNA. 
To make up an alkaline 1.33% (w/v) agarose gel, agarose was dissolved in H20 in a 
microwave oven. After cooling, 1/9th volume of lOx alkaline agarose gel electrophoresis 
buffer was mixed in and the gel was poured immediately. After the gel was set, it was 
transferred to a gel tank containing freshly made Ix alkaline electrophoresis buffer just 
covering the gel. The gel was run at <3.5 V/cm. After the bromocresol green had migrated 
approximately 0.5-1 cm into the gel, the power was turned off and a glass plate was placed 
on top of the gel. Electrophoresis was then continued until the bromocresol green had 
migrated approximately 2/3 of the length of the gel. The gel was soaked in neutralizing 
buffer for 45 minutes at room temperature before staining with ethidium bromide and 
visualisation as described in section 2.15.1. 
24 
2.14.2 Non-denaturing polyacrylamide gel electrophoresis 
Transposase electrophoretic mobility shift assays (EMS A) were performed using non-
denaturing polyacrylamide gel electrophoresis. A 30 ml solution containing 6% 
acrylamide: bis-acrylamide in a 37: 1 ratio and 1I3x TBE was prepared. Polymerisation was 
initiated by the addition of 18 III TEMED and 360 III 10% ammonium persulphate (APS). 
The comb was removed and the gel was assembled in a vertical gel tank with 1/3x TBE in 
top and bottom reservoirs. The gel was pre-run for 45 min at 200 V and 4°C. After loading 
the samples, the gel was run at a constant voltage (200 V) for 2-4 hours at 4°C. Non-
denaturing polyacrylamide gel electrophoresis in Ix TBE was also used to separate DNA 
fragments, running at 200 V for 2 hours at room temperature. 
2.14.3 Denaturing polyacrylamide gel electrophoresis 
DNase I footprinting and mapping the cleavage sites on the transposon ends were carried 
out on denaturing polyacrylamide gels using the BRL Sequencing System, Model S2. 80 
ml of gel mixture containing 8% acrylamide: bisacrylamide (19:1), 7.5 M urea in Ix TIE 
was prepared. Polymerisation was initiated by the addition of 800 III of 10% APS and 21.6 
III of TEMED. The gel was poured using 0.1 mm spacers, allowed to polymerise at room 
temperature, and was then set up according to the manufacturer's instructions. The gel was 
pre-run at 80 W for 45 minutes with Ix TIE buffer. An equal volume of formamide 
loading buffer (2x) was added to the samples and they were heated at 80°C for 5 minutes 
prior to loading. The gel was run for 1.5-3 hours at 80 W. The gel was dried under vacuum 
and autoradiography was calTied out as described in Section 2.32. 
Purification of synthetic oligonucleotides was carried out on denaturing 
polyacrylamide gels using CBS Scientific Co. Adjustable Slab gel kits (model # ASG-
250).40 ml of gel mixture was made containing 10% acrylamide: bisacrylamide (19:1), 7.5 
M urea and Ix TBE. Polymerisation was initiated by the addition of 400 III of 10% fresh 
APS and 12.5 III of TEMED. The gel kit was set up according to the manufacturer's 
instructions. The gel was pre-run at 400 V. An equal volume of formamide loading buffer 
(2x) was added to the samples and they were heated to 70°C, 5 min prior to loading. The 
gel was run at 400 V for 2 hours. The desired oligonucleotides were recovered from the gel 
as described in section 2.26. 
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2.14.4 Discontinuous SDS·polyacrylamide gel electrophoresis (SDS·PAGE) 
A discontinuous SDS-PAGE system (Laemmli, 1970) was used to analyse protein samples. 
Gels were prepared in two steps. First, 30 ml of resolving gel containing 10% acrylamide: 
bisacrylamide (37:1), 0.375 M Tris-HCl (pH 8.8) and 0.1% SDS was prepared. 
Polymerisation was initiated by addition of 160 III 10% APS and 16 III of TEMED. The 
gel was poured and overlaid with 1 ml of isopropanol and allowed to polymerise for 45 
minutes at room temperature. After polymerisation, 9 ml of stacking gel containing 4% 
acrylamide: bisacrylamide (37:1), 0.125 M Tris-HCl (pH 6.8), 0.1 % SDS was prepared. 
Polymerisation was initiated by addition of 60 III of freshly made 10% APS and 6 III of 
TEMED. The stacking gel was poured on top of the resolving gel after removing the 
isopropanol overlay, and the comb was added immediately. After polymerisation, the comb 
was removed and the wells were rinsed with Ix SDS - PAGE running buffer. 
An equal volume of 2x SDS-PAGE loading buffer was added to the protein samples 
and they were boiled for 2 minutes before loading. The gel was run at 120-150 V and 
stained as described in section 2.15.2. 
2.14.5 Tricine SDS·PAGE 
Cell extracts containing N-terminal transposase derivatives were analysed using a 
discontinuous tricine SDS-PAGE (Schagger and von Jagow, 1987).30 ml of separating gel 
mixture containing 16.5% acrylamide: bisacrylamide (19: 1), 10.7% glycerol in Ix Tricine 
gel buffer and 9 ml of stacking gel mixture containing 4% acrylamide: bisacrylamide 
(37: 1) in Ix Tricine gel buffer were prepared. Polymerisation was initiated by addition of 
150 III 10% APS and 15 III TEMED to the separating gel mix and 50 III 10% APS and 10 
III TEMED to the stacking gel mix. The separation gel was poured first, the stacking gel 
was poured immediately onto the top of the separating gel, and the comb was then inserted. 
After polymerisation, the comb was removed and the tricine gel was set up with Ix 
cathode buffer in the top tank and Ix anode buffer in the bottom tank. Protein samples 
were mixed with an equal volume of 2x Tricine gel sample buffer and were boiled for 2 
minutes before loading on the gel. The gel was run at 30 rnA for 16 hours and stained as 
described in section 2.15.2. 
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2.15 Visualising DNA and protein 
2.15.1 Visualising DNA 
After electrophoresis, agarose or polyacrylamide gels were stained with an ethidium 
bromide solution (0.5 /-tg/ml) for 30-60 minutes, and then were destained with deionised 
water for 60 minutes. DNA bands on the gels were visualised on a 254 nm UV short 
wavelength transilluminator, or on a 365 nm UV long wavelength transilluminator for 
preparative work. Gels were photographed as described in 2.32. 
2.15.2 Visualising Proteins 
Proteins on Laemmli gels were visualised by incubating gels in the SDS-PAGE staining 
buffer for 60 minutes with shaking. Gels were then destained in several changes of SDS-
PAGE destaining buffer. 
2.16. Ligation of DNA fragments 
Ligation of insert DNA fragment into linear vector DNA was performed with a molar ratio 
of 10: 1 insert to vector. Ligation of double stranded oligonucleotides into vector was 
performed with a molar ratio of 3: 1 insert to vector. A standard DNA ligation was carried 
out in Ix ligation buffer (NEB) with 33 units of T4 DNA ligase (NEB) in a volume of 10 
/-tl. The mixture was incubated at room temperature for 2-16 hours and then used to 
transform competent cells as described in section 2.10. 
2.17 Over-expression of ISYI00 transposase and its derivatives 
To express ISY100 transposase and its derivatives in E. coli, 4 ml of overnight culture of 
the expression strain BL21 (DE3) pLysS [or BL21 (DE3)] carrying the appropriate 
transposase expression plasmid was inoculated into pre-warmed (37°C or 30°C) L-broth 
(400 ml) supplemented with kanamycin (50 /-tg/ml) and chloramphenicol (25 /-tg/ml) [using 
kanamycin only for the strain BL21 (DE3)] in a 2 L flask. The cells were grown with 
vigorous shaking (200 rpm) at 37°C (or 30°C) to an OD6oo of 0.4-0.6. Transposase 
expression was induced by the addition of 0.5 mM IPTG and the cells were grown for a 
further 2 hours. Cells were harvested by centrifugation at 4,000 g for 5 minutes at 4°C in a 
precooled JA14 rotor. The supernatant was discarded and the cell pellet was resuspended 
on ice in 100 ml ofTME buffer (20 mM Tris-HCI pH 7.5,10 mM MgCh, 0.1 mM EDTA). 
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The cells were pelleted (4,000 g, 5 minutes, 4°C) and the supernatant was removed. Cell 
pellets were stored at -70°C. 
2.18 Purification of ISY100 transposase and its derivatives 
All the purification steps were carried out at 4°C or on ice unless otherwise indicated. One 
gram of frozen induced cells (from section 2.17) was resuspended in 10 ml TBP buffer (50 
mM Tris-HCI pH 7.5, 14.3 mM ~-mercaptoethanol, 1 mM PMSF). Cells were sonicated 
three times for 15 seconds using a Vibra-cell VClOO sonicator at 30% amplitude with a 
button probe 2. The cells were allowed to coolon ice between the bursts. An equal volume 
of TB buffer (50 mM Tris-HCI pH 7.5, 14.3 mM ~-mercaptoethanol) was added and the 
solution was made up to 10 mM MgCh and gently vortexed. After 5 minutes on ice, the 
mixture was centrifuged at 28,300 g for 15 minutes and the supernatant was transferred to 
a new tube. Over a pe110d of more than 5 minutes, 200 mM spermine was added drop by 
drop to a final concentration of 2.5 mM with stining. Stining was continued for a further 
10 minutes and the mixture was then centrifuged at 16,000 g for 5 minutes. The pellet was 
resuspended in 10 ml TB buffer, and an equal volume of TB + 2 M NaCI + 0.4% triton X-
100 was added drop by drop with gentle vortexing. The mixture was kept on ice for 1 hour 
and was centrifuged at 16,000 g for 15 minutes. The supernatant, containing soluble 
transposase, was applied onto a Ni-NTA (Qiagen) column, pre-charged with NiS04 
according to the manufacturer's instructions, for further purification. 
All steps of column chromatography were monitored by UV absorbance at 260 nm 
and 280 nm. After loading the sample, the column was first washed with 10 column 
volumes of Buffer A (50 mM Tris-HCl pH 7.5, 14.3 mM ~-mercaptoethanol, 1 M NaCl, 
0.2% triton X-lOO), and then a further 3 volume columns of Buffer A plus 20 mM 
imidazole, and 3 volumes of Buffer A plus 50 mM imidazole. The purified transposase was 
eluted from the column with Buffer A plus 200 mM imidazole. Fractions conesponding to 
absorbance peaks were analysed on a Laemmli gel to check the purity and estimate protein 
concentrations. The purified transposase fractions were dialysed against dialysis buffer (50 
mM Tris-HCl pH 7.5,1 M NaCl, 0.1 % triton X-lOO and 0.1 mM DTT) at 4°C overnight to 
remove imidazole. The sample was then centrifuged in an Eppendorf microcentrifuge at 
14,000 rpm for 5 minutes at 4°C. The supernatant, containing purified transposase, was 
transfened to new tubes, made up to 50% glycerol and kept at -20°C or -70°C for further 
use. 
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His6-tagged transposase was also purified under denaturing conditions. One gram of 
frozen cells (see section 2.17) was resuspended in 10 ml denaturing buffer (50 mM Tris, 
0.5 M NaCI, 6 M urea and 1 mM PMSF) and was then sonicated as described above. The 
sonicate was centrifuged at 28,300 g for 15 minutes and the supernatant was loaded onto a 
pre-charged Ni-NTA column. The column was washed by 10 column volumes of 
denaturing buffer B (50 mM Tris, 0.5 M NaCl and 6 M urea) and then by denaturing buffer 
B plus 50 mM imidazole to remove contaminating proteins. The purified transposase was 
eluted from the column with denaturing buffer B plus 200 mM imidazole. The fractions 
cOlTesponding to absorbance peaks were analysed on a Laemmli gel. The purified 
transposase fractions were dialysed against dialysis buffer (50 mM Tris-HCI pH 7.5, 1 M 
NaCl, 20% glycerol, 0.1 mM EDTA and 0.1 mM DTT) at 4°C overnight to remove urea 
and imidazole. The sample was centrifuged in an Eppendorf microcentrifuge at 14,000 rpm 
for 5 minutes at 4°C. The supernatant, which contained purified transposase, was 
transfelTed to new tubes and an equal volume of 80% glycerol was added. Purified 
transposase was kept at -20°C or -70°C for further use. 
2.19 In vivo transposition assay 
A suicide-vector in vivo transposition assay was established and used to detect 
transposition in vivo. A pBR322-derived target plasmid (Ampf) and a pCB 104-based donor 
A-dv plasmid which calTies a transposase gene and a kanamycin resistance marked mini-
ISY100 were introduced into arecA E. coli strain DH5a in succession by transformation. 
A transformant (or a portion of a mixture of several transformants equal to one 
transformant) was grown at 37°C with shaldng (200 rpm) for 18 hours in 5 ml L-Broth 
containing, ampicillin, kanamycin and chloramphenicol. 5 III of the culture was then 
inoculated into 5 ml L-Broth containing ampicillin, kanamycin and chloramphenicol and 
was then incubated at 37°C with shaldng for another 18 hours. Plasmid DNA was pmified 
from 3 ml culture using the Qiagen QIAprep Spin Miniprep Kit as desctibed in section 
2.12.2 and eluted in 30 III 1110 TE. 100 ng of this DNA was electroporated into 40 III of A-
lysogen E. coli strain DS964 by electroporation as described in section 2.10.2. After 
electroporation, the transformants were suspended in 1 ml SOC and incubated at 37°C with 
shaldng (200 rpm) for 1 hour. 100 ~l of a 10-3 dilution was spread on an L-Broth agar plate 
containing ampicillin and the rest was plated on an L-Broth agar plate containing 
kanamycin, followed by incubation at 37°C overnight. The total number of the Ampf 
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colonies and Kanf colonies in the electroporation reaction were then calculated. The total 
number of the Kanf Cms colonies was then calculated from the chloramphenicol resistance 
of 20 randomly picked Kanf single colonies. The transposition frequency was calculated by 
dividing the total number of Kanf Cms transformants by the total number of Ampf 
transformants. 
2.20. In vitro transposition assay 
2.20.1 In vitro transposition assay using supercoiled donor and target plasmids 
A standard in vitro transposition assay was carried out by incubating 0.12 pmol supercoiled 
donor plasmid or 0.37 pmol of purified pre-cut mini-ISY100, together with target plasmid 
and purified transposase in 20 III of transposase assay buffer (10 mM MgCh, 1 mM DTT, 
0.1 mg/ml BSA, 50 mM Tris-HCI pH 7.5, and 50 mM NaCl) at 30°C for 3-4 hours. The 
reaction was stopped by heating the samples at 75°C for 10 minutes. The samples were 
analysed by agarose gel electrophoresis or electroporated into DS964 as described in 
section 2.10.2. The transposition frequency was obtained by dividing the total number of 
the Kanf colonies by the total number of Ampf colonies. 
2.20.2 Cleavage assay 
DNA fragments carrying mini-ISY100 or a single end of ISYlOO was incubated with 1 III 
of purified transposase in 20 III of transposase assay buffer (10 mM MgCh, 1 mM DTT, 
0.1 mg/ml BSA, 50 mM Tris-HCI pH 7.5, and 50 mM NaCI) at 30°C for 3-4 hours. There 
is 50 mM NaCI in the reaction from the purified transposase. DMSO was included at a 
final concentration of 2% when double stranded oligonucleotides were used as substrate. 
The reaction was stopped by heating at 75°C for 10 minutes. 
2.20.3 Integration assay 
DNA fragment carrying transposon end(s) pre-cut at appropriate positions were incubated 
with target plasmid DNA together with purified transposase in 20 III of transposase assay 
buffer (10 mM MgCh, 1 mM DTT, 0.1 mg/ml BSA, 50 mM Tris-HCI pH 7.5 and 50 mM 
NaCI) at 30°C for 3-4 hours. The reaction was stopped by heating at 75°C for 10 minutes 
and was analysed by electrophoresis. 
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2.21 Electrophoretic mobility shift assay (EMSA) 
An appropriate amount of end-labelled DNA (~20-50 cps) was mixed with 1 p,g of poly 
drdC in 10 III of the binding buffer (10 mM Tris-HCl pH 7.5, 0.1 mg/ml BSA, 0.1 mM 
EDTA, 10% glycerol and 1 mMDTI). Transposase dilutions were added (1110 volume) to 
the mixture. The samples were mixed and then were incubated at 30°C for 10 minutes. 
Samples were separated by non-denaturing gel electrophoresis on 6% polyacrylamide gels 
in 1I3x TBE as described in section 2.14.2. Gels were dried and autoradiography was 
pelformed as described in section 2.32. 
2.22 DNase I footprinting 
A standard 8 III DNA binding assay was set up in DNA binding buffer (see section 2.21.1) 
with fragment (1,000 cps) containing ISY100 IRL or IRR which was 3' - or 5' - end labelled 
at one end. Purified transposase or cell extract containing transposase was then added. 1 III 
of DNase I (4 Ilg/ml) in 50 mM CaClz and 100 mM MgClz was mixed in and the mixture 
was incubated at room temperature for one minute. The reaction was stopped by adding 6 
III of formamide loading dye containing 30 mM EDT A. The samples together with size 
markers such as G+A ladder were separated on 6% or 8% denaturing polyacrylamide gels 
in Ix TIE buffer as described in section 2.14.3. 
2.23 peR 
Standard PCR reactions used either Pfu Turbo (Stratagene) or Taq (Promega) DNA 
polymerase and were carried out in 50 III of Ix buffer supplied by the manufacturer. 
Reactions contained 0.2 mM dNTPs, appropriate amount of template DNA and 2 11M of 
each primer. For PCR reactions using Taq polymerase, MgClz was added to a final 
concentration of 2.5 mM. A typical PCR reaction was denatured at 94°C for 1 minute and 
then went through 30 cycles of one minute at 94°C, one minute at 55°C and two minutes at 
72°C. Finally, the reaction was incubated at 72°C for 10 minutes. 
Colony PCR was carried out as follow: A single colony was touched with a toothpick 
and the cells were suspended in 40 III double distilled water in a 0.5 ml EppendOlf tube. 
The tube was heated at 100°C for 3 minutes and then was centrifuged at 16,000 g for 1 
minute. 0.5 III of the supernatant was used as template in a 25 III standard PCR. 
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The 3' termini of donor cleavage sites were determined using a two-step PCR 
reaction. pXF153 was cleaved with ISY100 transposase in a standard cleavage reaction 
and the donor backbone was purified from an agarose gel. The purified donor backbone 
(10 ng) was then treated at 37°C for 15 minutes with 25 units of recombinant terminal 
deoxynucleotidyl transferase (Invitrogen) and 2 mM dCTP in TdT buffer containing 2 mM 
CoCh (dC-tailing reaction). PCR was carried out for 4 cycles with 1 ng of the dC-tailed 
donor backbone as template, using primers Rev-ClaI and polyG to amplify the left donor 
flank, or Uni-MluI and polyG to amplify the right donor flank. The parameters for PCR 
were 30 seconds at 94°C, 30 seconds at 55°C and 70 seconds at 72°C. This PCR reaction 
was diluted 1 III into 25 III as template for a second PCR employing primers Rev-ClaI and 
nest-polyG for the left donor flank, or primers Uni-MluI and nest-polyG for the right donor 
flank. PCR was carried out using the same reaction conditions for a further 25 cycles. The 
PCR products were cloned by TOPO TA cloning (Invitrogen) following the 
manufacturer's instructions, and then sequenced. 
2.24 Site-directed mutagenesis 
ISY100 transposase gene was mutagenized using the QuikChange site-directed 
mutagenesis Kit (Stratagene) according to the manufacturer's instructions. Mutagenesis 
was also used to eliminate an extra SphI site on the plasmid pCB 104 to facilitate 
construction of donor plasmids for the in vivo transposition assay. 
2.25 Sequencing of plasmid DNA or peR products 
DNA samples were purified using the Qiagen Miniprep Spin Kit and then sequenced by 
MWG Biotech or MBSU DNA Sequencing Service, University of Glasgow. 
2.26 Purification of synthetic oligonucleotides 
Full-length oligonucleotides were separated from prematurely terminated oligonucleotides 
by denaturing polyacrylamide gel electrophoresis (section 2.14.3). After electrophoresis, 
the oligonucleotides were visualised by staining with "Stains-all" (I-Ethyl-2-[3-(I-
ethylnaphtho [1,2-d]thiazolin-2-ylidene)-2-methylpropenyl] naphth [1,2-d] thiazolium 
bromide; Sigma). The gel was first stained in 100 ml of staining solution [80 ml H 20, 20 
ml isopropanol and 10 ml of 0.1 % solution of "Stains-all" (w/v) in formamide]. After 
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destaining in water, the full-length oligonucleotide band was cut from the gel, and the 
DNA was recovered as described in section 2.27. The DNA pellet was dissolved in 1110 
TE buffer. The purified oligonucleotides were stored at -20°C. 
2.27 Purification of DNA fragments from polyacrylamide gels 
Following polyacrylamide gel electrophoresis, the gel was stained with ethidium bromide 
(EtBr) as described in section 2.15.1. DNA fragments were visualised on a long 
wavelength transilluminator (365 nm). The desired DNA band was cut out and transferred 
to a microcentrifuge tube. The gel slice was crushed against the tube wall using a pipette 
tip and then soaked into 500 /Ll acrylamide gel elution buffer or TE if T4 polynucleotide 
kinase treatment was to follow. The gel slurry was incubated at 37°C on a rotating wheel 
for 4-12 hours. The polyacrylamide was removed by spinning at maximum speed for 1 
minute and then passing the supernatant through a Costar Spin-X filter (0.22 /Lm) for 3 
minutes at 2,700 rpm in an Eppendorf microcentrifuge. The DNA was precipitated with 
ethanol and the pellet was dissolved in the desired volume of TE or H20 for fmiher use. 
2.28 Purification of DNA from agarose gels 
Following agarose gel electrophoresis, DNA was visualised on a long wavelength 
transilluminator (365 nm) as described in section 2.15.1. The desired DNA band was 
excised and transferred to a fresh tube. Depending on the size of the DNA fragment, it was 
purified from the agarose slice using QIAquick Gel Extraction Kit (Qiagen) or MinElute 
Gel Extraction Kit (Qiagen) following instructions provided by the manufacturer. 
DNA was purified from SeaPlaque GTG agarose gel using phenol extraction. The 
excised band was transferred to a 1.5 ml microfuge tube and melted at 67°C for 10 
minutes. 1 volume of pre-warmed (67°C) TE buffer (20 mM Tris-HCl, 1 mM EDTA, pH 
7.8) was added to the melted gel and mixed. This diluted SeaPlaque GTG agarose was 
extracted twice with an equal volume of phenol saturated with TE buffer, once with 
phenol/chloroform and then once with chloroform alone. The DNA was precipitated with 
ethanol and dissolved in the desire amount of buffer for further use. 
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2.29 Preparation of radiolabelled DNA 
2.29.1 Labelling 3" termini of double-stranded DNA using the Klenow 
fragment of E. coli DNA polymerase 
Double-stranded DNA was dissolved in 20 III of Ix EcoPol Buffer (NEB) or NEBuffer 2 
and mixed with 20 IlCi [a_32P]dNTP and 10 p,M of other three dNTPs. One unit Klenow 
per p,g DNA was added to the mixture and the mixture was then incubated at room 
temperature for 15 minutes. 2.2 III of 2 ruM solution of all 4 dNTPs was added to the 
reaction and the reaction was incubated for 5 minutes at room temperature. The reaction 
was stopped by adding 2.5 III of 250 ruM EDTA (pH 8.0). 
2.29.2. Phosphorylation of DNA molecules with protruding 5'-hydroxyl termini 
Double-stranded DNA restriction fragment was first dephosphorylated by calf intestinal 
phosphatase (CIP) as desclibed in section 2.30. In a 20 III reaction, dephosphorylated DNA 
(10-50 pmoles) was incubated with [y_32p] ATP (10 IlCi) and T4 kinase (1 Ill, 10 U) in the 
supplied T4 kinase buffer for 30 minutes at 37°C. Unlabelled ATP was then added to final 
concentration of 1 ruM and the reaction was incubated at 37°C for a further 15 minutes. 
The reaction was stopped by heating at 70°C for 5 minutes. 
2.29.3 Obtaining fragments labelled at only one end 
First double-stranded DNA fragment was labelled at both ends as described in 2.29.1 or 
2.29.2. Unincorporated labelled nucleotides were removed by MicroSpin G-50 column 
following the manufacturer's instructions (Amersham Biosciences). Proteins were 
removed by extraction once with phenol and once with chloroform. The labelled DNA 
fragment was precipitated with ethanol and dissolved in the restriction enzyme buffer. The 
labelled fragment was cleaved with an appropriate restliction enzyme as desclibed in 
section 2.13. 10 Ilg of tRNA was added to the reaction and the DNA was precipitated with 
ethanol and dissolved in 20 III of TE. The DNA was run on a polyacrylamide gel (as 
described in 2.14.2) and the desired band was cut and recovered from the gel as desclibed 
in section 2.27. Labelled DNA fragments were dissolved in TE buffer and stored at -20°C 
for further use. 
34 
2.29.45' end-labelling of oligonucleotides 
Synthetic oligonucleotides lack phosphate groups at their 5' ends so can be labelled by 
phosphorylation directly. In a 10 III reaction, 10 pmoles of purified oligonucleotide was 
incubated with [y_32p] ATP (10 IlCi) and T4 kinase (1 Ill, 10 U) in the supplied T4 kinase 
buffer for 30 minutes at 3]oC. The reaction was stopped by heating at 68°C for 10 minutes. 
Unincorporated labelled nucleotides were removed by MicroSpin G-50 column following 
the manufacturer's instruction (Amersham Biosciences). Proteins were removed by 
extraction once with phenol and once with chloroform. Double-stranded oligonucleotides 
were obtained by annealing the labelled oligonucleotide with its complementary 
oligonucleotide as described in section 2.31. Labelled double-stranded oligonucleotides 
were separated from single-stranded oligonucleotides by polyacrylamide gel 
electrophoresis as described and stored at -20°C for further use. 
2.29.5 Preparation of G+A ladder 
A 10 III reaction was set up in a 2 ml gas-tight microcentrifuge tube with 2,000 cps end-
labelled ds DNA and 1 Ilg poly dIdC in H20. 1 III of 1:26 diluted formic acid was added 
and the mixture was incubated at 37°C for 25 minutes. 150 III of 1: 10 diluted piperidine 
was added and the mixture was incubated at 90°C for 30 minutes. 1.8 ml of butanol was 
added, mixed, and the tube was centrifuged at the maximum speed for 1 minute in a 
desktop centrifuge. The supernatant was discarded and 150 III of 1 % SDS was added to 
resuspend the pellet. Another 1.8 ml of butanol was added for one more precipitation as 
described above. The DNA pellet was dissolved in TE and an equal volume of 2x 
formamide loading dye was added. The sample was stored at -20°C for future use, and 
heated for 5 minutes at 80°C prior to loading on urea denaturing polyacrylamide gels. 
2.29.6 Labelling of supercoiled plasmid. 
5 Ilg of plasmid was linearised by restriction digestion in 40 III of appropriate buffer. 2.5 
units of CIP was added 10 minutes from the end of the reaction. The reaction product was 
extracted three times with phenol and once with chlorofOlm to inactive the enzyme. The 
DNA was precipitated with ethanol and redissolved in T4 ldnase buffer (20 Ill). [y_32p] 
ATP (10 IlCi) and T4 kinase (1 Ill, 10 U) was added and the mixture was incubated for 30 
minutes at 37°C. ATP was added to the mixture to final concentration of 1 mM and the 
mixture was incubated for another 15 minutes. The reaction was stopped by heating at 
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70°C for 5 minutes. 100 III of 5x ligase buffer (Invitrogen), 370 III of water, and 10 III of 
100 Ilg/ml ethidium bromide was added to the reaction and mixed well. 2 units of T4 ligase 
was added and the mixture was incubated overnight at room temperature (16 h at 20°C). 10 
Ilg (1 Ill) of tRNA was added to the reaction and the DNA was recovered by ethanol 
precipitation. The pellet was dissolved in 20 III of TE and separated on a 1 % Seaplaque 
agarose gel. Supercoiled DNA was cut from the gel and purified as desclibed in 2.28. 
2.29.75' end-labelling by the phosphate exchange reaction 
The radioactive 1 kb DNA ladder used as DNA molecular marker on agarose gels was 
labelled by the phosphate exchange reaction following instructions provided by the 
manufacturer (Invitrogen). 
2.30 Dephosphorylation of DNA fragments with alkaline phosphatase 
5' -phosphate groups were removed from DNA with calf intestinal alkaline phosphatase 
(CIP) following instructions provided by the manufacturer (New England Biolabs). The 
product was extracted three times with phenol and once with chloroform to remove the 
CIP. The DNA was precipitated with ethanol and was dissolved in the desired amount of 
TE for further use. 
2.31 Annealing of oligonucleotides 
A pair of pulified complementary oligonucleotides were annealed by Illlxmg equal 
amounts (1-10 pmoles) of each oligonucleotide in 1 mM Tlis-HCI (pH 8.0), 0.1 mM 
EDTA, 100 mM NaCI and heating to 80°C for 5 minutes. The mixture was then cooled to 
room temperature over a peliod of 5 hours. Annealed oligonucleotides were stored at -
20°C. 
2.32 Photography, autoradiography and phosphorimagery 
Agarose and polyacrylamide gels were photographed using either a Polaroid camera and 
Polaroid 667 film, or a Canon EOS-D30 digital camera with a 480 nm band pass filter 
(Peca products). 
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For autoradiography, gels were dried under vacuum in a Bio-Rad slab gel dryer, and 
exposed to a sheet of Kodak X-ray film. The film was developed in an X-OMAT 
automated processor (Kodak). 
Phosphorimaging was canied out by drying the gel as described above, and then 
exposing it for 6-16 hours to a phosphorimaging screen. The screen was imaged in a Fuji 
BAS-lS00 phosphorimaging system and the image was analysed with the supplied 
software. 
2.33 Quantification of DNA and protein 
The concentration of double-stranded DNA was calculated from the OD26o of the DNA 
solution using the formula [DNA] = A260 x 50 /kg/ml. Oligonucleotide concentrations were 
determined from the absorbance at 260 nm using the extinction coefficient calculated from 
the DNA sequence. Protein concentration was measured by Bio-Rad protein assay 
according to the supplied protocol. 
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Chapter III 
In vivo transposition of ISYIOO 
3.1 Introduction 
ISYlOO was first found in the cyanobacterium Synechocystis sp. strain PCC6803 (Cassier-
Chauvat et al., 1997). There are 22 copies of ISYlOO in the genome of PCC6803 and at 
least three copIes have been found in plasmids from this strain 
(http://www.kazusa.or.jp/cyano/Synechocystis/). A typical ISYlOO is 947 bp in length and 
contains one open reading frame which is proposed to encode the transposase protein 
(Figure 3.1 A). In some copies of ISYlOO, the transposase gene contains a frame-shift 
mutation which will lead to the production of a truncated protein. ISYlOO has 24 bp 
imperfect inverted repeats (IRs) at its telmini (Figure 3.1 B). Insertions are flanked by TA 
dinucleotides, which are presumed to be target duplications. Based on sequence homology 
of its putative transposase, ISYlOO belongs to the IS630/Tc1/mariner superfamily of 
transposons. 
The structure of ISYlOO suggests that it is an insertion sequence, in other words a 
simple DNA transposon containing only the genes needed for its own transposition. 
ISYlOO is found in multiple copies in the genome of Synechocystis sp. strain PCC6803 and 
one copy was found in a putative IS4-like transposase gene suggesting recent transposition 
activity (Cassier-Chauvat et al., 1997). ISYlOO was confirmed to be active by Urasaki et 
al. (2002), who showed that expression of ISYlOO transposase leads to excision and 
transposition of ISYlOO in E. coli. Mapping of the cleavage products revealed that they 
were cut exactly at the transposon boundaries at the 3' ends but recessed by 2 nucleotides 
at the 5' ends. ISYlOO jumped exclusively into TA dinucleotides in E. coli, and these TA 
dinucleotides appear to be duplicated after transposition. These properties are all 
characteristics of the IS630/Tc1/mariner superfamily, consistent with ISY100 being a 
member of this group. 
This chapter describes my work on the transposition of ISYlOO in vivo. My ultimate 
aim was to set up an in vitro system using purified transposase and DNA. However, I 
started this work by setting up an in vivo assay for several reasons. First I wanted to 
replicate some of the results of Urasaki et al. (2002). This would allow me to ensure I had 
isolated an active transposase gene and to determine the cis requirements for transposition. 
The system was also used to study the effects of mutations in the transposase gene, the IRs 
and the flanking sequences. Furthermore, the plasmids constructed for the in vivo 
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A) 
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1----:----1----:----1----:----1----:----1----:----1----:----1----:----1----:----1 
taTAGTCATTTCAATTAACGATGAGAGAATTTAATGTAAAATTATGGAGTGTACAAAATGAACAGGTTTAAACAATGGCTTACAGTTTAGAT 
B) 
IRL: 
IRR: 
------------I.~ MAY S L D IRL 
100 llO 120 130 140 150 160 170 180 
----:----1----:----1----:----1----:----1----:----1----:----1----:----1----:----1----:----1 
TTAAGGCAAAGGGTAGTAGCTTATATAGAAGCTGGAGGAAAAATAACTGAGGCTTCCAAGATATATAAAATAGGAAAAGCCTCGATATAC 
L R Q R V V A Y I E A G G KIT E ASK I Y K I G K A SlY 36 
190 200 210 220 230 240 250 260 270 
----:----1----: 1 :----1 :----1----:----1----:----1----:----1----:----1----:----1 
AGATGGTTAAATAGAGTAGATTTAAGCCCAACAAAAGTAGAGCGTCGCCATAGGAAATTAGACTGGGAAGCTCTAAAAAAAGACGTAGAA 
R W L N R V D L S P T K V ERR H R K L D 1'1 E A L K K D V E 66 
280 290 300 310 320 330 340 350 360 
----:----1----:----1----:----1----:----1----:----1----:----1----:----1----:----1----:----1 
GAAAATCCCGATGCAAGATTGATAGACAGAGCCAAGAAATTTGGAGTGAGGCCGAGTGCCGTATATTACGCATTAAAGAAAATGAAAATA 
ENPDARLIDRAKKFGVRPSAVYYALKKMKI96 
370 380 390 400 410 420 430 440 450 
----:----1----:----1----:----1----:----1----:----1----:----1----:----1----:----1----:----1 
AACAGAAAAAAAAAAGAACTACGTTATCGAGAAAGAAACCGGGAGGAACGAGTTAAGTACTATAGAATGTTAAGAGAACTAATTAAGCTC 
N R KKK E L R Y R ERN R E E R V K Y Y R M L R ELI K L 126 
460 470 480 490 500 510 520 530 540 
----:----1----:----1----:----1----:----1----:----1----:----1----:----1----:----1----:----1 
TATGGTAGTCAAGCTATAGTTTACATAGATGAATCTGGATTCGAAGCAATCCAGGCTTGTATTTATGCCTGGTCAAAAAAAGGAAAAAAA 
Y G S Q A I V Y I ® E S G F E A I Q A elY A 1'1 S K K G K K 156 
550 560 570 580 590 600 610 620 630 
----:----1----:----1----:----1----:----1----:----1----:----1----:----1----:----1----:----1 
GTTTATGGAGATAGACAAGGAAAAAGGGGAGTCAGAGAAAATCTAGTAGCAGGGAGAAGAAAAGGAAAAAAAGATTTGATTGCGCCGATG 
V Y G D R Q G K R G V R E N L V A G R R K G K K D L I A P M 186 
640 650 660 670 680 690 700 710 720 
----:----1----:----1----:----1----:----1----:----1----:----1----:----1----:----1----:----1 
GTTTTTACCGGGAGTTTGAATGCAGAAGGCTTTGAAGGATGGTTAAAATTATATTTGCTACCCTCCCTCGACATTCCATCAATATTAATA 
V F T G S L N A E G F E G 1'1 L K L Y L L P S L DIP S I L I 216 
730 740 750 760 770 780 790 800 810 
----:----1----:----1----:----1----:----1----:----1----:----1----:----1----:----1----:----1 
ATGGATAATGCTCCTATTCATCGTAAAACTGCCATTAAAGAATTGGCTAAAGAAGCAGGTCATGAAGTTCTTTTTTTGCCGAAATATTCT 
M ® NAP I H R K T A IKE L A K E A G H E V L F L P K Y S 246 
820 830 840 850 860 870 880 890 900 
----:----1----:----1----:----1----:----1----:----1----:----1----:----1----:----1----:----1 
CCTGATTTAAATGATATTGAGCATGACTTTAGTGCCTTGAAACGAGCTAGAATGTACGCTCCTATTGACACGTCTCTTGATGAAATTATC 
P D L N D I (]D H D F SAL K R ARM YAP I D T S L DEI I 276 
910 920 930 940 950 
----:----1----:----1----:----1----:----1----: 1 
CGTTCTTACTGTGGCGTTTAGCGTCTCAGCTTTATTTGAAACTACTAta 
R S Y C G V • 282 
IRR 
10 20 30 
----:----1----:----1----:----1 
TAGTCATTTCAATTAACGATGAGAGAATTT 
1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 
TAGTAGTTTCAAATAAAGCTGAGACGCTAA 
Figure 3.1 Structure of ISY100a A) Terminal inverted repeats are shown by arrows. 
The lowercase TA sequences outside the ISY1 00 sequence show the target site duplication. 
The amino acid sequence of the transposase is shown below the nucleotide sequence. The 
positions of nucleotide residues are shown by the ruler; the position of the last amino acid 
residue in each line is indicated at the right. Potential helix-tum-helix domains are 
underlined. D 136, D218, and E253 of the predicted DDE motif are circled. B) Alignment 
ofIRL and IRR sequences ofISY100. 
transposition system could later be used to set up a sensitive genetic screen for 
transposition in vitro. 
3.2 Establishment of an in vivo transposition assay 
3.2.1 In vivo assays for transposition 
Various assays have been used to study transposition in bacteria. Many transposons have 
been discovered by phenotypic changes they bring about in their hosts. These changes can 
be caused by genes canied on the transposon itself, as in the case of antibiotics resistance 
conferred by the transposon, or by insertional mutagenesis or other effects on neighbouring 
genes. 
Two mam methods have been developed to study transposition quantitatively in 
bacteria: mating-out assays and assays based on suicide vectors. In both assays a marked 
copy of the transposon together with the transposase gene and a target DNA are introduced 
into the same cell. The two assays then use different strategies to distinguish between the 
transposon donor and the target DNA, so that the transposition frequency can be calculated 
without interference from the donor. Mating-out assays use a conjugative plasmid, such as 
the F factor-derived pOX38 which lacks all known transposable elements, as target. After 
allowing time for transposition to happen, conjugation is used to transfer the target plasmid 
to a recipient cell. The transposition frequency is calculated by comparing the number of 
transposon-containing exconjugants to the total number of exconjugants (Groenen et al., 
1985; Johnson and Reznikoff, 1984). 
In a typical suicide-vector transposition assay, the transposon is carried on a 
conditionally replicating vector. After allowing time for transposition to occur, the 
conditions are changed so that the transposon donor cannot replicate but the target can. 
Target molecules containing insertions are then selected using the antibiotic resistance 
conferred by the marked transposon. The transposition frequency is calculated as the 
number of colonies carrying the target DNA with inserted transposon (for instance see 
Tenzen and Ohtsubo, 1991). 
Both mating-out and suicide-vector assays allow the transposase gene to be in cis or 
in trans to the transposon ends, and mutations can be easily introduced into the transposase 
gene and the inverted repeat sequences. 
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3.2.2 Previous studies on transposition of ISYIOO in vivo 
In the study of Urasaki et ai. (2002), transposition of ISYlOO was studied in E. coli using a 
modified suicide-vector transposition assay. This used a pBR322-derived donor plasmid 
carrying an IPTG-inducible transposase gene and an artificial mini-ISYlOO, consisting of 
51 bp ISYlOO IRL and IRR sequences, flanking a chloramphenicol (Cm) resistance gene. 
The target plasmid used was a spectinomycin resistant (Spf) RlOO derivative. The assay 
was set up by transforming the donor plasmid into an E. coli K12 strain which already 
harboured the target plasmid. To allow transposition to take place, a transformant was 
incubated overnight, diluted into a fresh culture and incubated overnight again. IPTG was 
added to the second overnight incubation to induce expression of the transposase. Plasmid 
DNA was isolated and the plasmid mixture was then electroporated into the poiA E. coli 
strain JE6638. DNA polymerase I, encoded by the poiA gene, is required for replication of 
pBR322-based plasmids, but not for replication of RlOO (Grindley and Kelley, 1976). 
Therefore, the donor plasmid cannot replicate in this strain but the target plasmid can. 
Transformants carrying the target plasmid with a mini-ISYlOO insertion were distinguished 
from those carrying the original target plasmid by the mini-transposon-encoded 
chloramphenicol resistance. The transposition frequency was calculated as the ratio of the 
number of Spf Cmf transformants to the total number of Spf transformants and represents 
the fraction of target plasmids having a transposon insertion. 
3.2.3 Choice of transposition assay 
When setting out to develop an in vivo transposition assay for studies of ISYlOO, I had to 
decide whether to set up a mating out or a suicide-vector based system. One of the main 
problems with mating-out transposition assays is the low copy number of conjugative 
plasmids such as F and POX38. This makes it difficult to map the junction sequences 
between the transposon and the target directly. In the mating-out assay established for 
transposition of S. sonnei IS630 (my unpublished data), an extra step of inverse PCR was 
required to identify the IS630 target sites on the F plasmid. To avoid this extra step, it was 
decided to establish an in vivo transposition assay for ISYlOO based on the strategy used 
by Urasaki et ai. (2002). 
Results from mating-out experiments suggested that S. sonnei IS630 transposase acts 
preferentially in cis rather than in trans (my unpublished data). I thus decided to construct 
a suicide-vector transposition assay for ISYI00 in which the transposon ends and 
transposase gene are carried on the same donor plasmid. 
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3.2.4 Construction of plasmids for in vivo transposition assay 
The initial donor plasmid contained the same basic components as the donor plasmid used 
by Urasaki et al. (2002). 
First, the same copy of ISYlOO used by Urasaki et al. (ISYlOOa) together with shOlt 
flanking sequences was isolated from Synechocystis sp. strain PCC6803 genomic DNA 
(donated by C. Mullineaux) by PCR with primers 6803_Top and 6803_Bot (Figure 3.2). 
The PCR fragment was then cleaved at the EcoRI and XbaI sites incorporated into the 
primer sequences, and inserted into pUC18, yielding pXF106. 
A fragment containing 51 bp from ISYlOO left end, 49 bp from ISYlOO right end and 
the pUC18 vector sequences, was obtained by PCR with two outward facing primers 
within ISYlOO (ylOO-51_Top and ylOO-5LBot) using pXF106 as template. This PCR 
product was cleaved at BamHI sites within the primer sequences, and ligated to a 1.3 kb 
BamHI Kan f fragment from pUC4K, giving pXF109 (Figure 3.2). pXF109 therefore 
contains a kanamycin resistance gene flanked by 51 bp ISYlOO IRL and 49 bp ISYlOO 
IRR sequences in the natural genomic context of ISYlOOa. The Kan f marked mini-ISYlOO 
element contained within pXF109 is here referred to as ISYlOO-51-Kan. 
The transposase gene of ISYlOOa was isolated from pXF106 by PCR with primers 
TnplOO_Top and TnplOO_Bot, which introduce an NdeI site at the start codon and a 
BamHI site just after the stop codon of the transposase open reading frame. The 
transposase gene was then inserted into the NdeI-BamHI-cleaved expression vector 
pTrc99a to produce pXF104. 
To produce the finished suicide transposon donor plasmid, ISYlOO-51-Kan was 
inserted into the A-dv plasmid pXF80 to give pXF113 (Figure 3.2). Then the transposase 
expression cassette from pXF104 was inserted into pXF113 to give pXF115 (Figure 3.2). 
A-dv-based plasmids can replicate normally in most E. coli hosts, but are unable to 
replicate in A lysogens, or any other hosts that express the A repressor. 
An initial in vivo transposition assay was carried out using pUC18 as target (Figure 
3.3). The donor plasmid pXFl15 was transformed into the recA E. coli strain DH5a 
already containing pUC18 as target plasmid. A parallel control experiment was set up 
using pXF113, which contains ISYlOO-51-Kan but not the transposase gene, as donor 
plasmid. Because the donor and target plasmids have different origins, they are compatible 
and can co-exist in the same cell. The resulting strains were incubated in L-Broth overnight 
to allow transposition to occur. In this initial experiment, IPTG was added when the OD6oo 
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Figure 3.2 Construction of donor plasmid for in vivo transposition. ISY100a and its 
flanking sequence was first isolated from Synechocystis sp. strain PCC6803 genomic DNA 
by PCR and then inserted into pUC18 to construct pXF106. The tv-dv based donor plasmid 
pXF115 and the control plasmid lacking transposase (pXF113) were constructed using 
the steps shown. The donor plasmid pXF 116 was constructed in the same way as pXF 115 
but carries a C-terminal His-tagged transposase obtained from pXF106 by PCR using a 
different bottom primer. The donor pXF 114 was made in the same way as pXF 113 but 
carries a Kanf marked mini-ISY100 with 30 bp IRs produced from pXF106 by PCR using 
primers y100-30_Top and y100-30_Bot. The donor plasmids pXF117 and pXF118 were 
constructed from pXF 114 in the same way as pXF 115 and pXF 116. 
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Figure 3.3 In vivo transposition assay. A) In vivo transposition. Donor and target plasmids 
were co-transformed into the recA E. coli strain DH5a and incubated to allow transposition 
to occur (see chapter II for details). Expression of the transposase was expected to mediate 
transposition of the mini-ISYIOO from donor plasmid to the target plasmid. In the absence 
of transposase, no transposition should occur. B) Detection of transposition events. Plasmid 
DNA was purified from the DH5a after the incubation, and was then electroporated into 
a A-lysogen E. coli strain (DS964), in which the A-dv donor or donor control plasmid cannot 
replicate. 10 III of a 10.2 dilution of the transformation was spread onto an Amp plate and 
the rest was spread onto a Kan plate. The total number of target transformants was calculated 
from the number of single colonies on the Amp plate. The transposition frequency was 
calculated by dividing the total number of the Kanf ems colonies by the total number of 
Ampf colonies. 
reached 0.3 to induce expression of transposase. After overnight growth, plasmid DNA 
was purified and was then electroporated into a recA mutant A-lysogen E. coli strain 
(DS964), in which the donor A-dv plasmid cannot replicate. TransfOlmants were selected 
on plates containing ampicillin and kanamycin, to select for target plasmids containing 
ISYlOO-51-Kan. Such Ampf Kad' transformants were obtained from the pXF115 
transposition reaction, but not from the pXF113 reaction (data not shown). Therefore, 
transposition seems to be taldng place and is dependent on the presence of the transposase 
gene on the donor plasmid. A single colony gel was used to analyse the DNA from the 
transformants, demonstrating the presence of plasmids of the correct size to be the target 
pUC18 containing ISYlOO-51-Kan insertions (data not shown). 
3.3 Optimisation of the transposition assay and requirements for 
transposition 
A quantitative transposition assay was then developed and used to study the requirements 
for transposition. Since the mini-ISYlOO can potentially insert into the Ampf gene, 
resistance to kanamycin rather than ampicillin and kanamycin was used to identify target 
plasmids containing mini-ISYlOO insertions. The transposition frequency was then 
calculated by dividing the number of Kad' transformants by the number of Ampf 
transformants. This in vivo transposition assay was then tested and improved as described 
below using transposition frequency as the main indicator of transposition efficiency. 
In earlier work, I set up a similar assay to study transposition of S. sonnei IS630 (my 
unpublished data). In those assays, and in pilot assays for ISYlOO, a small number of Kanf 
transformants containing only the unmodified target plasmid were sometimes obtained 
from electroporation into DS964. These transformants were found even in the absence of 
transposaseand could be distinguished from the genuine transposition events because they 
were resistant to chloramphenicol as well as kanamycin. This suggests that the donor 
suicide plasmid was still present. The way in which the "suicide" donor plasmid survives 
in the A-lysogen cell is unclear. A may be lost from DS964 at low frequency, allowing 
replication of the low copy-number donor plasmid. However, the donor plasmid was never 
observed on single colony gels, so it may have integrated into the chromosome even 
though DS964 is recK. Although Kad' Cms transformants were rare, it was decided that 
their number should be estimated and that this number should be subtracted from the 
number of the Kanf colonies before calculating the transposition frequency. Normally, 20 
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Kanf transformants were randomly picked and checked separately for resistance to 
kanamycin and chloramphenicol, and the predicted total number of Kanf Cms transformants 
was then calculated accordingly. 
3.3.1 IPTG is not needed for efficient transposition 
In the study of Urasaki et al. (2002), IPTG at a final concentration of 0.5 mM was added 
when the OD600 of the cell-culture reached 0.3 in the second overnight incubation. In the 
experiments above, IPTG was used to keep the conditions as close as possible to those of 
Urasaki et al. (2002). To test whether IPTG made any difference to the transposition 
frequency, transposition assays were carried out with pXF115 and pXFI13 as donors and 
pUC18 as target, with and without IPTG. For each experiment, two individual 
transformant colonies containing donor and target plasmid were picked and incubated 
overnight for 18 hours in L-broth. The cultures were diluted 1 in 1000 and incubated for 
another 18 hours overnight, with or without the addition of IPTG when the culture reached 
an OD600 of 0.3. There was no transposition in the absence of transposase (pXF113; Table 
3.1). In the presence of transposase, there was a modest increase in the transposition 
frequency when IPTG was added (pXF115; Table 3.1), although it is not clear whether this 
increase was due to the presence of IPTG or was statistical variation in the assay (see 
section 3.3.5). 
Transposition in the absence of IPTG suggests that the Plfe promoter on pXF115 is 
not tightly regulated. The leakiness of the Plfe promoter has also been observed in this lab 
in experiments with the E. coli pepA gene (S. Colloms, personal communication). The 
presence of lac operators on the high copy number pUC18 target plasmid might also 
weaken repression by the lac repressor encoded on the donor plasmid. Although adding 
IPTG gave higher transposition frequencies, to simplify the assay and increase its 
reproducibility, IPTG was not generally used in later experiments. 
3.3.2 30 bp from IRR and IRL are sufficient for transposition 
ISYlOO contains impelfect 24 bp inverted repeats (Figure 3.1). This suggests that 24 bp 
from each transposon end might be sufficient for transposition. To test whether the 51 bp 
ISYlOO ends in pXF115 are required for transposition, a donor plasmid with only 30 bp 
from each end was constructed. ISYlOO-30-Kan, carrying 30 bp IRL and IRR flanking the 
kanamycin resistance gene, was constructed in a similar way to ISYlOO-51-Kan and 
inserted into donor plasmids with and without the transposase gene to give pXF116 and 
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Table 3.1 Frequency of simple insertion mediated by mini-ISYI00 
Reaction Amp' Transposition frequency (x 10-
5) 
Amp'Kan' Cms Amp' Kan' Cms 
No. pUC18 + IPTG(I) (x 106) Individual Average 
(mM) 
#1 pXFl13 (ISY1OO- 3.6 31 0/31 0 < 2.8 X 10-7 
< 6.6 X 10-8 51-Kan, Tnp-) - < 8.6 X 10-6 #2 11.6 14 0/14 0 
#1 pXFl13 (ISY1OO- 0.1 8.5 91 0/91 0 < 1.2 X 10-
6 
< 5.8 X 10-8 #2 51-Kan, Tnp-) 8.7 14 0/14 0 < 1.1 X 10-6 
#1 pXF1l5 (ISY1OO- 8.5 175 15120 131 1.5 1.5 ± 0.0 51-Kan, Tnpwt) - 10.7 172 19/20 163 1.5 #2 
#1 pXFl15 (ISY1OO- 0.1 6.4 141 20120 141 2.2 2.4 ± 0.2 #2 51-Kan, Tnp wt) 5.0 135 19120 128 2.5 
#1 pXFl14 (ISY1OO- 13.9 25 0125 0 < 7.2 X 10-8 
< 3.3 X 10-8 30-Kan, Tnp-) - 13 0/13 0 < 6.3 X 10-8 #2 16.0 
#1 pXF116 (ISY1OO-30- 0.1 2.8 369 20120 369 13.0 8.1 ± 6.9 #2 Kan, Tnpwt) 4.2 151 18/20 136 3.2 
#1 pXF1l7 (ISY100- 0.1 3.5 240 20120 240 6.8 7.1 ±0.4 #2 51-Kan, TnpHiS6) 3.1 227 20/20 227 7.4 
#1 pXF1l8 (ISY1OO- 0.1 4.8 169 18120 152 3.2 4.6 ±2.0 #2 30-Kan, TnpHis6) 3.2 193 20120 192 6.0 
(1): IPTG was added at OD600 = 0.3 during the second 18 hours incubation. 
DH5a containing pUC18 together with the indicated plasmid was incubated overnight for 18 hours, then diluted 1:1000 and incubated for a 
further 18 hours with or without IPTG as indicated. DNA was then isolated and electroporated into the A-lysogen strain DS964. A dilution was 
plated onto Amp plates and the remaining cells were plated onto Amp + Kan plates. At least 20 single colonies were picked from the Amp + Kan 
plate to test their resistance to chloramphenicol to assess the total number of Ampr Kanr Cms colonies. The transposition frequency was 
calculated by dividing the number of Ampr Kanr Cms colonies by the number of Ampr colonies. Transposition frequencies are shown as the 
average of all repeats of the assay ± the standard deviation (O"n-l). 
pXF114 respectively (Figure 3.2). These donor plasmids were used in an in vivo 
transposition assay with pUC18 as target. No Kad' Cms transformants were obtained in the 
absence of transposase (pXF114; Table 3.1). In the presence of transposase, transposition 
was observed at an even higher frequency than that obtained with ISYlOO-51-Kan 
(pXF116; Table 3.1). Although this increase in transposition frequency may not be 
statistically significant, it seems safe to conclude that 30 bp from the ends of ISYlOO are 
sufficient to mediate efficient transposition. A transposon with only 24 bp from each end 
has not yet been tested, but it seems likely that it would work. 
3.3.3 Transposase carrying a C-terminal His6-tag is active in transposition 
A PCR product encoding ISYlOO transposase with a C-terminal 6-His tag (Tnp-His6) was 
obtained from pXF106 with primers TnplOO_Top and TnplOO_Chis. Donor plasmids 
carrying this Tnp-His6 gene together with either ISYlOO-51-Kan or ISYlOO-30-Kan were 
constructed as described for pXF115, giving pXF117 and pXF118 respectively. The 
transposition frequency was then measured as described in the previous section giving 
frequencies similar to those obtained for equivalent plasmids with the wild-type 
transposase (Table 3.1). 
In a similar in vivo assay for IS630 transposition, the addition of a His6-tag at C-
terminus of IS630 transposase increased the transposition frequency more than 3 fold 
whereas the addition of a His6-tag at the N-terminus of IS630 transposase reduced the 
transposition frequency more than 20 fold (My unpublished data). 
The fact that ISYlOO transposase with a C-terminal His6-tag was active in vivo was 
later exploited in the purification of transposase for in vitro transposition. 
3.3.4 The time of incubation affects the transposition frequency 
Transposition occurs during the period when the cells containing both donor and target 
plasmid are incubated. A longer incubation time might lead to an increase in transposition 
frequency. To test this, the effect of changing the incubation time was investigated (Table 
3.2). In this experiment, the donor plasmid pXF116 containing only 30 bp from each 
transposon ends and wild-type transposase was used. pXF116 was transformed into DH5a 
already containing pUC18 as a target plasmid. Three single transformant colonies were 
picked and processed in parallel, to assess the variability of the assay. DNA was isolated 
from samples taken at 14, 16 and 18 hours after inoculation. After 18 hours, the culture 
was diluted 1000 fold into fresh L-broth and samples were again taken at 14, 16 and 18 
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Table 3.2 Incubation time affects the in vivo transposition frequency 
Incubation Reaction Ampr Kanr Transposition frequency (x 10-
6) 
time No. (x 104) Individual(l) Average 
1 891 29 3.25 
14 hours 2 861 15 1.74 2.96 ± 1.10 
3 695 27 3.88 
1 740 48 6.49 
16 hours 2 769 46 5.98 6.91 ± 1.20 
3 980 81 8.27 
1 843 43 5.10 
18 hours 2 644 62 9.63 7.56 ± 2.29 
3 804 64 7.96 
1 1047 68 6.49 
32 hours 2 1093 117 10.70 10.46 ± 3.85 
3 825 117 14.18 
1 1023 169 16.52 
34 hours 2 908 206 22.69 22.52 ± 5.92 
3 963 273 28.35 
1 1068 163 15.26 
36 hours 2 1087 186 17.11 16.52 ± 1.10 
3 1151 198 17.20 
(1) Not adjusted for the number of Cmf colonies. 
In vivo transposition was performed by incubating 3 single DH5a colonies carrying 
pXF116 and pUC18 for 14 hours, 16 hours and 18 hours. After 18 hours the cells were 
diluted 1:1000 into fresh media and incubated for a further 14 hours, 16 hours and 18 hours 
(32 hours, 34 hours and 36 hours total incubation time). The plasmids were purified and 
100 ng of the DNA from each individual assay was electroporated into DS964. One ten 
thousandth of each electroporation was plated onto an ampicillin plate and the rest was 
plated on a kanamycin plate. The transposition frequency was calculated by dividing the 
total number of the Kan f colonies by total number of Ampr colonies. 
hours. The DNA was electroporated into DS964 and the transposition frequency was 
calculated from the numbers of Kanr and Ampr colonies. The transposition frequencies 
from the different colonies varied by less than a factor of 2.5 at each time-point. The 
results at each time point were averaged, giving an equal weighting to the results from each 
starting colony and the standard deviation was calculated to give an idea of statistical 
variation in the assay. After the first overnight incubation, the transposition frequency 
increased from 3.0 ± 1.1 x 10-6 at 14 hours to 7.6 ± 2.3 x 10-6 at 18 hours incubation. After 
a second overnight incubation, the transposition frequency increased further to 10.5 ± 3.9 x 
10-6 at 14 hours and 22.5 ± 5.9 x 10-6 at 16 hours incubation, but then decreased to 16.5 ± 
1.1 x 10-6 at 18 hours. Although some of this variation may be due to random variation in 
the assay, there is an upward trend in the transposition frequency over time (Figure 3.4). 
The results suggest that longer incubation times and the second overnight culture lead to 
higher transposition frequencies. This presumably reflects the accumulation of 
transposition events into the target plasmid over time. However, competition between the 
target plasmid with and without mini-transposon insertions might complicate matters. The 
results suggested that it was important to fix the incubation time to make results 
comparable between different assays. For convenience, it was decided to use two overnight 
incubations of 18 hours in the standard assay. 
3.3.5 Variability in the transposition assay 
It was noticed in the time course and other experiments described above that there was 
some variation in transposition frequency obtained from independent repeats of the same 
experiments. Transposition is an inherently random event, and depending on whether 
transposition has occurred early or late in the colony that is picked, a higher or lower 
transposition frequency might be obtained. 
One way to attempt to smooth out this variation is to pool multiple transformant 
colonies and to prepare DNA from cultures started from these pools. To investigate the 
effects of this procedure, a transposition assay was carried out with pXF116 as donor and 
pUC18 as target. DNA was prepared from three individual transformants and from three 
pools of three colonies, then electroporated into DS964. Transposition frequencies from 
the three single colonies ranged from 1.94 x 10-5 to 9.45 X 10-5, a difference of nearly 5 
fold (Table 3.3). As expected, taking pools of three colonies seemed to smooth this 
variation somewhat, giving frequencies from 3.98 x 10-5 to 5.46 X 10-5 in the three 
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Figure 3.4 Incubation time affects the in vivo transposition frequency. In vivo transposition 
assays to test the impact of incubation time on the transposition frequency were calTied out 
as described in Table 3.2. The average transposition frequency after different incubation 
times is shown. The error bars represent the standard deviation cr 1. 
n-
Table 3.3 Comparison of transposition frequencies obtained from assays 
started with multiple colonies and single colonies 
Starting Reaction Ampf Transposition frequency Kad" (x10-5) 
colonies No. (x 104) Individual\l) Average 
Single 1 504 330 6.55 2 904 175 1.94 5.98 ± 3.79 
colonies 3 513 485 9.45 
Multiple 1 485 265 5.46 2 1610 640 3.98 3.98 ± 1.49 
colonies 3 1204 300 2.49 
(1) Not adjusted for the number of Cm! colonies. 
In vivo transposition assays employing pXF116 as donor and pUC18 as target were canied 
out using standard conditions. Cultures were started from 3 single colonies or from 3 
mixtures of 3 single colonies. 
Table 3.4 The amount of DNA electroporated affects the calculated 
transposition frequency 
DNA used Kanf colonies Ampf colonies Transposition efficiency 
(x 106) (x 10-4) 
50ng 151 1.06 1.42 
100ng 277 1.34 2.07 
200ng 342 1.26 2.71 
300ng 375 2.43 1.54 
500ng 257 1.34 1.94 
Different amounts of DNA from a single in vivo transposition assay were electroporated 
into same amount of competent cell, and transposition frequencies were calculated using 
the standard method. 
Table 3.5 In vivo transposition employing pH2 as target plasmid 
pH2+ 
Ampf Kanf Transposition frequency (xlO-4) 
(x 104) Cms Individual Average 
pXF114 23 0 < 4.3 X 10-6 
(ISY100-30-
< 5.6 x 10-6 
< 2.4 X 10-6 
Kan, Tnp-) 18 0 
pXF116 4 18 4.50 
(ISY100-30- 15 24 1.60 2.21 ± 1.53 
Kan, Tnpwt) 510 1128 2.21 
pXFl18 6 35 5.83 
(ISY100-30- 6 48 8.00 4.84 ± 3.75 
Kan, TnpHiS) 540 379 0.70 
replicates carried out (Table 3.3). It was decided it might be best to pool multiple colonies 
in future assays as done here, however, most of the assays reported in this chapter were 
canied out by taking three single colonies. 
Another factor that may affect the apparent transposition frequency is that the 
electroporation results may not reflect the true ratio of the plasmid molecules present. 
Specifically, the total amount of DNA used in the electroporation may affect the observed 
ratio. To investigate this, different amounts of the same DNA isolated from a transposition 
reaction with pXF116 and pH2 (see later) were electroporated into DS964. The number of 
Ampf and Kanf colonies depended on the amount of DNA, resulting in apparent 
transposition frequencies varying by nearly a factor of two between the highest and lowest 
(Table 3.4). It seems likely that different batches of competent cells, with different levels 
of competence might give similar variation to that seen here with different amounts of 
DNA. Thus the electroporation and plating procedures are another source of variability in 
these assays. 
Mixtures of known ratios of target plasmid and the transposition product could be 
used to determine whether the frequencies obtained by electroporation reflect the true ratio 
of DNA molecules present, however this was not done. 
The variation in transposition frequency obtained from independent repeats of the 
same experiment should be kept in mind when interpreting all of the results from in vivo 
transposition assays in this chapter and chapter V. 
3.3.6 The target plasmid affects the transposition frequency 
In their in vivo assays, the transposition frequency obtained by Urasaki et al. (2002) was 
3.3 x 10-4 Cmf Spf colonies per Spf colony in the presence of IPTG. However, the average 
frequency obtained here with pUC18 and pXFl15, which carries a transposon with the 
same ends used by Urasaki et al. (2002), was approximately 2.4 x 10-5 Kad' colonies per 
Ampf colony in the presence of IPTG and 1.5 x 10-5 in absence of IPTG (Table 3.1). 
pXF116, with only 30 bp ISY100 ends, gave a higher frequency (8.11 x 10-5) than pXF115 
in the presence of IPTG (Table 3.1), but this is still4-fold less than the frequency obtained 
by Urasaki et al. (2002). One difference between the assays described here so far, and that 
of Urasaki et al. (2002) is that they use a larger target plasmid (6.6 kb), with more potential 
T A target sites. It was therefore decided to test the effect of changing the target plasmid in 
the assay developed here. An alternative target plasmid called pH2 was used. This plasmid 
contains a 2.6 kb TA rich DNA fragment from Aspergillus nidulans in the pUC18-like 
47 
cloning vector pIC20. IS630 from S. sonnei transposes almost exclusively into the target 
sequence CTAG (Tenzen and Ohtsubo, 1991), a rare tetranucleotide in pUC18 and most 
other bacterial sequences (Burge et al., 1992). pH2 was originally used as a target in an in 
vivo transposition assay for IS630, where it gave higher transposition frequencies than 
pUC18 because it contains a large number of CTAG tetranucleotides (my unpublished 
results). 
pH2 was therefore tested as a target for ISY100 transposition, and the results are 
shown in Table 3.5. The transposition frequency obtained with pH2 was generally greater 
than 10-4 in absence of IPTG (average of 3 experiments with pH2 and pXF1l6 = 2.77 ± 
1.53 x 10-4), whereas frequencies obtained with pUC18 as target were generally lower than 
10-4 (average transposition frequency for 6 experiments with pXF1l6 and pUC18 = 3.81 ± 
3.37 x 10-5; Table 3.2, 3.3 absence of IPTG). 
This increase in transposition frequency might be caused simply by the increased size 
of the target plasmid and/or the increased number of available TA target sequences. 
Assuming that ISY100 transposes only into TA target sites, the number of potential targets 
in pUC18 and pH2 can be calculated. Insertions into the plasmid replication Oligin are 
likely to inactivate the origin and should not be recovered in the transposition assay. 
Therefore, the 589 bp region between the -35 box of the RNAII promoter and the point 
where DNA synthesis starts from the RNAII primer was excluded from this analysis. pH2 
contains 343 potential TA target sites outside the origin region, whereas pUC18 contains 
only 107. This three-fold difference in the number of target sites might therefore account 
for a large proportion of the difference in the observed transposition frequency between 
these two targets. Transposition of ISY100 is not random and there are some sites that are 
used preferentially as targets (see chapter V). It is possible that some of the difference in 
transposition frequency between pH2 and pUC18 could be accounted for by a difference in 
the number of preferred target sites on these two plasmids. 
3.3.7 Kanr ems colonies represent genuine transposition events 
Plasmid DNA was purified from 10 Kanf transformant colonies obtained after in vivo 
transposition with pXF1l6 and pH2 (here referred to as T1-TlO). A further 10 plasmids 
(here referred to as Tll-T20) were purified after transposition with pXF1l8 and pH2. All 
of them, except one from the pXF118 pH2 reaction, were chloramphenicol sensitive, and 
were therefore thought to be the products of transposition. Plasmid DNA isolated from 
these 20 transformants was run uncut and cut with BamHI on an agarose gel (Figure 3.5). 
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Figure 3.5 Restriction analysis of purified plasmids from in vivo transposition assays. 
A) Lanes Tl to TIO are plasmids purified from Kanr Cms colonies from the in vivo 
transposition assay which employed pH2 as target plasmid and pXF 116 as donor. Lanes 
TIl to T20 are plasmids purified from KanrCms (Kanr Cmrfor TI5) colonies from the in 
vivo transposition assay which employed pH2 as target plasmid and pXF 118 as donor. Top 
gel: Uncut plasmid from each colony. Bottom gel: BamHI digestion of each purified plasmid. 
B) pH2 is 5.3 kb and contains a single BamHI site. The transposition product pH2::ISYIOO-
30-Kan is 6.6 kb and contains three BamHI sites. Cleavage of transposition products is 
predicted to give a Kanr fragment of 1.3 kb (Kan) and two fragments of different sizes 
(adding up to 5.3 kb) depending on the site of insertion. 
All of the Kan f Cms colonies contained a plasmid of the same size, about 1.3 kb larger than 
pH2 consistent with an insertion of ISYlOO-30-Kan into pH2 (Figure 3.5A). Some of them 
also carried a minor extra plasmid the same size as pH2. This probably comes from co-
transformation of DS964 with two plasmid molecules, one molecule of pH2 and one of 
pH2::ISYlOO-30-Kan. Although these two plasmids contain the same origin and should be 
incompatible, it may take many generations for the Kans pH2 to segregate out. 
pH2 contains a single BamHI site, and ISYlOO-30-Kan contains two BamHI sites 
flanking the 1.3 kb kanamycin resistance gene. Therefore, pH2 with a ISYlOO-30-Kan 
insertion is expected to give a 1.3 kb Kad' fragment, and two other fragments that add up 
to the size of pH2 (5.3 kbp) when cleaved with BamHI. The exact sizes of these two 
fragments will depend on the position of the insertion. Cleavage with BamHI gave 
different restriction patterns for the different colonies, consistent with single insertions of 
the mini-ISYlOO into different positions in pH2. Those colonies containing a pH2-sized 
plasmid in the uncut sample also gave an extra band of the correct size to be linear pH2 in 
the BamHI cleaved samples. 
The Kan f Cmf colony from the pXF118 + pH2 transposition reaction contained only a 
plasmid of the correct size to be pH2 (TIS in Figure 3.5A). This supports the hypothesis 
that this class of colony comes from integration of the donor plasmid into the DS964 
chromosome, and reinforces the need to check that transformants are Cms. 
All 19 transposition products were sequenced using outward facing primers from the 
left and right ends of the ISYlOO-30-Kan (primers Kan_L and Kan_R, Table 2.3). The 
sequencing results confirmed that all 19 plasmids contained insertions into TAs in pH2. 
The insertions occurred precisely at the boundaries of the ISYlOO ends, and the TA target 
sequences appear to be duplicated. All of these properties are those expected for legitimate 
transposition events. 
Four of the 19 insertions sequenced were into the same site in the pIC20 vector 
sequence, and another two shared a site in the TA-rich A. nidulans sequence in pH2 
(Figure 5.4). It is not clear if these are independent transposition events or sibling 
plasmids. 11 out of the 15 different target sites (73%) were in the A. nidulans sequence, 
and the other four (27%) were in the pIC20 vector sequences, reflecting the fraction of TA 
dinucleotides in these regions (69% and 31 % respectively). The insertions sites used are 
analysed in more detail in chapter V. 
3.4 The two ends of ISYIOO are not equally proficient for transposition 
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The in vivo transposition assay described in the previous sections can be used to study the 
requirements for transposition and the steps involved in the transposition reaction. In this 
section, differences between the left and right ends of ISY100 are explored by using mini-
transposons containing either two ISY100 left ends or two ISY100 right ends. 
Like many transposons, ISY100 is bounded by imperfect inverted repeats. The 
terminal inverted repeats of ISY100 are 24 bp long, not counting the presumed TA target 
duplication. 19 out of these 24 bp are identical between the left and right ends, and there 
are thus 5 mismatches (Figure 3.1). It is possible that one or both ends of ISY100 are 
suboptimal for transposition. As a first step to investigate this possibility, mini-transposons 
containing either two left or two right ends were constructed and tested for transposition. 
A strategy was devised to construct KanT mini-ISY100 elements with different 
combinations of left and right ends, and with different flanking dinucleotides (Figure 3.6). 
Double stranded oligonucleotides representing 30 bp from the left or right end of ISY100 
were inserted into pUC18 between EcoRI and BamHI or HindIII and BamHI sites 
respectively. Fragments from these plasmids were then combined with the BamHI KanT 
fragment from pUC4K to construct pXF153, carrying a marked mini-ISY100 element with 
one left and one right end of ISY100 (Figure 3.6A). This mini-ISY100 was then moved 
into pUC19 to create pXF195, and fragments from pXF153 and pXF195 were combined to 
make pUC-based plasmids carrying mini-ISY100s with two right ends (pXF198; Figure 
3.6A) and two left ends (pXF199; Figure 3.6A). These three plasmids were designed so 
that the mini-ISY100s could be excised without flanking TA dinucleotides by digestion 
with AcuI, and inserted into the BseRI site of pXF208 (Figure 3.6A). This yielded a set of 
plasmids carrying marked mini-ISY100 elements with one left and one right end (pXF214, 
TA-IRUTA-IRR), two right ends (pXF220, TA-IRRlTA-IRR) or two left ends (pXF226, 
TA-IRUTA-IRL). These three mini-ISY100s, with identical flanking sequences and 
differing only in the sequences of their inverted repeats, were used to make A-dv based 
donor plasmids similar to pXF116 (pXF252, pXF258 and pXF259; Figure 3.6 D). It should 
be noted that the sequences flanldng these artificial mini-transposons are different from 
those found in pXF116, which carried a mini-ISY100 in its natural Synechocystis ISY100a 
genomic context. 
The new donor plasmids were used in an in vivo transposition assay with pH2 as 
target. The transposition frequency for pXF252 (TA-IRUTA-IRR) was 2.7 ± 1.5 x 10-4 
(Table 3.6A), similar to the frequency found for pXF116 using pH2 as a target (2.2 ± 1.5 x 
50 
A) 
EcoRI Hindlll 
~
Fragment from pXF153 
+ 
8 ECOR1 -l pUC19 Hindlll ~r 
AlwNI 
SHind~~u! lRR BamHl -l pXF149 EcoRl ~r 
AlwNI 
SHin~;~1ll !RL AcuI -l pXF147 EcoR! ~r 
AlwNl 
Fragment from pXF153, 
AlwN! pXF198 and pXF199 ! +ACUI~ACUI 
Hindlll 'i><?,o~ 
8~:RI <o,<>e EcoRI pXF208 -1~r 
B) BscRJ 
NNTim 
Nt'::::l 
Acul 
---+-
!RL Kan' !RR 
EE:J"\jr ... --_--rjC31 
BamHI BamHI 
BamHI
K 
r BamHI 
+1 an. l __ 
HindlIl 
~'N-IRL 
B><:R1 
pXF215: 
pXF216: 
pXF217: 
pXF218: 
pXF219: 
'N-IRR 
TG-L/TG-R 
TC-L/TC-R 
TT-L/TT-R 
AA-L/AA-R 
CA-L/CA-R 
C) 
0) 
E) 
Hind!J( 
HinJlII BamHI r BamHI ~_~N<1N ,-I~~HI +' Kan • ' ---+-
t.." ~~ 
B=HI .,<S' 
oNN-IRR i;<Y<O 
B,eRI ~~ 
ErnRl 
A!wNI 
Xbal TA-IRR 
Hindlll Acul recognition site Acul cleavage site 
GCT CTGAA TAAGAGCGCAGTATAGTAGTTTCAAATA .. . 
GACTT ATTCTCGCGTCA~CATCAAAGTTTAT .. . 
IRR 
EcoRI Acul recognition site Acul cleavage site 
... GATTAC ATT CTGAA TAAGAGCGCAGTATAGTCATTTCAATTA .. . 
. . . CTAATGCTTA GACTT ATTCTCGCGTCA~CAGTAAAGTTAAT .. . 
IRL 
BseRI recognition site BseRI cleavage site 
TA-IRL 
EcoRI 
Figure 3.6 Construction of donor plasmids carrying transposase mutants, changes at 
the IRs of mini-ISYIOO or the flanking sequence of the mini-ISYIOO. A) Construction 
ofpUC18-based plasmids carrying mini-ISYIOO with IRL and IRR, two IRRs and two 
IRLs. B) Construction of pUC18-based plasmids carrying mini-ISYlOO with identical 
flanking sequences apart from TAdinucleotides. C) Construction ofpUC18-based plasmids 
carrying mini-ISYIOO flanked by TA at one end and other dinucleotides at the other end. 
D) Construction ofA-dv donorplasmids from pUC 1 8-based plasmids carrying mini-ISYIOO 
with different ends or flanking dinucleotides, or pTrc99a-based plasmids carrying mutated 
transposase genes. E) Sequences of ds oligonucleotides inserted into pUC18 to make 
pXF149, pXF147 and pXF208-213. 
Table 3.6 Mutations at the transposase, transposon ends and flanking 
dinucleotides affect in vivo transposition frequency 
A) Inverted repeats sequences affect in vivo transposition frequency 
Transposition frequency 
Mini-ISYlOO Reac- Ampf Kanf (x 10-6) pH2+ and Flanking tion (xl04) Kan
f emf 
emS 
sequence NoY) Average/ Individual (relative) 
16 156 400 1/20 380 244 
pXF252 TA-L/TA-R 17 101 442 0/20 442 438 273 ± 152 (Wild-type) (100%) 
18 134 186 0/20 186 139 
34 153 103 0/20 103 67.3 65.1 ± 11.4 
pXF258 TA-RiTA-R 35 145 109 0/20 109 75.2 (23.8%) 
36 201 112 1/20 106 52.7 
37 98 548 0/20 548 559 
pXF259 TA-L/TA-L 38 122 656 0/20 656 538 563 ± 27 (206%) 
39 117 692 0/20 692 591 
B) Mutations in DDE motif inactivate ISYlOO transposase 
Reac- Transposition frequency Mutation in 
tion 
Ampf 
Kanf emf Kan
f (x 10-6) 
pH2+ Transposase No.(l) (x 104) emS Individual Average / (relative) 
16 156 400 1/20 380 244 
pXF252 Wild-type 17 101 442 0/20 442 438 273 ± 152 (100%) 
18 134 186 0/20 186 139 
1* 185 5 0/5 5 2.70 
pXF246 D136A 2* 99 6 1/6 5 5.05 3.75 ± 1.19 (1.37%) 
3* 143 9 4/9 5 3.50 
4* 155 7 117 6 3.87 
pXF247 D218A 5* 151 3 0/3 3 1.99 3.03 ± 0.96 (1.11%) 
6* 155 7 217 5 3.23 
7* 146 9 1/9 8 5.48 
pXF248 E253A 8* 149 2 0/2 2 1.34 3.10 ± 2.14 (1.13%) 
9* 162 4 0/4 4 2.47 
40* 162 2 0/2 2 1.23 
pXF249 K260A 41* 123 4 1/4 3 2.44 1.40 ± 0.97 (0.51 %) 
42* 189 1 0/1 1 0.53 
10* 126 7 117 6 4.76 
pXF25 0 R261A 11* 164 8 2/8 6 3.66 3.39 ± 1.52 (1.24%) 
12* 170 7 417 3 1.76 
13* 182 8 4/8 4 2.20 
pXF251 KR260AA 14* 147 5 2/5 3 2.04 2.60 ± 0.84 (0.95%) 
15* 140 7 217 5 3.57 
C) Mutations in flanking dinuc1eotides affect in vivo transposition frequency 
Mini-ISY100 Reac- Transposition frequency 
pH2+ and Flanking tion 
Ampf 
Kanf Cmf Kan' (x 10-
6) 
NoY) (x 104) Cms Average/ sequence Individual (relative) 
19* 72 5 115 4 5.56 
pXF253 TG-L1TG-R 20 97 42 3120 36 37.1 16.2 ± 18.l (5.92%) 
21* 68 7 3/7 4 5.88 
22* 105 3 1/3 2 1.90 
pXF254 TC-L1TC-R 23* 109 3 2/3 1 0.92 1.55 ± 0.55 (0.57%) 
24* 163 6 3/6 3 1.84 
25* 186 4 3/4 1 0.54 1.32 ± 0.70 
pXF255 TT-L1TT-R 26* 157 4 1/4 3 1.91 (0.48%) 
27* 200 6 3/6 3 1.50 
28* 192 3 2/3 1 0.52 
pXF256 AA-L1AA-R 29* 300 7 2/7 5 1.67 2.37 ± 2.28 (0.87%) 
30 183 12 3/12 9 4.92 
31 235 201 0120 201 85.5 
pXF257 CA-L/CA-R 32 189 352 0120 352 186 105 ± 73 (38.5%) 
33 184 85 1120 81 44.0 
43 131 518 0120 518 395 
pXF265 TG-L1TA-R 44 192 535 0/20 535 279 335 ± 59 (123%) 
45 262 868 0120 868 331 
46 159 11 4/11 7 4.40 
pXF266 TC-L1TA-R 47 163 22 5122 17 10.4 10.4 ± 6.0 (3.82%) 
48 164 34 4120 27 16.5 
49 167 96 2120 86 51.5 
pXF267 TT-R1TA-R 50 178 104 0120 104 58.4 49.5 ± 10.1 (76.l%)(2) 
51 210 81 0120 81 38.6 
52 149 260 1120 247 166 
pXF268 AA-R1TA-R 53 167 312 0/20 312 187 174 ± 11 (267%)(2) 
54 162 288 1120 274 169 
55 126 59 2120 53 42.1 
pXF269 CA-R1TA-R 56 176 214 2120 193 109 89.0 ± 40.7 (l37%/2) 
57 177 204 0120 204 115 
(1): Reaction number corresponds to the lane number in Figure 3.8 
(2): Compared with the donor plasmid carrying mini-ISYlOO TA-RiTA-R. 
*: No DNA was recovered from single Kanl' Cms colonies picked from these reactions. 
Standard in vivo transposition assays employing pH2 as target plasmid were carried out as 
described in section 2.19. Donor plasmids containing mutants in the transposase, or 
changes in the mini-ISYlOO at the IRs or flanking dinuc1eotides were tested. For each 
donor plasmid, three individual assays were performed. The transposition frequency is 
given as the ratio of KanT Cms to Ampl' colonies and also as a percentage of the frequency 
obtained with the appropriate unchanged donor plasmid. 
10-4; Table 3.5). Thus there seems to be little difference in transposition frequency due to 
the differences in flanking sequences in the new plasmids. The mini-ISY100 with two left 
ends (pXF259; TA-IRLlTA-IRL) transposed 2. I-fold more efficiently than the transposon 
with one left and one light end, giving a transposition frequency of 5.6 ± 0.3 x 10-4 (Table 
3.6A). In contrast, the transposon with two light ends (pXF258; TA-IRRlTA-IRR) 
transposed 4.2-fold less efficiently than the transposon with one left and one light end, 
giving a transposition frequency of 6.5 ± 1.1 x 10-5 (Table 3.6A). It seems that the 
sequence of the left end is in some way more optimal for transposition than the light end. 
The step in the transposition reaction affected by these sequence differences is studied in 
more detail in chapter IV. 
3.5 The effects of changing the flanking TA dinucleotides 
As well as the transposon ends, the flanking sequences of some transposons may affect 
their transposition (Ason and Reznikoff, 2004; Jaworski and Clewell, 1994). Although no 
difference was observed in transposition frequency between a donor plasmid containing 
ISY100 in its natural context (pXFl16, Table 3.5) and one containing ISY100 in an 
artificial context (pXF252, Table 3.6A), both of these donor transposons are flanked by the 
normal TA dinucleotide. To see if this sequence is important for transposition, it was 
decided to change it at one or both transposon ends. Another reason to change the sequence 
of the TA dinucleotides flanking ISY100 is to obtain information about the boundalies of 
the transposon (see section 1.4.1). 
The AcuI fragment from pXF153, carrying the mini-ISY100 without its flanking TA 
dinucleotides, was inserted into a selies of double stranded oligonucleotides cloned in 
pUC18. This produced a set of plasmids carrying mini-transposons with altered flanking 
dinucleotides (Figure 3.6B, E). These mini-transposons had one left inverted end (IRL) , 
one light inverted repeat (IRR) and identical changes in the flanking dinucleotides at both 
ends. These mini-transposons are referred to here as NN-LINN-R, where the sequence of 
the flanking dinucleotide is given at both ends reading 5' to 3' from the outside towards the 
transposon inverted repeat. The A at position -1, just outside the proposed transposon end, 
was changed to all three possible nucleotides, producing TG-LlTG-R, TC-LlTC-R and TI-
LlTI -R. The T at position -2 was changed to two of the three other possible nucleotides, 
giving CA-LlCA-R and AA-LlAA-R. 
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A-dv based donor plasmids carrying the wild-type transposase cassette and these 
altered mini-transposons were constructed (Figure 3.6 D) and tested in a standard in vivo 
transposition assay (Table 3.6C). Changing the A at the -1 position to a G at both ends led 
to a reduction in transposition frequency to 5.9% of the wild-type level (Figure 3.7). 
Changing this A to C or T at both ends led to a further decrease in transposition frequency, 
to 0.6% or 0.5% of the wild-type level (Figure 3.7). Changing the T at the -2 position to C 
at both ends resulted in a decrease in transposition frequency to 38.5% of the wild-type 
level, while changing it to an A decreased the transposition frequency to 0.9% of wild-
type. 
Donor plasmids were also constructed with changes to the flanking TA at only one 
end (Figure 3.6C). Two plasmids were constructed containing IRR with the normal 
flanldng TA, and IRL with the A at position -1 changed to either G or C (TG-LiTA-R and 
TC-LlTA-R). Another three plasmids were constructed, which unintentionally contained 
two copies of IRR, with TA at one end and TT, AA or CA at the other end (TT-RiTA-R, 
AA-RiTA-R and CA-RiTA-R) (Figure 3.6C). In the constructs with one IRR and one IRL, 
changing the A adjacent to IRL at position -1 to G gave a small increase in the 
transposition frequency, whereas changing this A to C decreased the frequency to 3.8% of 
the wild-type transposition level (Table 3.6C; Figure 3.7). Changing the A at position -1 to 
T at one end of the IRRlIRR mini-ISYlOO decreased the transposition frequency slightly, 
to 76% of the level seen for TA-RiTA-R. Changing the T at position -2 to A, at one end of 
the IRRlIRR mini-ISYlOO, increased the transposition 2.67-fold, while changing this T to 
a C increased the transposition frequency 1.37-fold relative to TA-RiTA-R. It is hard to 
explain why changes at one end appear to increase the transposition frequency of the mini-
transposon with two right ends, and some of these results might be due to random variation 
in the assay. However some general conclusions can be drawn. The effect of changing the 
TA at only one end is much less severe than the effect of the equivalent change at both 
ends (Figure 3.7). At position -1 the order of preference appears to be A»G>T=:C, so that 
purines are preferred over pyrimidines, but a T is better than a C, while the base at the -2 
position seems to be less important than the base at position -1. 
Plasmid DNA was purified from a single Kanr Cms colony for each transposition 
reaction (3 for each donor plasmid), and a BamHI digestion was carried out to check that 
transposition had taken place. Surprisingly, a number of colonies failed to give any 
plasmid DNA at all (Figure 3.8). These colonies were all from reactions giving low 
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Figure 3.8 Restriction analysis of purified plasmids from in vivo transposition assays. 
In vivo transposition assays employing target plasmid pH2 and donor plasmids carrying 
transposase mutants, changes at the IRs of mini-ISYI 00 or the flanking sequence of the 
mini-ISYI00 were carried out as described in Table 3.6. Plasmid was purified from one 
randomly selected single Kanr Cms colony for each individual assay and subjected to 1.2% 
agarose gel electrophoresis after cleavage with BamHI. The number of each digestion 
corresponds to the number of the assay showed in Table 3.6. A brief description of the 
assay is given above each set of 3 lanes. 
transposition frequencies « 1 % of wild-type level, or a total number of Kanl' Cms colonies 
< 7) and might be explained in several ways. One possibility is that transposition occurs 
after electroporation into DS964, and is from the donor plasmid onto the chromosome of 
DS964. This will give a KanT Cms colony canying an insertion of marked mini-ISYlOO on 
the chromosome of DS964, but containing no plasmid. Another possibility is that there was 
a low level of contamination of the DS964 electrocompetent cells during this experiment. 
Unfortunately, a negative control electroporation was not carried out to test this possibility 
during these experiments. It seems likely that many or all of the colonies seen at low 
frequency in these assays are the result of some background process that may not involve 
transposition, so that the transposition frequencies reported in Table 3.6 should be taken as 
maximum values. 
All of the colonies that yielded plasmid DNA gave restriction patterns consistent with 
insertion of mini-ISYlOO into different sites in pH2 (Figure 3.8). This included one 
plasmid from a donor with the A at position -1 changed to a G at both ends and 9 plasmids 
from donors with the A at position -1 changed to G, C or T at only one end. All of the 
resulting plasmids were sequenced with outward facing mini-ISYlOO primers. All of the 
mini-ISYlOO had inserted into TA targets in pH2 and were flanked by TA dinucleotides at 
both ends, regardless of the flanking sequence in the donor plasmid (Figure 5.4). Therefore 
the T A dinucleotides at the inseltion sites are target duplications and are not part of the 
transposon, consistent with the sequence of the excised ISYlOO repOlted by Urasaki et al. 
(2002) and the cleavage sites mapped in vitro in chapter 4. 
3.6 Mutations in the DDE catalytic motif abolish transposition in vivo 
To test the requirement for the three acidic residues of the proposed DDE motif of ISYlOO 
transposase, the codons for D136, D218 and E253 (Figure 3.1) were individually changed 
to alanine codons by site-directed mutagenesis. The mutant transposase genes were then 
used to replace the wild-type transposase gene in pXF116 to make a new set of donor 
plasmid (Figure 3.6E), and the tested in triplicate in a standard in vivo transposition assay 
(Table 3.6B). The transposition frequencies from all three mutant transposases were less 
than 1.5% of the wild-type frequency, and no more than 6 Kad' Cms colonies were 
observed in any transposition assay. A single Kan l' Cms colony was picked from each assay 
and used to isolate plasmid DNA. However, no plasmid DNA was recovered from any of 
these colonies (Figure 3.8). These assays were canied out at the same time as the assays 
53 
reported in section 3.5, and it appears that the same level of background events are giving 
rise to KanT Cms colonies that do not represent transposition events. Nevertheless, it is safe 
to conclude that mutations in the DDE motif substantially reduce the transposition 
frequency. 
A number of transposases from various transposon families contain a conserved basic 
residue (lysine or arginine) 6-7 amino acids downstream from the glutamate residue in the 
DDE motif. In the IS4 family, this conserved lysine is a part of Y(2)R(3)E(6)K signature, 
in which the E is the last acidic amino acid of the DDE motif acting in the catalytic 
activity. This motif is involved in binding hairpins at the termini of these elements. Studies 
on the IS4 members Tn5 (Naumann and Reznikoff, 2002) and TnlO (Bolland and 
Kleckner, 1996) demonstrated that mutations in the Y or R residues of this YREK 
signature reduced the overall catalytic activity of transposases whereas mutation at the K 
residue reduced the ability of Tn5 transposase to form protein-DNA complexes (Naumann 
and Reznikoff, 2002). Although no conserved Y and R residues are found in the correct 
position relative to the DDE motif in members of IS630/Telimariner supelfamily, some 
active transposases like Tel, Sleeping Beauty and ISYlOO have basic residues (K and/or R) 
in the correct position. ISYlOO transposase has two basic residues (K260 and R261) 6 and 
7 residues downstream from E253. To see if these residues are important for catalysis of 
transposition, they were changed to alanine, and tested for their effects on transposition in 
vivo. Single mutants K260A and R261A and the double mutant transposase gave 
transposition frequencies of <1.5% of wild-type transposase, and again no plasmid DNA 
could be recovered from the KanT Cms colonies representing apparent transposition events 
(Figure 3.7, Table 3.6B). 
3.7 Discussion 
In this chapter, a standardised in vivo transposition assay was set up for ISYlOO 
transposition. This assay was used to study the effects of changing the sequences of the 
terminal inverted repeats of ISYlOO and their flanking sequences. Mutations in proposed 
catalytic residues of the transposase protein were also studied. 
Transposons containing two left ends transposed at a higher frequency than 
transposons containing two right ends, so it appears that the left end is in some way better 
for transposition. This situation seems to be quite common in transposons. For instance, a 
similar study on the Mos1 mariner element revealed that a transposon with two right ends 
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jumped more efficiently in bacteria than one with one left and one right end (Auge-
Gouillou et al., 2001). There are five differences between the sequences of the left and 
right inverted repeats of ISYlOO. The sequences responsible for the different efficiencies 
of transposition could be ascertained by making mosaic ends, combining sequences from 
both left and right ends as has been done for Tn5 (Zhou et aI., 1998). However, this has not 
yet been done. 
Changes in the TA dinucleotides that normally flank ISYlOO were also studied. 
Changes in these sequences had a surprisingly large effect on the transposition frequency. 
Changes at position -1 had a stronger effect than changes at position -2, transitions (pUline 
to purine and pyrimidine to pyrimidine) were tolerated better than trans versions and 
changes at a single end had a much smaller effect than changes at both ends. 
Sequencing the products of transposition from donors with alterations in the flanking 
TAs revealed important information about the exact boundaries of the transposon. Two 
strategies have been used to determine these boundaries and whether the target T A is 
duplicated during transposition. One method is to analyse the cleavage points in the 
excised transposon. For ISYlOO the ends of the excised transposon produced in vivo have 
been mapped precisely by Urasaki et al. (2002). Their study indicated that the TA is not 
part of the excised transposon, and these results are consistent with my findings in vitro 
(Chapter IV). The other strategy is to change the sequence of the dinucleotides flanking the 
donor transposon and to ascertain whether these changes are moved with the transposon to 
new insertion sites. When changes were made at the -1 positions at both ends of the 
transposon, transposition was rare. However the one event recovered and sequenced had 
inserted into a TA and had the normal TA flanking sequences. When changes at -1 position 
were made at only one end, transposition was more efficient and a total of 9 insertions 
were recovered and sequenced at both ends. All of these insertions contained TAs at both 
ends, again consistent with duplication of the target TA (Figure 5.4). It therefore appears 
that the flanking TAs are target duplication and not part of the transposon, consistent with 
findings for all other members of the IS630/Tcl/mariner family of transposons. 
In previous experiment on IS630 and Tc3, the flanking TAs were changed to GA or 
GC (Tenzen et al., 1990; van Luenen et al., 1994). These changes had a much smaller 
effect on transposition frequency than those reported here. However, all insertions were 
into TA targets and these TAs were duplicated, consistent with the result shown here. 
Finally, the in vivo transposition assay was used to study the effects of mutations in 
the DDE motif of ISYlOO transposase. These three residues coordinate one or two divalent 
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metal ions (Mg2+ or Mn2+) in the crystal structures of a number of transposase proteins and 
retroviral integrases (Bujacz et al., 1996; Davies et al., 2000; Hickman et al., 2000; 
Maignan et aI., 1998; Richardson et al., 2006) and are essential for catalysis. Consistent 
with this finding, mutations in any of these three residues in ISYlOO transposase reduced 
transposition in vivo to the background level of the assay. Mutations in two basic residues 
just downstream from the E253 had a similar effect on transposition, suggesting these 
residues may playa catalytic role in transposition. However, the significance of this result 
is less clear because these residues are not conserved in other members of the 
IS630/Tc 1/mariner family. 
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CHAPTER IV 
Transposition of ISYIOO in vitro 
4.1 Introduction 
The prevIous chapter reports my studies of ISYlOO transposition in vivo In E. coli. 
Although these studies gave us important information about ISYlOO transposition, an in 
vitro system is required to determine the detailed mechanism of ISYlOO transposition. The 
transposition reaction can be broken down into a number of different steps which include: 
binding of transposase to IR sequences, synapsis of transposon ends, cleavage of 
transferred and non-transferred strands, target binding and strand transfer. With an in vitro 
transposition system using purified transposase, each of these steps can be studied 
individually. For example, electrophoretic mobility shift and footprinting assays can be 
used to study the protein and DNA requirements for DNA binding and synapsis. Cleavage 
and transposition assays with simple oligonucleotide substrates can provide important 
information about the biochemical mechanism of the later steps in the reaction. In addition, 
if the entire transposition reaction can be made efficient, the in vitro system could be used 
for a number of practical applications. These include the generation of insertion libraries to 
characterise plasmid-borne genes and provide primer sites for sequencing projects. 
In this chapter, the purification of a His-tagged version of ISYlOO transposase is 
described. It is demonstrated that this protein has transposition activity in vitro. Various 
steps in the transposition mechanism, including DNA binding, cleavage of transferred and 
non-transferred strands, and the strand transfer reaction are then studied in more detail. 
4.2 Purification of His-tagged ISY100 transposase by metal chelate 
affinity chromatography 
To study transposition in vitro, the first challenge is to obtain soluble and active 
transposase protein. Purification removes any contaminating activities such as nucleases 
and proteases, which might interfere with transposition and other assays. Furthermore, 
purification will allow the identification of any host factors that are necessary for 
transposition. Many transposase proteins are poorly soluble and over-expression in 
bacterial expression systems often leads to the production of insoluble inclusion bodies. A 
number of different strategies have been used to overcome this problem including: 
expressing the transposase as a fusion protein, expressing it at relatively low temperatures 
(25° - 30°C) to reduce the expression rate and allow chaperone proteins to aid proper 
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protein folding, using detergents, high ionic strength and other unusual buffer conditions to 
increase protein solubility, and using mutant transposases with increased solubility. 
The solubility of ISYlOO transposase, and how it was affected by induction and cell 
lysis conditions was first investigated. ISYlOO transposase with a C-terminal 6-His-tag has 
approximately the same activity as wild-type transposase in vivo (see chapter III). Since 
proteins containing a His-tag can be purified relatively simply using metal affinity 
chromatography, it was decided to use the His-tagged ISYlOO transposase in these studies. 
A DNA fragment containing the His-tagged transposase gene was excised from pXF105 
(Chapter III) and inserted into the bacterial expression vector pKET3a as a Ndel-BamHI 
fragment to make pXF102 (Figure 4.1A). This places the transposase gene under the 
control of the strong T7 promoter. pXF102 was transformed into the E. coli B strain BL21 
<DE3> with or without pLysS. Upon induction with IPTG, BL21<DE3> expresses a 
chromosomal copy of the T7 RNA polymerase gene from the lacUV5 promoter. pLysS 
encodes the T7 lysozyme gene, a natural inhibitor of the T7 RNA polymerase, and 
therefore cuts down on the levels of gene expression, both in the absence and the presence 
of IPTG, which might be helpful in the case of toxic proteins. BL21 also lacks the Lon and 
OmpT proteases, which may help to prevent proteolytic degradation of the over-expressed 
transposase protein. 
BL21<DE3> pXF102 and BL21 <DE3> pLysS pXF102 were grown in L-broth to an 
OD6oo of 0.5, and the expression of transposase was induced by adding IPTG to 0.5 mM. 
Cells were grown for a further 2 hours at 37°C and cells were then harvested and analysed 
by SDS-PAGE. A protein of the correct size to be ISYlOO transposase (33.6 kDa) was 
present in the induced cultures, but absent in the uninduced control cultures, with and 
without pLysS (Figure 4.1B). However, BL21 <DE3> pLysS gave a slightly higher level 
of expression. It was noticed that the strain without pLysS grew slower than that 
containing pLysS, even in the absence of IPTG, suggesting that there might be a low level 
of transposase expression in the absence of pLysS, and that this is harmful to the host cell. 
This might lead to selection for cells that have lost the expression plasmid, or plasmid 
mutants that do not express transposase, and give a lower level of expression. It was 
therefore decided to use BL21 <DE3> pLysS pXF102 in subsequent expression 
experiments. 
Since many transposase proteins are insoluble after over-expreSSIOn III E. coli, 
finding cell lysis conditions to maximise the amount of soluble transposase protein was the 
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Figure 4.1 Expression of His-tagged ISYI00 transposase in BL21 <DE3> and BL21 
<DE3> pLysS. A) Map of the expression plasmid pXF102. ISYIOO transposase with a 
C-tennina1 His6 tag was expressed from the T7 promoter in pKET3a, a kanamycin resistant 
version ofpET3a (Studier et ai.) 1990; S.l Rowland unpublished) B) His-tagged ISY100 
transposase was expressed from pXF102 in BL21 <DE3> (lanes 2 and 3) or BL21 <DE3> 
pLysS (lanes 4 and 5). P1asmid-canying strains were either uninduced (U) or induced (1) 
with 0.5 mM IPTG. Lane 1 contains a protein standard marker. Transposase is indicated 
by an alTOw. 
first priority. The solubility of transposase in vanous cell lysis buffers was therefore 
investigated. Lysis buffers containing 50 mM Tris-HCI (pH 7.6), 0.1 mM EDTA and 
different concentrations of NaCI were first tried. It was found that the majority of 
transposase was soluble at all of the NaCI concentrations tested, from 0 mM to 1 M. The 
addition of 0.2% triton X-IOO increased the solubility of transposase, especially at high 
NaCI concentrations. 
When the cells were lysed at 0 mM NaCl, the transposase could be co-precipitated 
with DNA, by the addition of 2.5 mM spermine. It appears that much of the transposase is 
associated with cellular DNA at low ionic strength. Transposase could then be recovered 
from the spelmine pellet in a buffer containing 1 M NaCI and 0.2% triton X-IOO. The His-
tagged protein could then be purified further using metal chelate affinity chromatography 
on a Ni-NTA column. Transposase bound well to the column in this buffer, and was eluted 
by the addition of 200 mM imidazole. One slight disadvantage of using triton X-IOO is that 
its absorbance peaks at 254 nm and 278 nm made it difficult to monitor the protein 
purification by ultraviolet absorption at 260 nm and 280 nm. 
The steps outlined above were used to develop a non-denaturing purification of 
ISYIOO transposase as outlined in Figure 4.2 and described in detail in chapter II. The 
purification was followed by coomassie-stained SDS-PAGE and the results of a typical 
purification are shown in Figure 4.3. Comparison of lanes 3 and 4 shows that the majority 
of the transposase was soluble in the lysis buffer, although some was insoluble. 
Precipitation with spermine is a very good step and removes many of the contaminating 
cellular proteins (Figure 4.3; lanes 5-6). Recovery in buffer A (containing 1 M NaCI and 
0.2% triton X-IOO) was also very efficient (Figure 4.3; lanes 7-8). Comparison of lanes 8 
and 9 shows that more than 50% of the transposase bound to the Ni-NTA column while 
most of the contaminating proteins flowed through. It is possible that the His-tag is not 
available for binding to the column on a proportion of the protein, perhaps because the 
protein is misfolded or maybe because the His-tag is bound by some other factors. Low 
concentrations of imidazole (20 - 50 mM) were used to elute proteins which were not 
tightly bound to the column (Figure 4.3; lanes 11, 12) and transposase eluted from the 
column substantially pure at an imidazole concentration of 200 mM (Figure 4.3; lane 13-
16). Imidazole was removed by dialysis, an equal volume of glycerol was added to the 
dialysed transposase, and it was stored at -20°C for future use. Typical transposase 
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Sonication (15s x 3) in 50 mM Tris (pH 7.5),1 mM PMSF 
and 14.3 mM p-mercaptoethanol 
~ 
Centrifuge 28,300g, 4°C 15 mins 
~ ~ 
Supernatant Pellet 
~ 
Add spermine to 2.5 mM 
~ 
Ice 10 mins, centrifuge 20,000g, 4°C 5 mins 
! ~ 
Pellet Supernatant 
! 
Resuspended in Buffer A [1M NaCI,50 mM Tris (pH7.5),O.2% Triton X-100] 
! 
Ice 1 hr, centrifuge 20,000g, 4°C 15' mins 
! ~ 
Supernatant 
! 
Pellet 
Load on Ni-NTA column 
! ~ 
Wash with Buffer A Flow through 
! 
Wash with Buffer A + 20 mM imidazole 
~ 
Wash with Buffer A + 50 mM imidazole 
~ 
Wash with Buffer A + 200 mM imidazole 
~ 
Dialyse and store at -20°C with 50% glycerol 
Figure 4.2 Flowchart for the purification ofISYlOO transposase. 
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Figure 4.3 SDS-polyacrylamide gel electrophoresis of fractions obtained during 
purification of ISYIOO transposase by Ni-NTA column chromatography. Approximately 
equivalent proportions of the total material were loaded at each step. 
Lane 1: Protein standard marker 
Lane 2: IPTG induced BL21 <DE3> pLysS pXF102 whole cells (C) 
Lane 3: Sonication pellet (P) 
Lane 4: Sonication supernatant (SN) 
Lane 5: Spermine supernatant (Sp SN) 
Lane 6: Spermine pellet (Sp P) 
Lane 7: 1 M NaCl/triton X-100 pellet (P) 
Lane 8: 1 M NaClItriton X-100 supernatant (load) (S) 
Lane 9: Flow through (FT) 
Lane 10: Buffer A wash 
Lane 11: Buffer A plus 20 mM imidazole wash fraction #5 
Lane 12: Buffer A plus 50 mM imidazole wash fraction #5 
Lane 13-16: Buffer A plus 200 mM imidazole elution fractions 3 - 6 
concentrations were 0.09 - 0.17 mg/ml. Transposase stored at -200 remained stable and 
active for at least one year in these conditions. 
In other experiments, the transposase was purified under denaturing condition. Cells 
expressing transposase were broken in a buffer containing 6 M urea and centrifuged at 
28,300 g to remove insoluble material. The supernatant was then directly applied onto a 
Ni-NTA column. The column was washed with low concentrations of imidazole in a buffer 
containing 6 M urea, and transposase was then eluted in the same buffer containing 200 
mM imidazole. The purified transposase was then renatured by dialysis against a buffer 
containing no urea (see chapter II for details). The transposase purified in this way showed 
the same activity in vitro as that purified under native condition (data not shown). 
4.3 Purified transposase binds to transposon ends 
The simplest assay for transposase activity is for binding to transposon end sequences. 
Electrophoretic mobility shift assays (EMS A) were therefore used to investigate binding of 
fractions from the transposase purification to a DNA fragment IRL 29, which contains 29 
bp from the left end of ISYlOO (Figure 4.4). The induced BL21 <DE3> plysS pXF102 cell 
extract bound to this DNA fragment to give one major retarded complex (Figure 4.5, lane 
2, complex I). This binding appears to be dependent on expression of ISYI00 transposase 
since an extract from cells containing just the empty expression vector did not bind to a 79 
bp labelled DNA fragment IRL79 (Figure 4.lOB, lane 2), containing 51 bp from the left 
end of ISYlOO (Figure 4.4). The DNA binding activity was still present in the spermine 
precipitated material (Figure 4.5, lane 3), though at least two other slower migrating 
complexes (II and III) were also visible. The majority of the DNA-binding activity 
producing complexes I and III did not bind to the nickel column, coming out in the flow 
through and the buffer A wash (Figure 4.5, lanes 4 and 5). In contrast, the purified full-
length protein eluting at 200 mM imidazole specifically produced complex II. One possible 
explanation of this is that proteolytic fragments of transposase with DNA-binding activity 
were present in the cell extract. Since transposase has a C-terminal His-tag, N-terminal 
fragments will flow through the nickel column, whereas full-length transposase, and any 
C-terminal fragments, will bind to the column and elute at 200 mM imidazole. Consistent 
with this idea, N-telminal fragments of transposase bound to transposon end sequences 
producing complexes with similar mobility to complex I in Figure 4.5 (see section 4.3.2). 
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IRL79: 
IRL 
.. 
5'- tagtttctaaagtaaaaattaagaggtaTAGTCATTTCAATTAACGATGAGAGAATTTAA 
atcaaagatttcatttttaattctccatATCAGTAAAGTTAATTGCTACTCTCTTAAATT 
TGTAAAATTATGGAGTGTA-3' 
ACATTTTAATACCTCACAT 
IRR58: 
.. 
IRR 
5'- acgaattcctgaagaggaggatcagctaTAGTAGTTTCAAATAAAGCTGAGACGCTAA -3' 
tgcttaaggacttctcctcctagtcgatATCATCAAAGTTTATTTCGACTCTGCGATT 
IRL29 (Apol fragment from pXF11 0): 
5'-
Apol 
tattc~tatgtccggacttcgctatagtttctaaagtaaaaattaagagg 
g atacaggcctgaagcgatatcaaagatttcatttttaattctcc 
.. IRL taTAGTCATTTCAATTAACGATGAG~ - 3 ' atATCAGTAAAGTTAATTGCTACTC~ 
Apol 
IRR30 (EcoRI-Hindlli fragment of pXF149): 
Hindlll .. IRR 
5'- lagctt~tgaagctaagagcgCagtaTAGTAGTTTCAAATAAAGCTGAGACGCTAA 
a acttcgattctcgcgtcatATCATCAAAGTTTATTTCGACTCTGCGATT 
ggatccccgggtaccgagct~ -3' 
cctaggggcccatggctcga~ 
EcoRI 
IRL30 (EcoRI-Hindlll fragment of pXF147): 
EcoRI IRL 
5'- laatt~tgaagctaagagcgCagta~AGTCATTTCAATTAACGATGAGAGAATTT 
acttcgattctcgcgtcatATCAGTAAAGTTAATTGCTACTCTCTTAAA 
ggatcctctagagtcgacctgcaggcatg~ -3' 
cctaggagatctcagctggacgtccgtac~ 
Hindlll 
IRR49 ( Hindlll-EcoRI or Hindlll-BamHI fragment of pXF121) 
Hindlll 
5'- lagctlgcatgcctgcaggtcgactctagatgtcctcatccgtataatgct 
cgtacggacgtccagctgagatctacaggagtaggcatattacga 
.. 
IRR 
ttctcgtattaTAGTAGTTTCAAATAAAGCTGAGACGCTAAACGCCACAG 
aagagcataatATCATCAAAGTTTATTTCGACTCTGCGATTTGCGGTGTC 
TAAGAACGG~gatc~cgggtaccgagct~-3' 
ATTCTTGCC ctag gcccatggctcga~ 
BamHI EcoRI 
Figure 4.4 Sequences of fragments containing ISYIOO end sequences used in binding 
and footprinting reactions. Transposon sequences are shown in uppercase, the 24 bp 
inverted repeats are shown in bold. IRL 79 and IRR58 were made by annealing single 
stranded oligonucleotides. The other fragments were obtained from plasmids by restriction 
digestion as indicated. 
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Figure 4.5 DNA-binding activities of fractions from the purification. Indicated fractions 
from the purification ofISY100 transposase (Figure 4.3) were incubated with 3' end-
labelled IRL29, in a standard binding reaction for 5 minutes at 30°C. Bound and unbound 
DNA were separated on a 6% native polyacrylamide gel. 
Lane 1: Protein dilution buffer 
Lane 2: BL21 <DE3> pLysS pXF102 sonication supernatant 
Lane 3: Spermine pellet resuspended in 1M NaCI and 0.2% triton X-lOa (column load) 
Lane 4: Ni-NTA flow through 
Lane 5: Buffer A wash 
Lane 6: Buffer A plus 20 mM imidazole wash fraction #6 
Lane 7: Buffer A plus 20 mM imidazole wash fraction #7 
Lane 8: Buffer A plus 50 mM imidazole wash fraction #5 
Lane 9: Buffer A plus 200 mM imidazole elution fraction #3 - #6 mixture 
Lane 10: Buffer A plus 200 mM imidazole elution fraction #7 - #8 mixture 
Further binding assays were canied out with the purified full-length transposase. To 
measure the affinity of binding, transposase dilutions were incubated with a DNA fragment 
IRL30 or IRR30 (Figure 4.6), containing 30 bp from either the left or the right end of 
ISYlOO (Figure 4.4). Transposase bound to both DNA fragments with similar affinity, 
giving 50% binding somewhere between the 2-0 and the Tl dilutions, corresponding to an 
apparent Kd of approximately 130 nM. Both left and right end fragments gave single 
retarded complexes with similar mobility to each other (relative mobility Rf = 0.70 and 
0.71 respectively) and to complex II in Figure 4.6 (Rf = 0.71). The fact that 30 bp of 
ISYlOO end sequences were sufficient for DNA binding is consistent with the fact that 
these same end sequences were functional for transposition in vivo (see chapter III). 
4.3.1 Analysis of transposase binding by DNase I footprinting 
The experiments above suggest that purified transposase can bind to ISYlOO ends. Binding 
reactions were carried out in the presence of a large excess of poly dIdC so this binding 
appears to be specific. To find out what regions of ISYlOO ends are bound by transposase, 
DNase I footprinting experiments were carried out. DNase I footprinting is one of the 
simplest methods for mapping protein binding sites on DNA (Galas and Schmitz, 1978), 
and has been used to study transposase-DNA interactions for many different transposons 
for example see Arciszewska et al., (1991) and Mizuuchi et al., (1991). DNase I cuts 
double-stranded DNA relatively non-specifically, leaving 5'-phosphate and 3'-hydroxyl 
ends. Where a protein is bound to the DNA, it prevents access by DNase I, producing a 
"footprint" of uncleaved positions in the DNA molecule. 
DNA restriction fragments containing transposon right end sequences were 3' end 
labelled at just one end on either the top or the bottom strand. Work on other transposons 
has shown that the 3' -OR at the transposon end is transferred to the target DNA (Bainton 
et al., 1991; Bhasin et al., 1999; Mizuuchi, 1984). This is later shown also to be the case 
for ISYlOO (see section 4.7). The bottom and top strands as shown in Figure 4.4 are 
hereafter referred to throughout this chapter as transferred and non-transfened strands 
according to this result. Labelled DNA fragments were incubated in binding buffer with or 
without transposase, and then subjected to mild cleavage by DNase I, to cleave the DNA 
on average once per molecule. The cleavage products were then separated on a denaturing 
polyacrylamide gel adjacent to a Maxam and Gilbert G plus A sequencing ladder (Figure 
4.7 A) (Maxam and Gilbert, 1980). Comparison of the ladders produced in the presence and 
absence of transposase reveals the sequences that were protected by transposase, and the 
62 
Tnp 
Tnp-IRL. 
Complex III .- Tnp-IRR "' " Complex 
5' 3'. Ii 5' 3' * • 1- . -1 ~ Free IRL30 lI· Free IRR30 
1 2 3 4 5 6 7 8 9 10 11 12 13 14 
Figure 4.6 Gel retardation ofIRL and IRR DNA fragments using purified His-tagged 
ISYIOO transposase. DNA binding assays were set up using purified ISYI00 transposase 
and 5' end-labelled IRL30 (lanes 1-7) or IRR30 (lanes 8-14), The binding reaction was 
canied out for 10 minutes at 30°C and complexes were separated by electrophoresis on 
a 6% native polyacrylamide gel. Positions of radiolabeUing are indicated by asterisks. 
Anows indicate nucleoprotein complexes. The relative protein concentration in each assay 
is given above the cOlTesponding lane. Lane 1 and lane 8 are negative controls containing 
protein dilution buffer. The transposase concentration in the undiluted lane (20) is 
approximately 130 nM. 
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.. 
IRR 
ttctcgtattaTAGTAGTTTCAAATAAAGCTGAGACGCTAAACGCCACAG 
aagagcataatATCATCAAAGTTTATTTCGACTCTGCGATTTGCGGTGTC 
TAAGAACGG~gatc~ccgggtaccgagctcgaatB 
ATTCTTGCC ctag ggcccatggctcgag~ 
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Figure 4.7 DNase I footprinting of ISYIOO transposase IRR complexes. A) HindIII-
or BamHI-cleaved pXF121 were 3' end-labelled by Klenow and then cut by EcoRI and 
HindIII respectively. The end-labelled fragments containing 49 bp ofIRR were gel purified. 
Binding reactions were set up with purified transposase and incubated at 30°C for 10 
minutes. The mixtures were then treated with DNase I as described in chapter II. Reactions 
were separated on a 8% denaturing polyacrylamide gel together with a G+A ladder. B) 
DNA sequence of the fragments used and summary of protection. Transposon end sequences 
are shown in capitals and flanking sequence in lowercase, the 24 bp ofIRR is in bold. The 
protected sequence is underlined. 
results are summarised in Figure 4.7B. To footprint the left end, top and bottom strands of 
IRL79 oligonucleotides (Figure 4.4) containing 51 bp from ISYlOO IRL were 5' end-
labelled with kinase and annealed to unlabelled complementary strands. These labelled 
oligonucleotides were footplinted in a similar way and the results are shown in Figure 
4.8A. The protected regions are quite similar at both ends with majolity of the 24 bp 
inverted repeat sequences protected on both strands. At both IRR and IRL, protection 
extended further on the bottom (transferred) strand than on the top (non-transferred) strand, 
extending inward beyond the start of the inverted repeat, and outward to cover the 
transposon end and, in the case of IRR, the flanking target T A. 
4.3.2 ISYIOO transposase contains an N-terminal DNA binding motif 
Many different DDE transposases have been shown to contain N-terminal DNA binding-
domains that specifically recognise the terminal inverted repeats of their own transposon. 
There is little sequence conservation between the terminal inverted repeats of different 
transposons, and it appears that transposases co-evolve with their terminal inverted repeats, 
so as to act on their own ends, but not those of other elements. The DNA binding domains 
of many DDE transposases, including all members of the IS630/Tc1lmariner family, 
appear to contain a pair of helix-tum-helix (HTH) DNA-binding motifs within their N-
terminal domains. The structure of one such DNA-binding domain, that of the C. elegans 
Tc3 transposase, has been determined by X-ray crystallography in complex with DNA 
(Watkins et al 2004). The N-terminal domain of Tc3 transposase folds into two 
independent helix-tum-helix domains separated by a linker that interacts with the minor 
groove of DNA. This linker contains an 'AT hook' -like motif, which is also present in 
other bipartite DNA-binding domains belonging to the paired domain family (Xu et al., 
1999; Xu et al., 1995). Each helix-tum-helix motif consists of three a-helices, with the 
third helix inserted into the DNA major groove in each case. In Tc3 transposase, the N-
terminal helix-tum-helix binds to more transposon internal sequences, while the second 
helix-tum-helix binds to sequences closer to the transposon end. 
To see if ISYlOO transposase contains any potential helix-tum-helix motifs, the entire 
protein sequence of the ISYlOO transposase was analysed using the program helixtumhelix 
from the EMBOSS package (Dodd and Egan, 1987, 1990; Rice et al., 2000). Two potential 
HTH structures were predicted by this program with high probability (Figure 4.9A). Both 
predicted HTH motifs were located N-terminally, one between residues 19-40 and the other 
between residues 71-92. To validate this method, the same program was also used on Tc3 
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IRL79: IRL 
.. 5'-*tagtttctaaagtaaaaattaagaggtaTAGTCATTTCAATTAACGATGAGAGAATTTAA 
atcaaagatttcatttttaattctccatATCAGTAAAGTTAATTGCTACTCTCTTAAATT 
TGTAAAATTATGGAGTGTA-3' - Top (non-transferred) strand 
ACATTTTAATACCTCACAT* - Bottom (transferred) strand 
Figure 4.8 DNase I footprinting of ISYIOO transposase IRL complex. A) double-
stranded oligonucleotide IRL79 containing 51 bp oflRL was 5' end-labelled by kinase 
on either the top or bottom strand. Binding reactions were set up with purified transposase 
and incubated at 30°C for 10 minutes. The mixtures were then treated with DNase I as 
described in chapter II. Reactions were separated on an 8% denaturing polyacrylamide 
gel together with a G+A ladder. B) DNA sequence oflRL 79 and summary of protection. 
Transposon end sequences are shown in capitals and flanking sequence in lowercase, the 
24 bp ofIRL is in bold. The protected sequence is underlined. 
A) 
B) 
ISYlOO 
1---------11-------- 21 --------31 -------- 41--------51-------- 61 --------71--------81--------91--------101-------1 11-------121--
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Score - 637 Score - 971 'AT hook'-like motif 
1u78 --------HHHHHHHHHHHH----HHHHHHHH---HHHHHHHHH------------------HHHHHHHHHHHHH----HHHHHHH------ HHHHHHHHHH-----------------------
HTH domain 1 
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Tc3 1 MPRGS~T ctUDVMK~VS----L~KISRS----R~I YLK-- 44 
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Figure 4.9 The N-terminal sequence of ISYIOO transposase has two potential HTH structures. A) The sequences 
of the N-tenninall23 amino acids ofISY100 (BAA16620), Mos1 (AAA28678) and Tc3 (BAA16620) transposases 
are shown with predicted helix turn helix motifs ( Dodd and Egan, 1990) shown underlined. The secondary structures, 
predicted by jpred (Cuff and Barton, 2000) are shown below each sequence (H = helix, E = sheet). B) Secondary 
structure guided sequence alignments ofISYlOO, Mos1 and Tc3 transposase HTH1, HTH2 and 'AT hook'-like domains. 
C) The crystal structure of the Tc3 DNA-binding domain bound to DNA (PDB accession code 1U78). 
HTH2 
and Mas} transposases, locating two potential HTH motifs in each case. However, the two 
predicted HTH motifs of Tc3 transposase overlap. The highest sCOling motif conesponds 
to a-helix 2 and 3 of the first HTH in the crystal structure, while the other conesponds to 
a-helix 1 and 2 of the same motif (Figure 4.9A). The second Tc3 HTH known from the X-
ray structure was not identified by this program. Finally JPRED was used to predict the 
secondary structure of ISYlOO transposase (Figure 4.9A). This program uses PSI-blast to 
make a multiple alignment of related proteins and uses this alignment to predict the 
secondary structure of the query protein with quite high accuracy (Cuff and Batton, 2000). 
JPRED predicted six a-helices in the N-terminal 95 amino acids of ISYlOO transposase, 
consistent with the presence of two three-helix HTH motifs (residues 3-41 and 58-92) in 
this domain. A similar prediction was made for Mas}. The secondary structure prediction 
and the helixtumhelix results were used to guide the alignment of ISYlOO transposase with 
the N-terminal domains of Tc3 and Mas} transposases (Figure 4.9B). The results show that 
the N-terminal domain of ISYlOO transposase is likely to have a similar structure to Tc3 
transposase, with two three-helix HTH motifs separated by a linker containing the basic 
sequence RRHRK (residues 51-55) which may bind in the DNA minor groove like the 'AT 
hook' -like motif found in Tc3 transposase. 
To verify that these predicted HTH structures bind specifically to ISYlOO ends, the 
DNA-binding activity of a set of truncated transposase derivatives, containing zero, one or 
two predicted HTH motifs, was investigated. The 5' end of the ISYlOO transposase gene 
was amplified using a forward primer that introduced an NdeI site at the transposase start 
codon, and reverse primers that introduced C-terminal His6 tags at various positions within 
the first 110 codons of the transposase gene. These PCR fragments were inserted into the 
expression plasmid pKET3a under the control of the T7 promoter. In this way, plasmids 
encoding the N-terminal 37, 38, 46, 57, 68, 77, 95 and 110 amino acids of ISYlOO 
transposase (Tnpl-37, Tnpl-38, Tnpl-46, Tnpl-57, Tnpl-68, Tnpl-n Tnpl-95 and Tnpl-llO) were 
constructed (Figure 4.lOC). These plasmids were introduced into the strain BL21 <DE3> 
pLysS, and N-terminal transposase derivatives were induced by the addition of IPTG. 
pXF102, expressing C-terminal His-tagged full length transposase, and pKET3a, the empty 
expression vector, were used as controls. Extracts were produced from the induced cells by 
sonication followed by centrifugation at 28,300 g. These cell extracts were then separated 
by electrophoresis on a tricine-SDS gel, which can resolve proteins of much lower 
molecular weight than standard Tris-glycine gels, and stained with coomassie blue. 
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Figure 4.10 N-terminal derivatives of ISY100 transposase. A) Tricine-SDS gel electrophoresis of whole cell extracts from strains 
expressing truncated transposase derivatives. DNA fragments encoding N-terminal fragments oflSYlOO transposase with C-terminal 
6 x His tags were inserted into pKET3a and expressed in BL21 <DE3> pLysS. Cells were grown at 37°C to an A600 of 0.5 and 
induced for 2 hours with 0.5 mM IPTG. Cells were sonicated in 50 mM Tris-Cl (pH 7.5) and 10 mM ~-mercaptoethanol and 
centrifuged at 19,000 rpm (JA20) for 15 minutes at 4°C, and supernatants were analysed on a 15% Tricine-SDS polyacrylamide gel. 
Cell extracts from induced BL21 <DE3> pLysS containing pKET3a only (lane 2) or pXF102 carrying full-length transposase (lane 
11) were run on the same gel. Induced transposase fragments are indicated with arrows. B) The cell extracts shown in A were used 
in a gel shift assay with labelled IRL79. Purified full length Tnp-His6 was used as a control (lane 12). C) Structure ofN- terminal 
domain of ISYI 00 transposase, showing the positions of the predicted HTH motifs and sequences of the truncated transposases. 
Induced proteins of the correct size were observed for Tnpl-57, Tnpl-68, Tnpl-77, Tnpl-95 and 
Tnpl-110 and the full length transposase (Figure 4.lOA). However, no induced bands were 
visible for Tnpl-37, Tnpl-38, Tnpl-46. It may be that these proteins are too small to be well 
separated on this gel system. Alternatively, these smaller proteins may not be efficiently 
expressed, or they may be missing from the cleared lysates because they are insoluble or 
degraded for some reason. 
Cell extracts containing transposase N-terminal derivatives were used in a gel shift 
DNA binding assay (Figure 4.lOB) with IRL79, a 79 bp DNA fragment containing 51 bp 
from the left end of ISY100 (Figure 4.4). The vector alone extract gave two faint retarded 
bands that were presumably due to binding by cellular proteins. Tnpl-37, Tnpl-38, Tnpl-46 
gave no additional retarded bands, either because these derivatives do not bind the 
transposon end, or because no transposase derived protein is present in these extracts. At 
the protein concentration used, the extract containing Tnpl-57 gave one major retarded 
band, and a slightly less prominent slower migrating band. Tnpl-68 and Tnpl-77 both gave a 
similar pattern of bands, but as the size of the transposase derivative was increased, the 
complexes migrated more slowly. Tnpl-95 and Tnpl-110 also bound to the ISY100 left end 
fragment, but the fastest migrating complex in both cases ran quicker than the fastest 
migrating complex produced by Tnpl-n This faster migration could be due to a different 
conformation of the complexes formed by the proteins containing two HTH motifs, or 
could be caused by the presence of shorter protein fragments in the cell extract. 
From these results, it appears that the N-terminal HTH motif and an extra 16 amino 
acids containing the 'AT hook' -like motif (Tnpl-57), is sufficient to bind to an ISY100 end. 
It is not clear whether the single HTH motif without the 'AT hook' -like motif found in 
Tnpl-46, is unable to bind to the transposon end, or whether this protein is not present in the 
extract. The fact that Tnpl-95 and Tnpl-110 leave no unbound DNA (Figure 4.lOB, lanes 9 
and 10) suggest that they might bind more tightly, consistent with the presence of two 
HTH-motifs in these proteins. Confirmation of this result awaits more quantitative 
experiments with purified proteins. 
In the Tc3 crystal structure, the first HTH motif binds to the inner end of the IR, 
while the second binds the IR closer to the transposon end. To see whether the same is true 
for ISY100 transposase, footprinting experiments were carried out with cell extracts 
containing N-terminal derivatives of ISY100 transposase. It was thought that Tnpl-57, Tnpl_ 
68 and Tnpl-77, containing just one HTH, might protect only the inner parts of the IR, while 
Tnpl-95 and Tnpl-110 might protect all or most of the IR. DNase I footprinting assays were 
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canied out with IRL79 labelled at the 5' end on either the top or bottom strand. Tnpl-95 and 
TnpI-110 protected almost all of the IR sequence, consistent with the presence of two HTH 
motifs binding to two different regions of the IR. Somewhat surprisingly, this protection 
was indistinguishable from the protection by the full length transposase, suggesting that the 
catalytic domain does not interact with the DNA in the footprinting reactions with the full 
length protein. The three truncated transposases with only a single HTH failed to protect 
IRL in this assay (Figure 4.11). Tnpl-57 and Tnpl-77 were purified on a Ni-NTA column and 
tested, but neither of them gave any detectable protection in the footprinting assay although 
they did produce retarded bands on a gel shift assay (data not shown). The lack of a 
footprint might reflect the reduced specificity or reduced affinity of binding of transposase 
derivatives containing only one HTH motif. 
4.4 Attempts to observe paired end complexes 
After DNA binding, the transposase must bring two transposon ends together to form a 
synaptic complex, also known as a paired end complex (PEe). For many transposons, 
including Mu, Tn5, TnlO and IS911, the ends are cleaved only after the formation of a 
PEe (Bhasin et al., 2000; Normand et al., 2001; Sakai et al., 1995; Savilahti et al., 1995). 
However, for Mas], it is thought that cleavage of the non-transfened strand precedes PEe 
formation (Dawson and Finnegan, 2003). The simplest way to detect a PEe is to carry out 
a DNA binding assay, using a mixture of two different length DNA fragments. If a PEe is 
produced in the binding reaction, three different complexes will be seen on the binding gel: 
one complex containing two long DNA fragments, one containing two short DNA 
fragments and one containing one short and one long DNA fragment. 
Long and short radiolabelled oligonucleotide substrates containing ISY100 inverted 
repeat sequences (IRL79 and IRR58, Figure 4.4) were incubated with purified His-tagged 
transposase either singly or in an equimolar mixture. Mg2+ and DMSO were added to allow 
catalysis of strand transfer in case this was required for PEe formation. IRL79 and IRR58 
both produced one major retarded band, and at least one other more retarded minor band. 
However no additional bands, diagnostic for PEe formation, were observed in the presence 
of both DNA fragments in any of the conditions tested (Figure 4.12), strongly suggesting 
that the observed complexes contain only one molecule of DNA. 
For Mas], cleavage of the non-transfened strand is required for PEe formation. For 
this reason, PEes can only be detected in conditions that allow strand cleavage (Dawson 
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Figure 4.11 Footprinting of N-terminal transposase derivatives to the ISYIOO left 
end. A) IRL 795' end-labelled on either the top or bottom strand was incubated with cell 
extracts containing the indicated protein and subjected to a standard DNase I footprinting 
reaction. Reactions were separated on an 8% sequencing gel adjacent to a G+A ladder 
generated from the same DNA fragment. Binding reactions contained either 1 III or 0.5 
III of the indicated cell extract. B) Summary offootprinting results. The 24 bp IR is shown 
in bold, transposon end sequences are shown in uppercase and regions protected by Tnpl-
95 and Tnpl-llo are underlined. 
Lane 1 2 3 4 5 6 
IRL79 + + + + 
IRR58 + + + + 
MgCI2 
DMSO 
Tnp + + + 
7 8 9 10 
+ + + 
+ + 
+ + + + 
+ 
+ + + + 
11 12 
+ 
+ + 
+ + 
+ + 
+ + 
IRL79 
-Tnp 
IRR58 
-Tnp 
Free 
IRR58 
Figure 4.12 Binding reactions with DNA fragments of different lengths to detect PEes. 
Labelled DNA fragment IRL 79 and IRR58 were incubated singly or in combination, with 
purified transposase in standard binding conditions (lanes 4-6) or with the addition of 10 
mM MgCh (lanes 7-9), or 10 mM MgCh and 20% DMSO (lanes 10-12). Reactions were 
calTied out for 10 minutes at 25°C and loaded directly onto a native polyacrylamide gel. 
Complexes formed by IRL 79 or IRR58 are indicated. 
and Finnegan, 2003). Mos} transposase requires DMSO and divalent cations for catalysis, 
and for this reason DMSO and Mg2+ were added to one set of binding reactions shown in 
Figure 4.12. However, the reactions were not run on strand separating gels to check 
whether any strand cleavage had occurred. In later experiments, it was shown that 
oligonucleotide substrates are cleaved inefficiently even in the presence of Mg2+ and 
DMSO. The binding reactions shown here were only allowed to proceed for 10 minutes, so 
it is possible that strand cleavage is required for PEC formation and not enough time was 
allowed for this to happen. Another possibility is that synaptic complexes form, but are not 
stable enough to survive on the gel system used here. 
4.5 Cleavage by ISYIOO transposase 
After synapsis, the next step in transposition is strand cleavage, to excise the transposon 
from its donor site. 
An in vitro cleavage assay is required to study how ISYlOO transposase catalyses 
strand cleavage and whether this is similar to Mos} and other members of the Tel/mariner 
family of transposons (see chapter I). This section describes work to set up assays for 
strand cleavage on supercoiled plasmid substrates and on short oligonucleotide substrates 
containing transposon terminal inverted repeat sequences. The conditions for cleavage 
were optimised, and the positions of strand cleavage were mapped. 
4.5.1 ISYI00 transposase cleaves at ISYI00 terminal inverted repeats in vitro 
To test whether transposase can carry out the excision reaction in vitro, pXF109, 
containing Sl bp IRL and 49 bp IRR sequences flanking a 1.3 kb kanamycin resistance 
gene in pUC18, was incubated with ISYlOO transposase. Supercoiled pXF109 was 
incubated for four hours at 30°C with transposase in a simple buffer containing SO mM 
Tris-HCl pH 7.S, 10 mM MgCh, 0.1 mg/ml BSA and 0.1 mM DTT. The reactions also 
contained SO mM NaCl and 0.01 % triton X-IOO from the transposase protein or dilution 
buffer. The reactions were stopped by heating at 7SoC for 10 minutes and then loading 
buffer containing SDS and proteinase K was added before electrophoresis on an agarose 
gel (Figure 4.13). The products of excision were detected after staining with ethidium 
bromide. Two bands were produced of the correct size to be the 1.3 kb excised transposon 
and the 2.7 kb vector backbone. Thus transposase appears to produce double strand breaks 
specifically at the transposon ends. Linearised plasmid, probably from cleavage at only one 
67 
A) 
pXF109 
4114 bp 
8) 
IRL51 
12.2 kb-
8.1 kb-
6.1 kb-
5.1 kb-
4.0 kb-
3.0 kb-
2.0 kb-
1.6 kb-
1.0 kb-
0.5 kb-
======L-lntermolecUlar 
~ transposition? 
Nicked monomerlSC dimer 
Amp' 
Backbone -----i __ .... ---
SC 
Excised 
ISY100 
Figure 4.13 In vitro cleavage catalysed by ISYIOO transposase. A) Map of donor plasmid 
pXF 1 09. B) Purified transposase cleaves supercoiled donor plasmid in vitro. pXF 1 09, 
carrying a 1.3 kb mini-ISY100, was incubated with purified His-tagged transposase in a 
buffer containing 50 mM Tris-HCl (pH 7.5), 10 mM MgCh, 0.1 mg/ml BSA and 0.1 mM 
DTT for 4 hours at 30°C. The products were separated by electrophoresis on a 1.2% 
agarose gel and stained with ethidium bromide. Excised mini-ISYlOO, supercoiled substrate 
(SC), linear substrate, and backbone of the donor plasmid left after excision of the mini-
ISY100 are indicated. 
transposon end in pXF109, was also produced (see section 4.5.4). Another major product 
was open circular DNA that has lost all supercoiling because it contains a nick on at least 
one strand. Recent work has demonstrated that this DNA contains nicks specifically on the 
non-transferred strand at the transposon ends (Sean Colloms and Victoria Moffat, personal 
communications). Other products migrating slower than open circle substrate are also 
visible on the gel. Some of these are probably higher molecular weight cleavage products 
coming from the supercoiled dimer plasmid present in the substrate DNA. It is later shown 
that at least one of these higher bands is the product of one ended intermolecular 
transposition into the substrate plasmid. 
4.5.2 Optimisation of cleavage by ISYIOO transposase 
Next, the reaction conditions for cleavage by ISY100 transposase were optimized and the 
requirements for cleavage were defined. First the requirement for divalent metal ions was 
investigated. The side chains of the catalytic DDE residues have been shown to coordinate 
divalent metal ions in a number of different transposases (Junop and Haniford, 1997; 
Richardson et ai., 2006; Steiniger-White et ai., 2004). Magnesium ions are thought to be 
the physiologically relevant cation, but manganese often functions as well or better in 
vitro. In some cases, manganese causes a relaxation in specificity, allowing reactions to 
proceed that do not work in the presence of magnesium (Allingham et ai., 1999; Kim et ai., 
1995; Rowland et ai., 1995). Cleavage reactions were carried out at a range of Mg2+ and 
Mn2+ concentrations (Figures 4.14 and 4.15), using pXF153 carrying 30 bp from each 
transposon end, flanldng a Kanf gene. Excision was detectable at Mg2+ concentrations from 
4 - 20 mM, while Mn2+ gave excision from 0.2-10 mM. The highest level of cleavage was 
obtained at around 10 mM MgCh or 2 mM MnCh (Figures 4.14 and 4.15). A range of 
concentrations of NiS04, ZnS04, CUS04, CoCh, and CaCh from 0.1 mM to 15 mM were 
also tested in the cleavage assay but gave no detectable excision (data not shown). 
Mn2+ gave more open circular product and a lower level of cleavage than magnesium. 
Mn2+ also gave much lower levels of the presumed intermolecular transposition products 
than did Mg2+. The use of Mn2+ at higher concentrations led to nicldng even in the absence 
of protein, probably through the production of reactive oxygen species such as hydroxyl 
radicals. For these reasons, Mg2+ (10 mM MgCh) was used for subsequent cleavage 
experiments. 
To investigate the effect of NaCI concentration on the cleavage reaction, the 
transposase stock solution, containing 500 mM NaCl, was diluted 8 fold into a buffer 
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Figure 4.14 Effect ofMg2+ concentration on the cleavage activity oflSYI00 transposase 
in vitro. A) Map of donor plasmid pXF 153. B) Cleavage assays were performed by incubating 
0.15 pmole supercoiled pXF153 together with 2.6 pmoles purified His-tagged transposase 
in a standard cleavage reaction buffer with the indicated concentration ofMgCh for 4 hours 
at 30°C. The products were separated by electrophoresis on a 1 % agarose gel and stained 
with ethidium bromide. Lanes 2 and 3 show supercoiled and EcoRI linearised pXF153 
respectively. Excised mini-ISYI00, supercoiled (SC), linear and nicked substrate, and 
backbone of the donor plasmid are indicated. 
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Figure 4.15 Effect of Mn2+ concentration on the cleavage activity of ISYI00 
transposase in vitro. Cleavage assays were performed by incubating 0.15 pmole 
supercoiled pXF153 plasmid with 2.6 pmoles purified His-tagged transposase in a 
standard cleavage reaction buffer (see Chapter II) without MgCh but containing the 
indicated concentrations of MnCh, for 4 hours at 30°C. The products were separated 
by electrophoresis on a 1.2% agarose gel and stained with ethidium bromide. Bands 
are indicated as in Figure 4.14. 
without NaCl. This dilution was then used in cleavage reactions with additional NaCI in 
the individual reactions to give final NaCI concentrations from 6.25 mM to 500 mM. 
Excision could be detected from 6.25 to 150 mM NaCI, and was most efficient at 40 to 80 
mM NaCI (Figure 4.16). As the NaCI concentration was increased, the amount of single 
end cutting started to increase, and then above 80 mM NaCI the amount of nicking also 
increased. At 200 mM NaCI almost all of the substrate was nicked and there was very little 
double strand cleavage, and at 350 mM NaCI and above there was almost no activity at all. 
After this, 50 mM N aCI, coming from a one in ten dilution of the transposase dilution 
buffer, was used in the standard reaction conditions. 
Next the effect of changing the reaction temperature was investigated (Figure 4.17). 
The reaction worked best between 20 and 30°C. There was almost no cleavage at 16°C and 
below, and temperatures of 37°C and above led to a marked reduction in the level of 
double strand cleavage. 30°C was adopted as the standard reaction temperature for 
subsequent experiments. 
Then the effect of varying the pH was investigated (Figure 4.18). Reactions were 
performed in buffers ranging in pH from 7.0-10.7. Excision was only efficient in the 
buffers with pH 7.0,7.5, 8.0 and 8.5. Some nicking and linearisation of the substrate were 
observed at higher pH, but further work is needed to determine whether cleavage is 
occurring at the transposon ends. It should be noted that different buffers were used to 
obtain the different pH values: Tris-HCI was used for pH 7.0 to 8.5, CHES was used for 
pH 9.0 to 9.5, CAPS was used for pH 9.7 to 10.5 and K2HP04 was used for pH 10.7. 
Excision was only efficient in Tris buffers, so it is possible that the buffer as well as the pH 
is having an effect on the efficiency of cleavage. 
Cleavage at ISY100 ends in pXF153 was then investigated in a time course 
experiment (Figure 4.19). Cleavage products were first detected at about 60-90 minutes 
and continued to accumulate over time. Cleavage continued throughout the time course 
and the maximum amount of cleavage was observed at the final 16-hour time point. The 
nicked substrate also accumulated over the full time course, appearing more quickly than 
the double strand cleavage products. There may be slightly less nicked substrate at 16 
hours than at 4 hours, suggestion that the nicked substrate may be converted to double 
strand cleavage products by cutting of the second strand. For convenience, a four-hour 
incubation period was used for subsequent cleavage assays. 
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Figure 4.16 Effect of changing NaCI concentration on the cleavage activity ofISYlOO 
transposase in vitro. Cleavage assays were performed by incubating 0.1 pmole supercoiled 
pXF153 together with 2.6 pmoles purified His-tagged transposase in a standard cleavage 
reaction buffer in the presence of 10 mM MgCh and the indicated concentration ofNaCI 
for 4 hours at 30°C (lanes 2 - 12). The products were separated by electrophoresis on a 
1.2% agarose gel and stained with ethidium bromide. Lane 1 shows untreated substrate. 
Bands are indicated as in Figure 4.14. 
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Figure 4.17 Effect of reaction temperature on the cleavage activity of ISYI00 transposase 
in vitro. Cleavage assays were performed by incubating 0.10 pmole supercoiled pXF153 
plasmid together with 2.6 pmoles purified His-tagged transposase in a standard cleavage 
reaction buffer for 4 hours at the indicated temperatures. The products were separated by 
electrophoresis on a l.2% agarose gel and stained with ethidium bromide. Bands are indicated 
as in Figure 4.14. 
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Figure 4.18 Effect of pH on the cleavage activity ofISYI00 transposase in vitro. Cleavage 
assays were performed by incubating 0.10 pmole supercoiled plasmid pXF153 together 
with 2.6 pmoles purified His-tagged transposase in a standard cleavage reaction buffer at 
different pH values. The products were separated by electrophoresis on a 1.2% agarose gel 
and stained with ethidium bromide. pH values and buffers used are indicated on the top of 
each lane. Bands are indicated as in Figure 4.14. 
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Figure 4.19 Effect of incubation time on the cleavage activity of ISYI00 transposase 
in vitro. Cleavage assays were setup in a single 340 III reaction containing 0.12 pmoles 
supercoiled donor plasmid pXFl53 together with 2.6 pmoles purified His-tagged transposase 
for each time point. 20 III samples were withdrawn at the indicated time points and stopped 
by heating at 75°C for 10 minutes. The products were separated by electrophoresis on a 
1.2% agarose gel and stained with ethidium bromide. The incubation time is indicated on 
the top of each lane. Bands are indicated as in Figure 4.14. oln indicates overnight for 16 
hours. 
To see if the ratio of transposase to DNA is important for the amount of DNA 
cleavage, reactions were carried out at a range of DNA concentrations at two different 
protein concentrations (Figure 4.20). At a given transposase concentration, increasing the 
amount of DNA present increased the amount of excised transposon produced up to a 
certain point. As the DNA concentration increased beyond this point, the total amount of 
excised transposon did not increase any more, and even started to decrease slightly. When 
the protein concentration was doubled, the DNA concentration giving maximum excision 
also doubled. In other words, having too much or too little protein per DNA molecule 
inhibited the cleavage reaction and it was the ratio of protein to DNA that determined the 
extent of the reaction. Too much protein per DNA molecule might lead to multimerisation 
of transposase on the transposon ends or binding at incorrect sites, inhibiting cleavage. Too 
little protein per DNA molecule might produce plasmid molecules that have transposase 
bound at only one end and prevent synapsis and concerted cleavage. An excess of 5 -10 
fold of protein over DNA was required to nick approximately 50% of the substrate in 4 
hours. This could be because a proportion of the transposase is inactive. However it 
appears that each transposase does not catalyze multiple events. 
All of the experiments reported above were carried out using a plasmid with two 
ISY100 ends. To see whether two ends are required for cleavage, cleavage assays were 
carried out with supercoiled substrates carrying only one IR from ISY100 (Figure 4.21). 
Supercoiled pXF119 and pXF121, carrying 51 bp and 49 bp from the left and right ends of 
ISY100 respectively, were incubated for four hours with dilutions of transposase under 
standard reaction conditions. Nearly half of the substrate DNA was nicked in this time at 
the highest transposase concentration, and a small amount of linearised plasmid was also 
produced. However, the main conclusion from this experiment is that substrates with one 
transposon end are cleaved much less efficiently than substrates with two transposon ends 
(compare the pXF109 control in lane 1 with the equivalent pXFl19 and pXF121 reactions; 
Figure 4.21 lanes 1, 3 and 9). This result suggests that communication between the two 
ends on the same DNA molecule is required for efficient cleavage. 
4.5.3 Cleavage on linear DNA substrates 
The experiments reported in the previous section all used supercoiled DNA substrates, 
mimicking the state of DNA in vivo. To test the requirement for DNA supercoiling, 
cleavage assays were carried out on linearised substrates carrying one or two ISY100 ends 
(Figure 4.22). In standard conditions, cleavage of linearised pXF109, pXF119 and pXF121 
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Figure 4.20 Effect of transposase / substrate ratio on the cleavage activity of ISYIOO 
transposase in vitro. Cleavage assays were performed at different DNA concentrations in 
the presence of two different concentrations of transposase in a standard cleavage reaction 
at 30°C for 4 hours. The products were separated by electrophoresis on a 1.2% agarose gel 
and stained with ethidium bromide. The amounts of protein and substrate used in the 
reactions are indicated on the top of each lane. Bands are indicated as in Figure 4.14. 
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Figure 4.21 In vitro cleavage activity of ISYI00 transposases on substrates containing 
one end of ISYI00. A) Structure of plasmids used in this assay. pXF119 and pXF121 
contain 51 bp and 49 bp from the left end and right end ofISY100 respectively in pUC18. 
Small amounts of supercoiled dimer were present in the plasmid substrates. B) Cleavage 
assays were performed with the indicated relative concentrations of purified His-tagged 
transposase in a standard cleavage reaction buffer at 30°C for 4 hours. 2° corresponds to a 
2.6 pmoles protein per 20 ~l reaction. Nicked and linearised monomer and dimer bands are 
indicated. 
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Figure 4.22 DMSO enhances the cleavage activity of ISYIOO transposase on linear 
substrates. pXF109, pXF119 and pXF121 containing IRL + IRR, or just IRL or IRR of 
ISY100 were linearised with AlwNI and then treated with purified transposase in a standard 
cleavage assay with various concentration ofDMSO at 30°C for 4 hours. The products were 
separated by electrophoresis on a 1.2% agarose gel and stained with ethidium bromide. The 
concentrations of DMSO are shown above each lane, and the predicted fragments from 
cleavage at transposon ends are shown to the right of the gel. 
(with IRL and IRR, just IRL or just IRR respectively) was almost undetectable. The 
addition of DMSO has been reported to allow transposition on linear DNA substrates in 
other systems (Baker and Mizuuchi, 1992; Dawson and Finnegan, 2003), so the effect of 
DMSO on cleavage of linearised pXF109, pXF119 and pXF121 was tested (Figure 4.22). 
When 5%-20% DMSO was added to the reactions, the amount of cleavage on all three 
substrates increased, although cleavage was still relatively inefficient. The efficiency of 
cleavage at 10%, 15% and 20% DMSO was approximately equal, and the three higher 
concentrations appear to give better cleavage than 5% DMSO. The plasmid with two ends 
was not cleaved much better than the plasmids with one end, and cleavage on pXF109 does 
not appear to be highly concerted at the two ends. 
The effect of DMSO was also tested on a supercoiled substrate containing two 
ISY100 ends, with a slightly different result (Figure 4.23). DMSO was not required for 
excision and has a smaller effect. As the concentration of DMSO was increased from 0 to 
10%, the efficiency of first strand cleavage increased so that the amount of supercoiled 
substrate decreased. At 10% DMSO and above, no supercoiled substrate remained. 
However DMSO appeared to have very little effect on the extent of double strand 
cleavage. Increasing the DMSO concentration from 0-10% also reduced the yield of 
presumed intelIDolecular transposition product. 
4.5.4 The sequence of the flanking dinucleotide affects cleavage efficiency 
The results reported in chapter III show that the dinucleotide sequences flanking ISY100 
affect the transposition frequency in vivo. The flanking sequences are removed at the 
cleavage step so it seems most likely that their effect on transposition is before or during 
this step. To test this, supercoiled substrates carrying mini-ISY1OOs with different flanking 
dinucleotides were tested in the in vitro cleavage assay (Figure 4.24). 
The results of standard cleavage assays on plasmids containing identical changes at 
both ends of mini-ISY1OO elements are shown in Figure 4.24A (lanes 1-12). Changing the 
base adjacent to the transposon (position -1) from A (reading 5' to 3' into ISY1OO) to any 
of the other three nucleotides almost completely abolished double strand cleavage. 
Transposase still nicked these substrates efficiently, although it has not been determined 
whether this nicking occurs at the transposon ends. When the base at position -2 was 
changed at both ends from T to A or C, double strand cleavage was greatly reduced, giving 
just a small amount of linear full length cleavage product, but almost no detectable excised 
transposon fragment (ETF) or vector fragment. Again, these changes did not seem to have 
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Figure 4.23 Effect of DMSO concentration on the cleavage activity of ISYIOO 
transposase in vitro. Cleavage assays were performed by incubating 0.10 pmo1e supercoiled 
plasmid pXF153 together with 2.6 pmoles purified His-tagged transposase in a standard 
cleavage reaction with various concentrations ofDMSO at 30°C for 4 hours. The products 
were separated by electrophoresis on a 1.2% agarose gel and stained with ethidium bromide. 
Concentrations of DMSO are indicated above each lane. Excised mini-ISY100 and 
backbone of the donor plasmid are indicated. 
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Figure 4.24 Flanking dinucleotides affect the cleavage activity of ISYIOO transposase in vitro. Standard cleavage assays were performed 
on supercoiled substrates carrying mini-ISYIOOs with alternative flanking dinuc1eotides. Transposons with two left IRs or two right IRs were 
also tested. The products were separated by electrophoresis on 1.2% agarose gels and stained with ethidium bromide. A) Mini-transposons 
with symmetrical changes in the flanking dinuc1eotides at both ends and transposons with two left inverted repeats or two right inverted repeats 
as indicated. B) Mini-transposons with changes at only one end. C) Mini-transposons are referred to according to the sequences of the flanking 
dinuc1eotides reading 5' - 3' towards the transposon at both ends. 
much of an effect on first strand cleavage, as large amounts of nicked substrate were 
produced. These same changes were also introduced at just one end of the mini-transposon, 
abolishing production of ETF and donor backbone, but also greatly reducing the yield of 
linearised plasmid (Figure 4.24B). It appears that changes at one transposon end have an 
effect on double strand cleavage at the other end. However, there was no detectable effect 
on first strand cleavage, as all of these substrates were nicked efficiently by transposase. 
To investigate whether the linear product from these reactions was cleaved at one of 
the transposon ends and, if so, at which end, the full-length linear cleavage product was gel 
purified from reactions with TA-LiTA-R, CA-L/CA-R and TC-LlTA-R. This DNA was 
then cut with AlwNI and run on an 1.2% agarose gel (Figure 4.25). This analysis revealed 
that the linear product from TA-LiTA-R had been cleaved by transposase either at IRL or 
at IRR, with more cleavage at IRL than at IRR (Figure 4.25; lane 5). Altering the T at 
position -2 to C at both ends (CA-LlCA-R) reduced the amount of linear product so that 
the AlwNI products were very hard to detect by ethidium staining. Nevertheless, cleavage 
at both left and right ends was just detectable (Figure 4.25; lane 7). When a change was 
made at just one end (TC-LlTA-R), although double strand cleavage was greatly reduced, 
the cleavage that did take place occUlTed only at the unaltered end (Figure 4.25; lane 9). 
The sequence of the inverted repeats affected the transposition frequency in vivo, 
such that a mini-transposon with two copies of IRR transposed less efficiently than one 
with two copies of IRL (see chapter III). This effect could be caused by a difference either 
before or after the cleavage steps. Substrates containing two IRR sequences or two IRL 
sequences with normal flanldng T As were therefore tested in the cleavage assay. Under the 
same reaction conditions, more ETF and donor backbone were obtained from the substrate 
containing two copies of IRL in inverted repeat than from the substrate containing two 
copies of IRR (Figure 4.24 A; lanes 13-16), suggesting this substrate is affected at the 
cleavage step of transposition. 
4.5.5 Mapping the cleavage site on the transposon ends 
Different transposons employ different mechanisms to cleave the transposon ends prior to 
the strand transfer reactions. The replicative transposons cleave only the transfened strand 
at each end, while non-replicative transposons cleave both strands. The mechanism for 
cleaving both strands can involve a hairpin intermediate, which can be on the transposon 
end as in Tn5 and TnlO (Bhasin et al., 1999; Kennedy et al., 1998) or on the flanlting 
sequence as in Hennes (Zhou et ai., 2004). In other cases, such as mariner and Tn7, there 
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Figure 4.25 Analysis of linear products from cleavage assays on supercoiled substrates 
with different flanking dinucleotides. A) 1.2% agarose gel electrophoresis oflinear 
products from cleavage reactions with supercoiled substrates with the indicated flanking 
dinucleotides (see Figure 4.24). Lanes 1 - 3 contain digestion products of supercoiled 
substrate as size markers. Lanes 4, 6 and 8 contain gel purified linear products from the 
cleavage reactions and lanes 5, 7 and 9 contain the AlwNI digestion products. Lanes 4 -
9 are shown at the right with the contrast adjusted to enhance faint bands. B) Map of 
substrate showing restriction sites and predicted transposase cleavage products. 
is no hairpin intermediate. In all DDE transposons studied so far, the transferred strands are 
cleaved exactly at the transposon boundaries to produce 3 'OR ends that attack the target 
DNA in the strand transfer reaction. The non-transferred strand can be cleaved outside the 
transposon, exactly at the transposon end, or within the transposon, giving protruding 5' 
ends, blunt ends, or recessed 5' ends respectively. In all cases studied to date, the non-
transferred strand carries a 5' phosphate group. Studies on the positions of cleavage by 
transposase, and intermediates in the cleavage reaction, provide information on the 
mechanism of the transposition reaction and the organisation of the transposase at the 
transposon ends. 
The cleavage sites on ISYlOO were first mapped by Urasaki and colleagues (Urasaki 
et al., 2002). In that study, excised transposon fragments were produced in vivo from a 
mini-ISY100 donor plasmid by over-expression of transposase in E. coli. The excised 
transposon fragment was purified electrophoretic ally and then tailed with dGTP using 
terminal deoxynucleotide transferase (TdT). The poly-G tailed transposon end was 
amplified by PCR using a poly-C primer and an end specific primer, and the PCR product 
was then sequenced, demonstrating that the transposon was cleaved exactly at the 
transposon boundary at its 3' ends. The fact that the 3' ends could be extended with 
terminal transferase implies that a 3' OR was present at these ends. The 5' ends of the 
transposons were mapped by a more indirect method. The transposon ends were first made 
blunt with the Klenow fragment of DNA polymerase I in the presence of dNTPs. This 
should extend the 3' ends if protruding 5' ends are present, or shorten the 3' ends if the 5' 
ends are recessed. After this treatment, the transposon 3' ends were determined using the 
same dG-tailing PCR based method described above. The results of this experiment 
implied that the 5' ends of the excised ISYlOO transposon were recessed by two 
nucleotides. The experimental techniques used by Urasald et al. (2002) to determine the 
transposase cleavage sites have some disadvantages: 1) The excised transposon was 
produced in vivo, and may have been processed by other enzymes after cleavage by 
transposase. 2) The method only reveals the cleavage points of those molecules that have a 
3' OR. Any molecules that cannot be extended by TdT will be missing from the analysis. 
3) Klenow may not efficiently produce blunt ends, so the 5' cleavage site deduced may not 
be accurate. 4) The sequencing reaction on the PCR products will miss any minor cleavage 
products. For these reasons, it was decided to determine the positions of cleavage by 
purified transposase in vitro. 
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The first approach taken was to use T4 DNA ligase to circularise the vector fragment 
produced in an in vitro transposition reaction. The circularised vector fragment was 
transformed into DH5a giving a large number of colonies, suggesting that both ends of the 
fragment contained compatible sticky or blunt ends. Plasmid DNA was purified from two 
single colonies and sequenced. Both plasmids had identical sequences, with both flanking 
TA dinucleotides and an extra TA dinucleotide at the empty donor site (Figure 4.26A). 
This result is consistent with the results of Urasaki et al. (2002), cleavage at the exact 3' 
ends of transposon ends with 2 nucleotide recessed 5' ends. However, it is also consistent 
with 5' ends exactly at the transposon ends and two nucleotides recessed 3' ends, or with 
blunt cleavage 1 bp inside the transposon ends (Figure 4.26B). The latter two suggestions 
seem unlikely as they would leave tmncated transposon 3' ends. A drawback of this 
method is that it only gives information about the cleavage sites in those molecules that 
can self-ligate, that is those with 5' phosphates, 3' hydroxyls and compatible overhanging 
or blunt ends. 
Another approach was therefore taken to determine the cleavage sites directly. An 
experiment was first carried out to map the cleavage position on the non-transferred strand 
of IRL in the presence and absence of DMSO, to see if DMSO is required for cleavage on 
short linear substrates and to see if DMSO has any effect on the cleavage position. A DNA 
fragment (IRL30; Figure 4.4) containing 30 bp from ISYlOO IRL was labelled at the 3' end 
at the HindIIl site. This DNA fragment was incubated with transposase and the cleavage 
products were separated on a sequencing gel adjacent to a G+A Maxam and Gilbert 
sequencing ladder. To provide an additional marker, the DNA fragment was also cut with 
Acul, which cleaves the top (non-transferred) strand 2 nucleotides inside the transposon 
end on this fragment, exactly at the transposase cleavage position predicted from the 
results of Urasaki et al. (2002). As expected, cleavage was much more efficient in the 
presence of DMSO, although a long exposure revealed that some cutting occurred in the 
absence of DMSO (Figure 4.27 A). One major cleavage site, one nucleotide outside the 
transposon, and a minor cleavage site, two nucleotides outside the transposon, were 
observed on the non-transferred strand. DMSO did not alter the sites of cleavage (Figure 
4.27). There was no evidence of cleavage at the expected site, two nucleotides inside the 
transposon. The cleavage products were treated with phosphatase to see if cleavage left a 
phosphate group on the transposon 5' end. Removing the 5' phosphate should decrease the 
charge and hence the mobility of the cleavage product. This result was not so clear, but 
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Figure 4.26 Junction sequence of self-ligated donor backbone. A) Two plasmids produced by circularising the 
backbone fragment from an in vitro excision reaction were recovered by transformation into DH5a and sequenced using 
the M13 uni-43 and rev-49 primers. The junction sequence is shown. B) Models for cleavage at ISYIOO ends. Yellow 
represents transposon end sequences and green represents vector sequence. 
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Figure 4.27 DMSO enhances the cleavage activity of ISYIOO transposase on a 
radiolabelled IRL DNA fragment ill vitro. IRL30 was 3' end-labelled at the HindIII site 
with [a_32p] dATP and the Klenow fragment of DNA polymerase. This was incubated with 
purified His-tagged transposase in a standard cleavage assay at 30°C for 2.5 hours with 
or without 20% DMSO. Reactions were stopped by heating at 75°C for 10 minutes and 
then were split into 2 fractions, one of which was treated with calf intestinal alkaline 
phosphatase (CIP) for 30 minutes at 37°C. The labelled fragment was also digested by AcuI 
for 30 minutes and half of the digestion product was then dephosphorylated by CIP. Samples 
were separated on an 8% denaturing polyacrylamide gel together with a G+A ladder and 
visualized on X-ray films by autoradiography. A) Results from 24 (left) and 48 (right) 
hours exposure. B) Sequence of IRL30 showing the AcuI recognition site, and predicted 
cleavage site, and the position of transposase cleavage relative to the AcuI cleavage site. 
there was some evidence for the appearance of slower migrating bands behind the cleavage 
products, suggesting that there is a 5' phosphate and that the phosphatase reaction was 
incomplete. 
In the experiments reported above, the cleavage sites were determined by comparing 
to a G + A ladder and AcuI cleaved fragment. Interpretation of these sequencing ladders is 
complicated by the different ends left by chemical and enzymatic degradation of DNA. To 
check that the sequencing ladder was being interpreted correctly, another set of cleavage 
reactions were carried out using a double stranded oligonucleotide containing IRR adjacent 
to sites for a variety of restriction enzymes that cut at different distances from their 
recognition sites. The oligonucleotide was designed so that cleavage with these restriction 
enzymes would provide markers near to the predicted transposase cleavage sites. For some 
unknown reason the restriction markers ran 1 Y2 nucleotides different from the G+A 
sequencing ladder instead of the V2 nucleotide difference predicted. However using the 
restriction markers it can be seen that the major cleavage site on the presumed transferred 
strand was one nucleotide inside the transposon, with a minor cleavage site just at the 
transposon end (Figure 4.28A). On the non-transferred strand, there was a cut at the 
expected position, two nucleotides inside the transposon, and then five more cut sites, at 
the transposon boundary and 1, 2, 3 and 4 nucleotides outside the transposon (Figure 
4.28B). It is not clear why the non-transferred strand of IRR is cleaved with less sequence 
specificity here than IRL was in the previous assay, though the different sequence of the 
substrate may be responsible. 
In these experiments, a hairpin structure on either the flanking or transposon DNA 
would be observed as a single stranded DNA longer than the original labelled DNA 
substrate. No such products were observed on any of the labelled cleavage gels run (data 
not shown). 
Cleavage of the transferred strand one nucleotide inside the transposon end would 
lead to loss of transposon sequences. Furthermore, the major cleavage sites are not 
compatible with the sequence of the ligated vector reported above. If the cleavage sites 
mapped on linear substrates are correct, it seems that the majority of the cleavage product 
will not be suitable for subsequent steps of the transposition reaction. Alternatively, the 
cleavage sites mapped on short linear substrates may not accurately reflect the cleavage 
sites on supercoiled plasmid substrates with two transposon ends. 
Therefore, the cleavage site on a supercoiled plasmid containing a mini-ISYIOO was 
investigated. An in vitro transposase cleavage reaction was carried out on pXF153, and the 
75 
OJ » 
- -
... ... 
tI.) 1\10 
\ 1\10 
1Jr. tI.) 1J,.0 
-4 ole-
W 11.'~!":irfEPlmr\.· n , C: 'I" ci -4Cq I 'te/~ OJ ill w' 
"0 G~-4 2-
~ G~-4 -Iq(1, :::s ~ Iq(1, 0-
UI 
<~.] (te,. 0 <~.] (te,. 3 
1"" :::s 
'h 
-4" 'J) ~ UI .q "IJ .-;::; 
en 1 ,,, \ X' If q I Q.) 
Iq I Dl 
y s:§'Z!i~it'~~ ::::J en <'< :::s <'< en 
....... 
'h ...., 'h 
en 
-<I "IJ CD ....... -<I "IJ 
c;' 
I", .., I", 
.., 
00 
I ~ 
I .., 
<~1 C. 00 <~lh [ 
(,0 1"" en 
l!l "IJ en 
l!l 'J) ..... (,0 ~ ~ 
... 
.se~ Dl ... G I Q.) 
G I :::s o ~-4 :::s 
0 '~-4 c. 
I~ C. 
... 
I~ - ::::: <0'h (t(te,. -
... 
<0'h (t(te,. .it, "IJ 
... 
.it, "IJ ... °IJ 
tI.) 0 
'" • , ~ ,,"019/;, 
, ~ ~ 
1J,.0 
Ie-
'I" 
5 -aagaggaggatcagctaTAGTAGTTTCAAATAAAGCT -3' 
5 - TT ATTTGAAACTACTAtagctgatcctcctcttcaggaat -3' 
:-... C) :;~" ~ d :; ~~c4'~ ~ 
5'-*aCgaattcctgaagaggaggatcagtJaJJbTAGTTTCAAATAAAJCTGAGACGCTAA -3' 
3'- tgcttaaggacttctcctcctagtcgatATCATCAAAGTTTATTTCGACTCTGCGATT*-5' 
t +t. t 
" :-... ':-... ....... ~ t '* ~ Acul: 5'- CTGAAG(N)16" -3' "r" 0 ~ "r" 
GACTTC(N) " CO S' 14 (j 
~ 
BseRI: 5'- GAGGAG(N)10" -3' 
Alwl: 
Alul: 
D) 
CTCCTC(N)s " 
5'- GGATC(N)4" -3' 
CCTAG(N)5" 
5'- AG"CT -3' 
TC"GA 
5'- AG"CT -3' 
TC"GA 
••• .1... t 5'-*acgaattcctgaagaggaggatcagc~aTAGTAGTTTCAAATAAAGCTGAGACGCTAA -3' 
3'- tgcttaaggacttctcctcctagtcgaf~CATCAAAGTTTATTTCGACTCTGCGATT*-5' 
Figure 4.28 Mapping the cleavage sites on IRR in vitro. IRR58, an oligonucleotide 
carrying 30 bp of IRR and multiple restriction sites, was labelled at the 5' end of either 
the top or bottom strand. Labelled IRR58 was incubated with the indicated concentration 
of purified His-tagged ISYI 00 transposase in cleavage buffer together with 20% DMSO 
for 2 hours at 30°C. The cleavage products were separated on 8% denaturing polyacrylamide 
gels. Labelled IRR58 was also digested by AcuI (lane 2), AluI (lane 5), AlwI (lane 7) and 
BseRI (lane 9) and the digests were run as markers. A) Bottom strand cleavage. B) Top 
strand cleavage. C) Recognition sites and predicted cleavage positions of restriction 
enzymes. The transposon end sequence is shown in bold uppercase. D) Positions of 
transposase cleavage calculated relative to restriction enzyme cleavage sites. Thick anows 
indicate prefened cleavage sites. 
DNA fragments representing excised transposon and donor backbone were recovered from 
an agarose gel. These fragments were tailed using terminal transferase with dGTP or dCTP 
to add poly-G or poly-C tails to the 3' ends. PCR reactions were then performed using 
specific vector or outward facing transposon primers and either poly-C or poly-G primers 
as appropriate. The PCR products were ligated into the TOPO T A cloning vector pCR2.1 
and then sequenced to determine the excised transposon fragment and donor backbone 3' 
ends. Unfortunately, due to a poly-G tract near the ends of the kanamycin cassette, the 
PCR reactions with the excised transposon fragment failed to give the correct product. Five 
junctions from the left end of the donor backbone, and nine from the right end were 
sequenced. These junction sequences reveal the sequence of the 3' end of the donor 
backbone, which presumably reflects the sequence of the 5' end of the transposon. The 
majority (4 out of 5 for IRL, 7 out of 9 for IRR) of the inferred cut sites on the non-
transferred strands were two nucleotides inside the transposon. The remaining junctions 
indicated cleavage sites only one nucleotide inside transposon and at the exact transposon 
end (Figure 4.29). 
Another approach was attempted to determine the cleavage site at the 3' end of the 
transposon. The gel-purified excised mini-ISYlOO was tailed with dGTP and terminal 
transferase and annealed to pUC18 cleaved with Pst! and dC-tailed with terminal 
transferase. After transformation into E. coli, 5 colonies carrying insert were selected for 
sequencing but only one of them gave a readable sequence, showing an intact mini-ISYlOO 
flanked by poly-G (Figure 4.29D). This result suggests that the transferred strands of the 
transposon were cleaved at the exact transposon end. 
These results suggest that the fOlID of the substrates may affect the cleavage 
specificity of transposase. When supercoiled donor plasmid was used as substrate, the 
results supported the proposed cleavage sites from the in vivo studies of Urasaki et ai., 
(2002): cleavage at the transposon boundaries at the 3' ends, with 2 nucleotide recessed 5' 
ends. Only a small fraction of molecules were cleaved elsewhere. However, when linear 
oligonucleotide substrates were used, cleavage at the 3' end was mainly one nucleotide 
inside the transposon and cleavage at the 5' ends occurred mainly one nucleotide outside 
the transposon. 
4.6 Strand cleavage occurs with a defined order 
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GCTAAGAGCGCAGTATAGTAGTTTCAAATAAAGCTGAGACGCTAA 
GCTAAGAGCGCAGTATACCCCCCCCCCCCCAAGCTTCATATGGATGGGGG 
GCTAAGAGCGCAGTAT-CCCCCCCCCCCCAAGCTTCATATGGATGGGGG 
GCTAAGAGCGCAGTATACCcccccCCCCCCCAAGCTTCATATGGATGGGGG 
GCTAAGAGCGCAGTATACCCCCCCCCCCCAAGCTTCATATGGATGGGGG 
GCTAAGAGCGCAGTATACCcccccccCCCCCCCAAGCTTCATATGGATGGGGG 
GCTAAGAGCGCAGTA--CCccccCCCCCCCAAGCTTCATATGGATGGGGG 
GCTAAGAGCGCAGTATACCcccccCCCCCCCAAGCTACATATGGATGGGG 
GCTGAGAGCGCAGTATACCCCCCCCCCCCCAAGCTTCATATGGATGGGGG 
GCTAAGAGCGCAGTATACCccccccccccCCCCCCCAAGCTTCATATGGATGGGGG 
I I 
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• polyG 
• 
nest-polyG 
Backbone IRL 
II 
GCTAAGAGCGCAGTATAGTCATTTCAATTAACGATGAGAGAATTT 
GCTAAGAGCGCAGTATACCcccccCCCCCCCAAGCTTCATATGGATGGGGG 
GCTAAGAGCGCAGTAT-CCCCCCCCCCCAAGCTTCATATGATGGGGG 
GCTAAGAGCGCAGTATACCcccccCCCCCCCTCAAGCTTCATATGGATGGGGG 
GCTAAGAGGGCAGTATACCCCCCCCCCCCAAGCTTCATATGGATGGGGG 
GCTAAGAGCGCAGTATACCccccccCCCCCCCAAGCTTCATATGGATGGG 
I I 
C-tail 
• polyG 
• 
nest-polyG 
IR Vector 
I 
IRL: TTAGCGTCTCAGCTTTATTTGAAACTACTAGGGGGGGGGGGGGGGGGGTTATATCCTTTTATCTATCCT 
IRR: AAATTCTCTCATCGTTAATTGAAATGACTAGGGGGGGGGGGGGG TGCAGGCATGCAAGCTTGGCA 
Figure 4.29 M apping of cleavage sites by C-tailing and PCR. A) The donor backbone 
fragment was tailed with TdT and polyC and then amplified by PCR with a backbone 
specific primer and a polyG primer (see chapter II). PCR products were cloned by TOPO 
TA cloning and then sequenced. B) 3' end of excised backbone sequence flanking IRR. C) 
3' end of excised backbone flanking IRL D) Junction between a tailed excised mini-ISYI 00 
and C-tailed Pst! cleaved pUC18. 
Dawson and Finnegan (2003) reported that cleavage of the two strands at the transposon 
end by Mos1 transposase occurs with a defined order. The non-transferred strand is cleaved 
first to produce a transposon 5' phosphate end, and only then is the transferred strand 
cleaved to produce a 3' OH. To investigate whether this is also the case for ISYlOO, the 
kinetics of top and bottom strand cleavage on IRL79 were measured. IRL79 was 5' end-
labelled at both ends, cut with Apo I and run on a denaturing gel acrylamide gel to assess 
the efficiency of labelling on top and bottom strands. IRL79 was then incubated with 
transposase in a time course experiment and run on denaturing and non-denaturing gels. 
Cleavage of the top strand yields a labelled single stranded fragment of approximately 30 
nucleotides, whereas cleavage of the bottom strand yields a labelled single stranded 
fragment of 51 nucleotides that can be seen on the denaturing gel. Cleavage of both strands 
yields double-strand cleavage products that can be seen on the non-denaturing gel. The 
gels were quantitated using a phosphoimager, and the percentages of top-, bottom-, and 
double-strand cleavage were calculated at each time-point (figure 4.30D). The top (non-
transferred) strand was cleaved much faster than the bottom strand. Furthermore, the 
kinetics of double-strand cleavage exactly followed the kinetics of bottom strand cleavage. 
This shows that bottom strand cleavage only occurs on molecules where the top strand has 
already been cleaved, and that the non-transferred strand is always cleaved first. 
4.7 Integration catalysed by ISYIOO transposase. 
Results presented in the previous section showed that transposase can cleave ISYlOO from 
a donor plasmid. The next step in the transposition reaction is integration of the excised 
transposon into a new target. This step was studied with double stranded oligonucleotide 
substrates designed to mimic excised transposon ends. Because contradictory results had 
been obtained about the exact cleavage sites at ISYlOO ends, substrates were designed with 
a number of different 5' and 3' transposon ends. 
The first experiment used an IRL substrate with a 3'OH precisely at the predicted 
transposon end on the bottom (transferred) strand. The other strand had either a 1 
nucleotide protruding 5' end, coinciding with the major cleavage point on oligonucleotide 
substrates, or a 2 nucleotide recessed 5' end coinciding with the cleavage point on 
supercoiled substrates in vivo and in vitro (Figure 4.31A). Double stranded 
oligonucleotides, 5' end-labelled on either the top or bottom strand, were incubated with 
pH2 target DNA and transposase in a standard transposition reaction. The products were 
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Figure 4.30 Kinetics of IRL 79 cleavage by purified transposase in vitro. IRL 79 was 
5' end-labelled on both strands and was used in a cleavage assay. Samples were withdrawn 
at the indicated time points and stopped by adding either agarose loading dye or formamide 
loading dye containing EDTA in excess over the Mg++ concentration in the sample. A) 
IRL 79 was cleaved with ApoI and separated on an 8% denaturing gel to determine the 
relative efficiency of labelling of both strands. B) Cleavage reactions stopped at the 
indicated time points were separated on a 10% non-denaturing polyaclylamide TBE gel 
to measure the extent of double strand cleavage. C) Cleavage reactions stopped at the 
indicated time points were separated on a 8% denaturing polyacrylamide TTE gel to 
measure the extent of single strand cleavage. D) Graph showing the extent of top-strand, 
bottom-strand and double strand cleavage ofIRL 79 over time. The phosphorimages shown 
in Band C were quantitated using the peak area analysis function of the Fuji Image gauge 
software. Values shown are the percentage of initial substrate cleaved. Top and bottom 
strand cleavage were conected for the relative efficiency of labelling on top and bottom 
strands. E) DNA sequence ofIRL 79. Transposon end sequences are shown in capitals and 
flanking sequence in lowercase, the 24 bp IRL is in bold. The ApoI recognition site is 
indicated. 
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Figure 4.31 Strand transfer by ISYI00 transposase. A) Sequence of synthetic 
oligonucleotides. ISY100 sequence is shown in uppercase and the 24 bp IRL is shown in 
bold. A bottom strand oligonucleotide consisting of nucleotides + 1 to +51 was annealed to 
a top strand oligonucleotide consisting of either nucleotides -1 to +51 or +3 to +51. Band 
C) Integration reaction. Double strand oligonucleotides (+3 top / + 1 bottom or -1 top / + 1 
bottom) were 5' end-labelled on only one strand, as indicated by the asterisk (*), and used 
in an integration assay with pH2 as target (see chapter II). Reaction products were separated 
on a 1.2% non-denaturing agarose gel (B) and a 1.2% denaturing alkaline agarose gel (C). 
The gels were stained by EtBr and then visualised by UV transillumination (left panel), and 
then dried and visualised by autoradiography (right panel). 
then run on a TAE agarose gel and visualized by both ethidium bromide staining and 
autoradiography (Figure 4.31B). The substrate with a recessed 5' end produced a major 
product co-migrating with the open circular form of pH2, and a minor product migrating at 
approximately the same size as linear pH2. The major band is most likely to be pH2 with a 
single copy of the oligonucleotide transposon end integrated at a T A dinucleotide. 
Integration will introduce a single nick, yielding a non-supercoiled circular product with a 
small protruding tail that will migrate at almost exactly the same position as open circle 
pH2. The minor product is thought to come from concerted integration of two transposon 
ends on both strands at approximately the same position, yielding a linear molecule with a 
labelled oligonucleotide covalently attached at both ends. The oligonucleotide substrate 
with a protruding 5' end gave much less product, and only the one ended integration 
product was detectable (Figure 4.31B). The position of the label, on either the top or 
bottom strand, made no difference to the products observed on this non-denaturing gel 
system. 
The same reaction products were then run out on a denaturing gel to see if the 
labelled oligonucleotides became covalently attached to the pH2 target DNA (Figure 
4.31C). A radioactively labelled product of the correct size to be the oligonucleotide 
covalently linked to a single strand of pH2 was observed only when the bottom strand of 
the oligonucleotide was 5' end-labelled. This result therefore shows that the transposon 3' 
end becomes covalently linked to the target DNA, as has been found previously for all 
other DDE transposons. 
A major cleavage was observed on oligonucleotide substrates one nucleotide inside 
the transposon on the transferred strand (Figure 4.28). To see it transposon ends cleaved at 
this position can integrate into a target, or are dead-end products, oligonucleotide 
substrates were made to mimic these cleavage products. Top and bottom strand-labelled 
substrates were made with 3' ends 1 nucleotide inside the transposon end, and 5' ends 
either 1 nucleotide outside or 2 nucleotides inside the transposon end. When these were 
incubated together with transposase and pH2, no strand transfer products were seen (Figure 
4.32). Thus it seems that cleavage products missing the 3' terminal nucleotide of ISYlOO 
are dead-end products that cannot be integrated into a target plasmid. 
The divalent ion requirements of the strand transfer reaction were also tested (Figure 
4.33). Integration was dependent on the presence of divalent cations, and had similar 
requirements to the cleavage reaction, occurring at 5-15 mM Mg2+ and 0.5-2.0 mM Mn2+. 
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Figure 4.32 Integration assays with truncated bottom strand substrates. A) Sequence 
of synthetic oligonucleotides. ISYIOO sequence is shown in uppercase and the 24 bp IRL 
is shown in bold. A bottom strand oligonucleotide consisting of nucleotides +2 to +51 of 
the sequence shown was annealed to a top strand consisting of either nucleotides -1 to +51 
or +3 to +51. B) Integration reaction. Double strand oligonucleotides were 5' end-labelled 
on only one strand as indicated by asterisk (*) and used in an integration assay with pH2 
as target (see chapter II). Reaction products were separated on a 1.2% non-denaturing 
agarose gel. The gel was stained by EtBr and then visualised by UV transillumination (left 
panel), and then dried and visualised by autoradiography (right panel). 
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Figure 4.33 Influence of divalent metal ions on the integration. 20 pmoles of radio labelled 
double stranded IRL oligonucleotide, consisting of nucleotides + 1 to +51 on the bottom 
(transferred) strand and nucleotides +3 to +51 on the top (non-transferred) strand (see Figure 
4.31A), was used in an integration assay (see chapter II) in the presence of various 
concentrations ofMg2+, Mn2+ or Ca2+. 0.15 pmole of super coiled plasmid pH2 was used as 
target in each reaction. Reaction products were separated on 1.2% non-denaturing agarose 
gels. The gels were stained by EtBr and then visualised by UV transillumination (left panel) 
and then dried and visualised by autoradiography (right panel). Concentrations of divalent 
ions used are indicated. 
However, unlike the cleavage reaction, a small amount of integration could be detected in 
the presence of 15 rnM Ca2+. 
A slightly different integration assay was carried out using a linear 1.3 kb excised 
transposon fragment with ISY100 left and right ends. This fragment was radioactively 
labelled at an internal XhoI site, and then cut out from pXF153 using AcuI, so that it had 
the exact same ends produced by transposase: 3'OH ends precisely at the transposon ends 
and 2 nucleotide recessed 5' phosphates. This fragment was incubated with purified 
transposase and pUC18 plasmid DNA as target. This produced one new major radioactive 
product (Figure 4.34C, band II), running significantly slower than nicked pUCI8, and a 
less abundant even slower product (band I). When cleaved with XhoI, this produced two 
labelled products, one migrating close to pUC18 open circle (band VI) and the other (band 
V) migrating closer to band II. When cleaved with ClaI, there were two major bands (VII 
and VIII) only one of which was radioactive. This is fully consistent with integration of 
only one end of the transposon into pUCI8, with the left and right ends inserted at roughly 
equal frequency (Figure 4.34C). When this product was cleaved with EcoRI, which cleaves 
once in pUC18 but not in the transposon fragment, a series of bands was produced (III), 
presumably containing one-ended insertions at different sites in pUCI8. A small amount of 
product was seen migrating at the 4.0 kb position (band IV) in the EcoRI, ClaI and XhoI 
digestions. This is consistent with concerted integration of both ends of ISY100 into a 
single site in pUC18 to produce a nicked circular insertion product that can be linearised 
with a restriction enzyme that cuts once either in pUC18 or in the transposon fragment. 
If this is the case, then these products could be recovered as Kanf Ampf colonies by 
transformation into E. coli. To test this idea, various amounts of the purified pXF153 AcuI 
excised mini-transposon fragment were incubated with transposase and supercoiled pH2 as 
target, and the resulting products were run on an agarose gel (Figure 4.35 B). A band that 
could be one-end integration was seen in increasing amounts as the amount of mini-
transposon fragment was increased. When the products were electroporated into DS964, 
kanf colonies were obtained with increasing frequency as the amount of mini-transposon 
fragment was increased, and over 1 per 1000 of the target plasmids had received a 
transposon insertion at the highest mini-transposon concentration. Individual kanf colonies 
were picked for plasmid isolation, restriction mapping and DNA sequencing, 
demonstrating that they represented genuine transposon insertions into T A dinucleotides in 
pH2 (see chapter V for more details). 
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Figure 4.34 Integration of pre-cut mini-ISYIOO into target DNA. pXF153 was cleaved 
with XhoI, end-labelled with 32p using T4 polynucleotide kinase and then re-ligated. This 
was then cleaved with AcuI to release a 1.3 kb mini-ISYI00, cleaved precisely at the 
transposase cleavage sites, internally labelled at the XhoI site. 0.37 pmole of labelled 
precut mini-ISYI00 was incubated with 0.92 pmole ofpUC18 together with 1.31 pmoles 
purified His-tagged transposase in a standard transposition buffer for 3 hours at 30°C. The 
reaction was stopped, proteins were removed and the buffer was changed using a Qiagen 
gel extraction kit. The products were then digested with either EcoRI, XhoI or ClaI. A) 
The products were separated on a 1.2% agarose gel and the gel was stained with EtBr and 
visualised by UV transillumination (top gel), and then dried and visualised by autoradiography 
(bottom gel). The region of the gel containing integration products is shown expanded to 
the right of each gel. Bands of interest are indicated with roman numerals (I - VIII). B) 
Diagram of substrate DNAs (precut mini-ISYI00 and pUC18 target) used in the assay. 
C) Diagram showing the products of integration and restriction digestion. Products are 
indicated with roman numerals as in A). 
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Figure 4.35 In vitro transposition using pre-cut mini-ISYIOO as donor. In vitro 
transposition was perfonned by incubating various amount of 1.3 kb pXF153/AcuI digestion 
product, a mini-ISYI 00 with 2 nucleotide recessed 5' ends, with supercoiled target plasmid 
pH2 and purified transposase in a standard transposition buffer for 4 hours at 30°C. A) 
Transposition frequencies measured by electroporation into DS964. B) Analysis of products 
from the in vitro transposition on a 1.2% agarose gel. 
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Figure 4.36 In vitro transposition assay. A) Map of A,-dv donor plasmid pXF114. B) 
Map of target plasmid pH2. C) Transposition frequency of two independent in vitro 
transposition assays employing purified transposase, pXF114 and pH2 in a buffer 
containing 10 mM Mg2CI (see Chapter II for details) D) Single colony gel analysis of 
kanamycin resistant colonies from in vitro transposition 1. 18 DS964 kanamycin resistant 
transfonnant colonies, of which one was also chloramphenicol resistant (labelled with *), 
were picked from in vitro transposition reaction 1. Plasmid DNA was analysed on a 1.2% 
agarose single colony gel. Illg of target plasmid pH2 (lane 1) and 0.28 Ilg of donor plasmid 
pXF114 (lane 2) were loaded on the gel as markers. 
Finally, transposase was tested for its ability to catalyse a complete transposition 
reaction. Purified transposase was mixed with a supercoiled donor plasmid pXF114 
(Figure 4.36A) and a supercoiled target plasmid (pH2) (Figure 4.36B) in a standard 
transposition assay. The DNA was then ethanol precipitated and electroporated into a A-
lysogen strain (DS964). The donor plasmid carries a kanamycin resistance gene flanked by 
30 bp ISY100 IRL and IRR sequences, on a A-dv vector. If transposition occurs, the mini-
ISY100 will jump from the donor plasmid into the target plasmid, giving DNA molecules 
that can be detected as Kad
o 
transform ant colonies in DS964. The donor plasmid cannot 
replicate in DS964 and so there should be no other way of obtaining Kad colonies. 
As shown in Figure 4.36C, such DNA molecules were detected with a frequency of 
approximately 1.5 - 2 Kado colonies per 103 AmpT colonies. The majOlity of KanT colonies 
obtained were sensitive to chloramphenicol, consistent with loss of the donor backbone, as 
expected for a proper transposition event. Gel electrophoresis of plasmids obtained from 
KanT Cms colonies was consistent with insertion of the mini-transposon into the target 
plasmid pH2 (Figure 4.36D). Subsequent sequencing results showed that transposition 
occurred exactly at the ISY100 ends with duplication of the target TA (see chapter V for 
details). 
4.8 Discussion and future work 
This chapter reports the purification of full-length His-tagged transposase from the ISY100 
insertion sequence of Synechocystis sp. PCC6803. The pmified transposase was active in 
vitro and catalysed all of the steps in a "cut and paste" transposition reaction. The fact that 
purified transposase was active in vitro demonstrates that no host factors are required for 
ISY100 transposition (although it is possible that host factors could contribute to the 
efficiency of transposition). The fact that ISY100 transposase is active in vitro without host 
factors suggests that it could be active in cultured mammalian cells, or in model organisms. 
ISY100 might therefore have applications in biotechnology as has already been shown for 
other members of the Tel/mariner family of transposons. The question of whether the 
bacterial ISY100 transposase can localise to the nucleus of a mammalian cell, where it 
would be required for activity, has yet to be addressed. 
A number of steps in the transposition reaction were studied in detail. An early step 
in transposition is binding of transposase to the transposon ends. It was shown that the N-
terminal 95 amino acids of ISY100 transposase, containing two helix-turn-helix motifs, 
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binds specifically to the left and right ISY100 inverted repeats. N-terrninal fragments of 
transposase carrying only one helix-turn-helix bound to transposon inverted repeats, but 
the binding appeared to have lower sequence specificity than protein fragments with two 
helix-turn-helix motifs. A ladder of complexes was found as the protein concentration 
increased (data not shown), suggesting binding to multiple site in the DNA, and no 
footprint was observed. 
The footprints obtained with Tnpl-95 and Tnpl-110 were identical to the footprint 
obtained with full-length transposase. This suggests that the catalytic domain of 
transposase is not interacting with the transposon end in the complexes obtained. Perhaps 
the catalytic domain only interacts stably with the transposon end in a paired end complex, 
which was not observed in the conditions used here. Alternatively, it is possible that the 
complexes observed with full-length transposase corne from N-terminal proteolytic 
transposase fragments that may be present in the purified protein. This seems unlikely, 
since transposase was purified with a C-terrninal His-tag. However it could be tested by 
cutting out the complex with full-length transposase from a binding gel, separating it by 
SDS-PAGE, doing a western-blot and looking for full-length transposase in the complexes 
with an antibody directed against the C-terrninal His-tag. 
The findings that Tnpl-95 is sufficient for recognition and binding transposon ends 
might have implications for the regulation of ISY100 transposition in the cyanobacterium 
Synechocystis sp. PCC6803. 25 copies of ISY100 were reported on the genome and 
plasmids of PCC6803 (http://www.kazusa.or.jp/cyano/Synechocystis/). Ten copies on the 
genome encode the full length ISY100 transposase, with only minor sequence variation. 
However, nine copies on the genome and three copies on the plasmids contain frameshift 
mutations that will lead to the production of proteins containing only the first 101 amino 
acids of transposase in a protein of 119 amino acids. A further copy contains a frame shift 
that will produce a 94 amino acid transposase derivative. These truncated transposase 
proteins are predicted to compete for binding with the full-length transposase and act as 
negative regulators of transposition. 
Although there was no evidence from footprinting experiments for interaction 
between the catalytic domain of transposase and the transposon ends, the catalytic domain 
must interact with the transposon ends in subsequent cleavage and strand transfer 
reactions. On supercoiled substrates, cleavage was exactly at the transposon end on one 
strand to produce a 3' -OH, and two nucleotides inside on the other strand to produce a 5' 
phosphate. On linear substrate, the specificity of cleavage was reduced and cleavage 
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occuned at a number of nearby positions on both strands. Conectly cleaved 3'-OH ends 
could be covalently attached to the target DNA in the strand transfer reaction. Although 
apparent concerted insertion of two transposon ends into opposite strands of a single target 
site could be observed, and could be recovered as transposon insertions after 
electroporation in to E. coli, single end insertions were much more cornmon. Further 
studies are needed to investigate whether the C-terminal His-tag interferes with the 
integration reaction, or whether a host factor helps bring about concerted integration. 
Some of the most interesting findings presented in this chapter concern the order of 
events in the strand cleavage reaction. To excise fully from its donor site, both strands of 
the transposon must be cleaved at both ends. On a small linear substrate, the non-
transferred strand was cleaved much faster than the transfened strand (Figure 4.30). 
Furthermore, the transfened strand was only cleaved on molecules that had already been 
cleaved on the non-transfened strand (Figure 4.30). Thus it appears that there is a strict 
order of strand cleavage at the transposon ends. Consistent with this, nicked molecules 
accumulated from supercoiled substrates much more quickly than double strand cleavage 
products, and later work done by Sean Colloms and Victoria Moffat has shown that these 
nicked molecules contain nicks only on the non-transferred strands. 
There is also evidence suggesting that cleavage of the transfened strands requires 
synapsis or some other communication between the two transposon ends, whereas cleavage 
of the non-transfened strands does not. Plasmids containing just one transposon end were 
nicked efficiently, but double strand cleavage was much less efficient than on plasmids 
with two ends. Intermolecular synapsis is much more likely than intramolecular synapsis at 
low DNA concentrations, and may be favoured by DNA supercoiling, so this result 
suggests that synapsis is required for second strand cleavage. 
Mutations in the flanking T A at just one end blocked double-strand cleavage at the 
unchanged end as well as at the mutated end, but nicking was not affected. This again 
supports the idea that synapsis is not required for cleavage of the first (non-transfened) 
strand but is required for cleavage of the second (transfened) strand. 
A final piece of evidence that second strand cleavage occurs in a synapse is that 
double strand cleavage appears to be concerted at the two ends on supercoiled substrates. 
Even when there was only a small amount of double strand cleavage, there was always at 
least as much ETF and donor backbone as there was linear cleaved plasmid. If cleavage at 
the two ends were independent, much more full-length linear than ETF and donor 
backbone would be produced when the overall level of cleavage was low. This concerted 
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cleavage at both ends was lost on linear substrates, suggesting that supercoiling is required 
for efficient synapsis. 
Thus the CUlTent worldng model for transposition of ISYlOO is that transposase binds 
to the two inverted repeats and cleaves the non-transfelTed strands without synapsis. After 
this, the two ends are brought together and the transfelTed strands are cleaved. The excised 
transposon with bound transposase then locates a target TA and the 3' -OR ends are 
transfelTed to the 5' phosphates of the T residues in a single transesterification step. A 
similar model for the order of strand cleavage events has previously been proposed for the 
Mas1 transposon (Dawson and Finnegan, 2003), where assembly of a paired end complex 
appears to be required prior to cleavage of the transfelTed strand. 
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Chapter V 
Target-specific transposition catalysed by chimeric transposases 
5.1 Introduction 
Transposition has been used for a wide variety of genetic and biotechnology applications. 
Traditionally transposons have been used to generate large numbers of different insertion 
mutations in a wide variety of organisms, including bacteria, insects and mammals. The 
recent development of in vitro transposition systems has allowed development of new 
applications for transposition such as delivery of primer sites for DNA sequencing 
projects, and in vitro mutagenesis of large DNA fragments carried on cosmids, Bacs or 
other vectors (Chatterjee and Coren, 1997; Chatterjee et al., 2004; Holtman et al., 2005). 
Transposons can also be used as gene delivery vectors for insertional transgenesis, 
because they generate stable single copy integrations into chromosomal DNA. For 
instance, P elements are routinely used to insert DNA into the model organism D. 
melanogaster, and retrovirus-based vectors have been used in gene therapy trials. Although 
size limitations might be a problem, essentially any DNA sequence can be inserted as long 
as it is flanked by transposon end sequences. There has been much interest in use of 
Tel/mariner family elements for gene delivery (reviewed in Plasterk et al., 1999). 
One of the chief disadvantages in the use of transposons and retrovirus-based vectors 
for gene delivery is their random integration into the host genome. This can have serious 
unwanted side effects. One problem is that insertions can occur into or adjacent to an 
important host gene, knocking it out or activating it inappropriately. This led to serious 
problems in gene therapy trials using retroviral vectors to replace the defective gene in 
severe combined immunodeficiency (SCID). In two patients, the retroviral vector 
integrated adjacent to a proto-oncogene in some cells, leading to activation of this 
oncogene and development of cancer (Hacein-Bey-Abina et al. , 2003). Another 
consequence of insertion into random sites is that insertion into areas of heterochromatin 
can lead to poor expression of the introduced gene (reviewed in Ellis, 2005). 
We hoped that ISYlOO could be used to develop a targeted transposition system that 
could deliver a trans gene to a chosen site in a complex genome, removing the risk of 
insertional mutagenesis. The method chosen for this was to fuse a zinc finger DNA-
binding domain (DBD) to ISYlOO transposase, in the hope that it would direct 
transposition into sites adjacent to its binding site. Similar experiments have previously 
been carried out with retroviral integrase (IN) proteins fused to the zinc finger DNA-
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binding domains from Sp1, Zif268 and E2C (Bushman and Miller, 1997; Peng et al., 2002; 
Tan et al., 2006; Tan et al., 2004). 
In the experiments of Tan et al. (2004, 2006), the synthetic polydactyl zinc finger 
protein E2C was fused to either the N- or the C- terminus of HIV integrase, giving proteins 
called IN-E2C and E2C-IN respectively. Integration catalysed by IN-E2C was clustered 
around the E2C binding site with an asymmetric distribution (Tan et al., 2004). 
Other DNA-binding domains, such as the lambda repressor and E. coli LexA 
repressor have also been fused to IN proteins (Bujacz et al., 1996; Bushman, 1994; 
Goulaouic and Chow, 1996). These DNA-binding domains increased HIV integration into 
sites adjacent to their binding sites (Bushman, 1994; Goulaouic and Chow, 1996). 
In these experiments, transposition reactions into defined DNA molecules were 
normally carried out in vitro. The distribution of target sites was then detelmined by PCR 
using a target-specific primer and a retrovirus-specific primer, and the results were 
generally displayed on a denatUling polyacrylamide gel (Bushman, 1994; Bushman and 
Miller, 1997; Tan et al., 2006; Tan et al., 2004). Thus the pattern of insertions was only 
monitored over a region of about 600 - 1,000 bp of DNA. Transposition generally 
increased close to the DBD-binding site, and was reduced in a region of DNA protected by 
the DBD. However the level of integration into sites distant from the specific binding site 
was unchanged. Therefore all of these systems still carry out random integration at a high 
level, and none of them can deliver a transposon to a precisely defined target sequence. 
It was hoped that the existing TA target specificity of IS630/Tc l/mariner superfamily 
elements and the broad host range of these elements might be a useful starting point to 
develop targeted transposition. This would be done by fusing a specific DNA-binding 
domain to the ISYlOO transposase. 
Although other DNA-binding domains have been used for some of these studies, we 
decided to use the Zif268 DNA-binding domain (Zif268-DBD) because techniques have 
been developed to produce Zif268 derivatives that bind specifically to virtually any chosen 
DNA sequence. Furthermore the Zif268-DBD was readily available from A. Akopian and 
W. M. Stark. Zinc fingers are one of the most common types of eukaryotic DNA-binding 
domains and are found in a wide variety of transcription factors. Zinc finger proteins are 
normally made up from 3 or more repeated zinc-binding motifs termed zinc fingers. Each 
zinc finger binds to a zinc ion using a total of four histidine and cysteine residues, and 
folds into an independent DNA-binding motif. There are several families of zinc finger 
proteins, classified according to protein sequence. Zif268 belongs to the Cys2His2 family of 
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zinc fingers, which contain two cysteines and two histidines in its consensus sequence 
(F/Y)-X-C-X2-s-C-X3-(F/Y)-Xs-1j/ -X2-H-X3-s-H, where X represents any amino acid and 
Ij/is a hydrophobic residue (Wolfe et al., 2000). Zif268 is a three zinc fingers domain from 
a murine transcription factor that specifically recognizes the 10 bp sequence 5 I -
GCGTGGGCGT - 3 I (Christy et al., 1988). The structure of the Zif268-DNA complex 
has been solved by X-ray crystallography (Elrod-Erickson et al., 1996). Each finger of 
Zif268 folds into a ~~a architecture to form a compact domain stabilized by zinc. A single 
zinc ion is coordinated between two cysteines from the N-terminal ~-sheet and two 
histidines from the C-terminal a-helix. In the structure, the C-terminal a-helix of each 
finger makes sequence-specific contacts with three basepairs in the major groove. 
Although each finger makes some interaction to the first base-pair of the next triplet 
(Figure 5.1), each finger binds relatively independently to 3 bp of sequence. The DNA-
binding specificity of each finger can be changed by mutations in amino acids that make 
base-specific contacts with the DNA. Using this structural information, strategies have 
been developed to select Zif268 derivatives that bind tightly and specifically to a large 
number of chosen 9-10 bp sequences (Greisman and Pabo, 1997; Rebar and Pabo, 1994; 
Wolfe et al., 2000). 
Several other strategies have been proposed to integrate a gene to a specific target 
sequence. One widely used strategy is to use a site-specific recombinase, for example Cre 
or <l>C31 integrase. Cre from bacteriophage PI can integrate a circular DNA molecule 
containing a loxP sequence into an existing genomic loxP site. The Cre-IoxP system has 
been widely used and commercialized for this and other purposes such as conditional gene 
inactivation or inversion. The Streptomyces phage <l>C31 integrase catalyzes recombination 
between the bacterial attB and phage attP attachment sites. The ilTeversible and stable 
nature of the integration makes <l>C31 integrase a favorable transgenesis tool, and it has 
been successfully applied in many species other than bacteria such as human cells, flies 
and mouse in vivo (Groth et al., 2004; Groth et al., 2000; Olivares et al., 2002). The 
advantage of using site-specific recombinases as mentioned above for the trans genesis is 
their simplicity and efficiency. However the requirement for pre-existing sites for 
integration on the target chromosome prevents them from being used more widely. 
Since zinc finger domains can specifically recognize virtually any chosen sequence, 
they are an attractive option for changing the target specificity of various enzymes that act 
on DNA. As well as the example of mv integrase mentioned above, other proteins have 
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Figure 5.1 Structure of the three fingers of Zif268 bound to DNA. A) Base contacts 
made from positions -1, 2, 3, and 6 of each a-helix are indicated schematically to the right 
of the structure. Arrows indicate contacts mediated by hydrogen bonds; open circles indicate 
hydrophobic interactions. B) The sequence of the three fingers of Zif268. Diagram shows 
the positions of the ~-sheets and a-helix above the corresponding residues. The cysteines 
and histidines involved in zinc coordination are indicated in bold. Filled squares below the 
sequence indicate the position of the conserved hydrophobic residues. Filled circles and 
triangles indicate residue positions that are involved in phosphate and base contacts 
respectively in most of the fingers. (Taken from Wolfe et al., 2000). 
also been modified by the addition of zinc finger domains to improve or change their target 
specificity. For instance, the Zif268 DNA-binding domain has been fused to the N-terminal 
catalytic domain of Tn3 resolvase. This chimeric recombinase can catalyze efficient 
recombination between recombination sites consisting of the central region of Tn3 res site 
I flanked by two Zif268 binding sequences in inverted repeat in E. Coli (Akopian et al., 
2003). If this chimeric recombinase is functional in eukaryotic cells, it may have 
applications in insertional trans genesis as well as controlled deletion of unwanted DNA 
sequences. 
Another strategy that has been used is to fuse a (Cys2His2) zinc finger DBD to the 
nonspecific DNA cleavage domain of the restriction enzyme Fold. This yields a protein 
that will cleave specifically at a site consisting of two adjacent zinc finger binding sites in 
inverted repeat (Smith et al., 1999). In this strategy, the specific double strand break can 
then invoke homologous recombination between the chromosome and a donor plasmid to 
integrate a foreign DNA sequence into the site (Smith et al., 2000). This zinc finger fusion 
nuclease works in human cells and plant cells at a reasonable efficiency, and may be a 
powerful tool for gene modification (Umov et al., 2005; Wright et al., 2005). 
This chapter reports my attempts to modify the target specificity of ISYlOO 
transposase by fusing the DNA-binding domains of Zif268 to ISYlOO transposase. 
5.2 Target sequence preference of wild-type transposase 
Before attempting to modify the target specificity of ISYlOO transposase, I first decided to 
investigate the target choice of wild-type and His6-tagged ISYlOO transposase. 
Different transposases show different levels of target selectivity, preferring or 
avoiding insertions into certain sequences, regions or structures (Craig, 1997). For 
instance, Tn7 transposes at high frequency into the attTn7 site, a single attachment site 
found in many bacterial genomes. This target-specific transposition uses transposon-
encoded proteins TnsA, TnsB, TnsC and TnsD. TnsD binds to the attachment site and 
introduces DNA distortions which are recognized by TnsC, which somehow directs 
TnsAB-mediated transposition to attTn7 (Kuduvalli et al., 2001; Waddell and Craig, 
1989). In another transposition pathway of Tn7, TnsA, TnsB, TnsC and TnsE bring about 
lower frequency transposition to sites which were initially thought to be random but were 
later found to be regions where chromosomal DNA replication terminates, and sites 
proximal to DNA double-strand breaks (Peters and Craig, 2000). Other transposons show 
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varying levels of preference for specific DNA sequences encompassing the duplicated 
target sequence and the surrounding region. For instance Tn5 prefers the sequences 5'-
AGNTT/cA/TA/GANCT-3' (N = any base). The sequence 5'- GATCA/TGATC -3' was a very 
good target site for in vivo transposition, especially when it was made into in a tandem 
array (Goryshin et al., 1998). TnlO prefers a 9 bp consensus target sequence 5' 
NGCTNAGCN (Bender and Kleckner, 1992; Halling and Kleckner, 1982), and the 
catalytic DDE domain is implicated in target choice (Junop and Haniford, 1997). As 
previously discussed, members of IS630/Tel family always jump into the dinucleotide TA. 
However, preferences for specific sequences outside the duplicated TA have also been 
reported for Tel, Tc3, IS630 and Sleeping Beauty (Liu et al., 2005; Preclin et al., 2003; 
Tenzen and Ohtsubo, 1991). 
Tc1 inserts into widely distributed sites on the C. elegans genome. A commonly 
studied target is unc-22 because insertion and excision events in this gene are associated 
with an easily observed (uncoordinated) phenotype. An alignment of 12 insertion target 
sites, including seven in unc-22, revealed a consensus sequence 5'- GA G/TATATGT -3' in 
which the TA (in bold) was duplicated after insertion (Mori et al., 1988). To investigate 
this further, target sequences of 204 independent Tel insertions and 166 Tc3 insertions in a 
1 kb region of gpa-2 gene were isolated by PCR and analyzed in more detail by DNA 
sequencing (van Luenen and Plasterk, 1994). No consensus target sequence was found for 
Tel or Tc3 in this study. However the different pattern of inserts for Tel and Tc3 
suggested that the hotspots may depend on the primary DNA sequences, and/or sequence 
dependent DNA structure, but not the local chromatin structure. In another study, 
sequencing 378 alleles of Tel left flanks and 340 alleles of right flanks in strains carrying 
high copy numbers of Tel revealed a weak consensus target sequence of 5'-
CA c/TATATG/ ATG -3', with the TA in the middle (Korswagen et al., 1996). Recently, 588 
Tel insertions and 223 Tc3 insertions into a wider region of the genome were analysed and 
the result suggested that Tel prefers a target sequence 5'-Ac/TATATG/ AT -3' and Tc3 
prefers 5'- ATATATTT -3' (Preclin et al., 2003). The observation that Tc3 does have a 
preferred target sequence suggests that the failure of the previous study to identify a 
consensus target site (van Luenen and Plasterk, 1994) might be due to the small sample 
size. 
To investigate the target preference of ISYlOO, the sequences flanking inseltions 
from various sources were analyzed as follows. The original target sequences were first 
reconstructed in silica by precise removal of the ISYlOO sequence and one copy of the TA 
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target duplication. The flanldng sequences were aligned from left to right in the direction 
of the insertion, that is with IRL on the left and IRR on the right. The base frequencies 
were then calculated at every position for 20 bp on either side of the target T A. The 
alignments were also analyzed using the program WebLogo, which generates graphical 
sequence logos showing the sequence similarity of multiple sequence alignments providing 
more information than simple consensus sequences (Crooks et al., 2004). The sequence 
logo is comprised of stacks of letters, one stack for each position in the sequence. The total 
height of each stack indicates the sequence conservation, or information content at that 
position, and the height of each letter within the stack represents the relative frequency of 
that nucleotide. The information content is measured in bits (calculated according to the 
formula shown in Figure 5.2C), where 0 indicates no deviation from random sequence and 
2 represents 100% DNA sequence conservation. Note that the smaller the sample size, the 
higher the probability of producing a high information content by chance, as indicated by 
the error bars on the diagrams. 
The target choice of the 24 ISY100 insertions in the genoIllic sequence of 
Synechocystis sp. strain PCC6803 and its plasmids pSYSG and pSYSA were analyzed 
first. Out of the 21 genomic ISY100 insertions, 11 are in one orientation and 10 are in the 
other. Both orientations are spread randomly throughout the genome, with no obvious 
correlation between the orientation of insertion and the presumed direction of DNA 
replication (Figure 5.2 A). All of the insertions are flanked by TA target duplications on 
both sides, except one chromosomal copy that has TA on one side and CA on the other. 
This could be due to a mutation that occUlTed after insertion of this copy of ISY100. The 
alignment of these 24 inseltions, and the WebLogo produced from this alignment, suggests 
that there is a tendency for three base-pairs on either side of the target TA to be A-T rich 
with weak consensus Ts at positions -1, +1, +2 and +3 as well as an A at position -3 
(Figure 5.2D,E). 
Urasald et al. reported the sequence of 21 mini-ISY100 insertions into plasmids 
pSEK80 and pAD5 generated in their in vivo transposition system (Urasald et al., 2002). 
The sequences of these insertions were analyzed in a similar way (Figure 5.3). Again there 
is a tendency for at least three base-pairs on either side to be A-T rich, although there was 
no strong consensus sequence outside the target T A. 
Next, the target sequences of 48 insertions generated in vivo in this work (Chapter 
III) were analyzed. These insertions were generated in a variety of assays, with donor 
plasmids containing different combinations of ISY100 left and right ends, or different 
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A) 
B) 
C) 
D) 
2 
origin 
5'- CGTATAATGCTTTCTCGTAT TA CCTCTTAATTTTTACTTTAG -3' 
AATAGCGTAAATTTTCCACT TA CTTTGGGATCAGGGTTGTCA 
CTGGAAGTATTCCCAGCTTT TA TGTGTCTAAATCAGGTTCAT 
CTCAAGGAAAGTTAGAAAAG TA ACGACCACAAAAATGCTAAT 
CCGGTTTGAATTACAAAGCA TA GTTCAAAAATTAACCGAAGA 
AGAGGTTGAGGCTTTGTTTT TA TTATCGGAACAACATTAATC* 
GTAAAGGAGCAAGTTTTAGT TA TATTCCGATCCCTATCCTCA 
TATATGAAAATAGTCAAATC TA TTTTCATAAAACTAAATTCA 
TTACCCACCTCTTTATATTT TA CTCCTGATACTTTTGTCATA 
TTGGGATAACAATTCGGGAA TA TTGTCTCGAATAATGCTCCA 
CTTCTATTGTTTCATTCCCA TA TTTATTATCATGACCTTGTC 
TGTTACCCGCTTTGAAGATT TA TTTGCTGAATTTTGCGGAAC 
ACAGTAAATATCAACGATTA TA TTTTTAAAATTTCTAGAAAC 
TTTTAGGCAAAATTTAGATT TA AAAATCAAACTTGCAGAGCT 
CATAGGTTTCTCCCAAAAAA TA ATGTATGAAGCTCTCTCTTA 
TCTTAATACATGATATTTGT TA TTCTCCTTTTGTAATCTCTT 
ACAATGCCAACTATGGGTTG TA TTTCACTTTCTGGGATAAAA 
ATTATCGGTCAACAAATCAA TA CTAATACGGCGCAAATGTTA 
AAGCAATCCAGGCTTGTATT TA TGCCTGGTCAAAAAAAGGAA 
AAAAGAGCTTGGTTTCAATA TA AAGGTAGTATTAGCATATAG 
GTTAACGGGCAAAATGTTGA TA CAGTCGAACAGAGACTTTTT 
CGAGCCTGATCGACGACGAT TA TATGGGATCTATGACCGCCG ]-pSYSG 
CCACATGAGACTCACTTACA TA ATTTTAGTGATGAACTAAAC 
ATCCTGGGGCGGATTCAAGA TA GATTGCACCACCGCATTCAA - pSYSA 
~ 
IRL Tnp IRR 
N 
Rseq = Smar - Sobs = log2 N -( - U,JOg2PIl) 
1/=1 
Rseq = information content of a single position 
Smar = maximum possible entropy 
Sobs = the entropy of the observed symbol distribution at that position 
N = number of possible symbols per position (=4 for DNA) 
PII = observed frequency of symbol n at that position 
weblogo.berkeley.edu 
E) 
-5 -4 -3 -2 -1 T A +1 +2 +3 +4 +5 
A 8 8 11 6 10 0 24 5 6 3 4 3 
C 4 4 241 0 0 5 2 358 
G 7 5 342 0 022 543 
T 5 7 8 1 0 11 24 0 12 14 13 11 1 0 
Figure 5.2 Analysis of target sequences of insertion of ISYIOO in the genome of 
Synechocystis sp. strain PCC6803. A) Distribution ofISYl 00 insertions on the chromosome 
of Synechocystis sp. strain PCC6803. Map of the PCC6803 genome showing the locations 
of 21 insertions. Lines on the outside of the circle indicate insertions in a clockwise 
orientation, those on the inside are anticlockwise. The presumed origin of replication 
deduced by the skewed oligomers method (Salzberg et al. J 1998) is also shown. B) 
Alignment of flanking sequences ofISY100 insertions on the genome and plasmids of 
Synechocystis sp. strain PCC6803. All the sequences are shown oriented in the direction 
of ISY1 00 transposase. The bold TA in the middle of the sequence was duplicated after 
the insertion of the ISY100. The insertion marked with an asterisk (*) was flanked by TA 
at one side and CA on the other. The last three target sequences are from the plasmids 
whose names are shown at the end of the sequence. C) The formula used by Weblogo to 
calculate the information content of a sequence aligmnent (Crooks et al., 2004). D) Weblogo 
of the sequence alignment shown in B). E) Base frequencies of 5 nucleotides on either 
side of the target TA. 
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5'-TGATGCAGAGAAACAAAGAT TA TCAGTGGCCCGTAAAAGAGC-3' 
AAGAGCTTCGTTCAAGGAAG TA AAAGTATTTCTTGAACCAAA(x2) 
ATACATGTGTATATACGTGG TA ATGACAAAAATAGGACAAGT 
AGAGGTCCCCTTTTTTATTT TA AAAATTTTTTCACAAAACGG 
CCTTTAATAGATTATATTAC TA ATTAATTGGGGACCCTAGAG 
TATCAGGTCAAGTCTGCTTT TA TTATTTTTAAGCGTGCATAA 
CATCTGGCGCAAAACGAGCA TA CAGAAAGGGGAATCCGCTTT 
GGTAACGATATCTGAATTGT TA TACATGTGTATATACGTGGT 
GGAGCTATCCAACGGCGGTA TA CCAGGAAAACACACAGCAGG 
TGTTATAAGGTATATATATA TA AGTGTGCAGTACAGGCCAAA 
GTCATGGTACTGTTCTGATG TA CCTGCTGTGTGTTTTCCTGG 
GAGTGAGGCCGAGTGCCGTA TA TTACGCATTAAAGAAAATGA 
TGTCGAGGGAGGGTAGCAAA TA TAATTTTAACCATCCTTCAA 
AGAAGGCTTTGAAGGATGGT TA AAATTATATTTGCTACCCTA 
AATAACTGAGGCTTCCAAGA TA TATAAAATAGGAAAAGCCTC 
ACTGAGGCTTCCAAGATATA TA AAATAGGAAAAGCCTCGATA(x2) 
TATAGAAGCTGGAGGAAAAA TA ACTGAGGCTTCCAAGATATA 
TTCGAAGCAATCCAGGCTTG TA TTTATGCCTGGTCAAAAAAA 
TGAAATGAGCTGTTGACAAT TA ATCATCCGGCTCGTATAATG 
~ 
IRL Cmr IRR 
2 
weblogo.befkeley.edu 
-5 -4 -3 -2 -1 T A 1 2 3 4 5 
A 8 5 8 6 8 0 19 9 8 9 8 5 
C 4 5 0 1 1 0 0 3 4 2 1 2 
G 5 4 5 4 4 0 0 0 1 2 6 2 
T 2 5 6 8 6 19 0 7 6 6 4 10 
Figure 5.3 Analysis of sequences flanking ISYIOO insertions isolated in vivo by Urasaki 
et al., 2002. A) Alignment of sequences flanking the duplicated target TA (in bold). B) 
Web logo of the aligned target sequences. C) Base frequencies of 5 nucleotides on either 
side of the target TA. 
flanking dinucleotides. All of the target sequences from these assays are shown aligned in 
Figure 5.4. Because only a small number of insertions were sequenced for some donor 
plasmids, it is not possible to see if the differences between the donors affected the target 
choice. However, because ISYlOO is likely to excise fully from the donor plasmid before 
the target is located, it seems unlikely that the donor flanking sequences will affect the 
target choice. The targets of in vivo transposition were therefore analyzed in three groups 
according to the combination of left and right ends in the mini-transposon. 33 insertions of 
ISYlOO-IRLlIRR, 12 insertions of ISYlOO-IRRlIRR, and 3 insertions of ISYlOO-IRLlIRL 
were analyzed separately. Although some individual target sites were used several times in 
these assays, each sequence was counted only once in any alignment, so as to avoid 
introducing an apparent preference for sequences that in fact have no effect on target 
choice. For ISYlOO-IRLlIRR, the strongest target preference outside the central TA was 
for an A at position -3 and a T at position +3 (Figure 5.4B). The number of insertions of 
the other two classes of elements was small, but the target sites used do not seem 
significantly different from those obtained with ISYlOO-IRLlIRR. Thus there seems to be 
no strong preference for left ends to insert adjacent to one type of sequence and right ends 
adjacent to another type. Adding the target sites of IRLlIRL and IRRlIRR insertions to the 
target sites of IRLlIRR insertions in either orientation did not significantly change the 
results obtained from the latter class alone. 
Finally, the insertions obtained from in vitro transposition reactions were analyzed in 
a similar way. In vitro transposition reactions used three different sources of transposon 
DNA: supercoiled donor plasmid, transposase-excised mini-ISYlOO, or AcuI-excised mini-
ISYlOO. Alignments of target sequences from these three groups gave similar Weblogo 
patterns and were then analyzed together (Figure 5.5). In the combined data set, there is a 
strong preference for A (with a weaker preference for T) at position -3, and a symmetrical 
preference for T (or A) at position +3. There is also a weaker preference for either A or T 
at positions ±1, A, G or T at position -2 and A, C or T at position +2. This preference 
coincides quite well with the preference deduced for ISYlOO-IRRlIRL in the in vivo 
assays. Combining the target sites of ISYlOO-IRLlIRR from in vivo and in vitro assays in 
this study gives a consensus sequence ARWT A WYT (W = A or T, R = A or G, Y = C or 
T; Figure 5.6). When all of the ISYlOO-IRLlIRR insertions from this study and study of 
Urasaki et al. (2002) and the genome of PCC6803, are analyzed together, the consensus 
target sequence ADWTAWHT (W = A or T, D = not C, H = not G; Figure 5.6) can be 
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A) 
No. Flanking sequences Orientation Position of of insertion insertion 
Tll TGACGTATAAACGTTGCTTG TA TTTATTATTACAATTAAAGG (+) 186 bp 
T12 GAGTGAGACAAAGAGCGAAA TA AGAGCTTCAAAGGCTATCTC (+) 2182bp 
T13 CCACGGTATCTTGTTAAAAA TA TATATTTGTGGCGGGCTTAC (+) 64 bp 
TA-L T14 GCAAACCTGAGATTAGTTTC TA ACTAGTCTCTAGGTTTTCTA H 232 bp 
TA-R T16 CAGCGTAAGCTCCCCGTCCT TA ACTGCCTCGAGATAGTGACA (+) 2023bp 
Tnp-His6 T17 CCTAGGTACGGGGCTGAATG TA ACTTGCCTTTCCTTTCTCAT (+) 1245bp T18 ACGGAAATGTTGAATACTCA TA CTCTTCCTTTTTCAATATTA (-) 3274bp 
T19 TTGGACTTGGTGCTGCTATA TA TTAGCTAATACACTAGTTAG (+) 1539bp 
T20 AGACTCAGACAAAGACCAAC TA GTTATTGACCAGTCTTCTAG (-) 937 bp 
T1 TCCCTCTGCCAACAGAAACA TA TTGGTCAAGCACTTGAAGGA (-) 1794bp 
T2 TTGTCTCATGAGCGGATACA TA TTTGAATGTATTTAGAAAAA (-) 32llbp (=T4/7/8) 
T3 TTGTGTGTTTAGTTTATAAT TA GTCTCTTATTAATTTGATGT (-) 108 bp 
T5 TGATAACACTGCGGCCAACT TA CTTCTGACAACGATCGGAGG (+) 3678bp 
TA-L T6 GAGTGAGACAAAGAGCGAAA TA AGAGCTTCAAAGGCTATCTC (+) 2182bp 
TA-R T9 TAAAAGAGATTTCGACTAGT TA TGTACCTGGAGTTTGGATAT (+) 2265bp 
T10 TTAAATTAAAAATGAAGTTT TA AATCAATCTAAAGTATATAT (-) 4176bp 
T16 ' TAAAAGAGATTTCGACTAGT TA TGTACCTGGAGTTTGGATAT (+) 2266bp 
T17' TtCGTGCTATCACAAAACAG TA TACAAAAAATAAGCTTTCGC H 16 bp 
T18' AGAGTAAGTAGTTCGCCAGT TA ATAGTTTGCGCAACGTTGTT H 3849bp 
TA-L [T37 GATCTTCACCTAGATCCTTT TA AATTAAAAATGAAGTTTTAA H 4196bp 
TA-L T38 GCCTTTCTGGTTCTACGAAG TA TCCAGTCCCGCCTGCAACGC H 2545bp 
T39 CAAACTATTAACTGGCGAAC TA CTTACTCTAGCTTCCCGGCA (+) 3861bp 
TA-R [T34 TGATGGCAGACATGGTAGGT TA ATACCTTGTTAGTTATTGCT (-) 635 bp 
TA-R T35 AGAGATTTCGACTAGTTATG TA CCTGGAGTTTGGATATAGGA (+) 2269bp 
T36 GCACCATATGCGGTGTGAAA TA CCGCACAGATGCGTAAGGAG (-) 2876bp 
TG-L T20 ACCGTGGAAAAACTTCGTGC TA TCACAAAACAGTATACAAAA (-) 29 bp TG-R 
AA-L T30 CAAGGTGTTCAGAGACTAGT TA TTGACTAGTCAGTGACTAGC (+) 596 bp AA-R 
CA-L [ T31 GAGCACTTTTAAAGTTCTGC TA TGTGGCGCGGTATTATCCCG (+) 3496bp 
CA-R T32 TGGCAGACATGGTAGGTTAA TA CCTTGTTAGTTATTGCTAGT (-) 631 bp 
T33 CCTTTAATTGTAATAATAAA TA CAAGCAACGTTTATACGTCA (-) 186 bp 
TG-L [ T43 GCTGCCGGATTTCAAGATAG TA AGCCGACCCGACTAGCTTTA (-) 1985bp 
TA-R T44 CGTTCCTCGGTGGTCGCAGA TA ACTCCCTAAATTCCCTGAGC (-) 2432bp 
T45 TGATAACACTGCGGCCAACT TA CTTCTGACAACGATCGGAGG (+) 3678bp 
TC-L [ T46 GTAGGTAAGCCCGCCACAAA TA TATATTTTTAACAAGATACC (-) 68 bp 
TA-R T47 CCTAGGTACGGGGCTGAATG TA ACTTGCCTTTCCTTTCTCAT (+) 1245bp 
T48 GATTCTGTGGATAACCGTAT TA CCGCCTTTGAGTGAGCTGAT (+) 4996bp 
TT-R [T49 AAATCTAGTCAAGAACTAGA TA CTTAACCTTCATACTGCTTA H 2224bp 
TA-R T50 TGCGTAAGTTTCTGTGAGTC TA ACTAGTGTATTAGCTAATAT (-) 1558bp 
T51 ATATATACTTTAGATTGATT TA AAACTTCATTTTTAATTTAA (+) 4176bp 
AA-R[ T52 AGTGGTGAGGATAATAGTAG TA AGTTATTCTAGCTTCAGAGT H 527 bp 
TA-R T53 TGGTGCTGCTATATATTAGC TA ATACACTAGTTAGACTCACA (+) 1546bp 
T54 TAATAAATACAAGCAACGTT TA TACGTCAAAAGCATTTATAA (-) 173 bp 
CA-R[ T55 GCACCCCAGGCTTTACACTT TA TGCTTCCGGCTCGTATGTTG (+) 5227bp 
TA-R T56 CGGGATAATACCGCGCCACA TA GCAGAACTTTAAAAGTGCTC (-) 3495bp (=T57) 
~ 
or 
~~~ 
IRL Kanr IRR 
B) 
ISY100 IRLlIRR 
-5 -4 -3 -2 -1 T A 1 2 3 4 5 
A 9 6 15 10 10 0 26 8 5 5 8 4 
C 9 7 2 5 4 0 0 5 7 4 6 9 
G 7 4 0 6 4 0 0 2 4 3 8 5 
T 1 9 9 5 8 26 0 11 10 14 4 8 
Figure 5.4 Analysis of sequences flanking ISYIOO insertions isolated in vivo in this 
study. A) Alignment of sequences flanking the duplicated target TA (in bold) from individual 
insertions. Multiple insertions at the same site are listed in the right hand column. All the 
assays used pH2 as target plasmid and the positions of the insertions are given. The 
orientation of the insertions were labelled as + or -, indicating the orientation from IRL 
to IRR of insertions (or the orientation of kanamycin resistance gene on mini-ISYIOO with 
two identical ends) relative to the ampicillin resistance gene on pH2. The first group of 
insertions were obtained with His6-tagged transposase. All of others were obtained with 
wild-type transposase. B) Base frequencies of 5 nucleotides on either side of the target 
TA. Duplicated target sequences were removed so that each target sequence contributed 
only once to the analysis in any direction. C) Weblogo of the aligned independent target 
sequences. 
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Flanking sequences Orientation of the insertion 
TGTCAGACCAAGTTTACTCA TA TATACTTTAGATTGATTTAA 
AACTAGTGTATTAGCTAATA TA TAGCAGCACCAAGTCCAAGG 
AGAAAAAGTCGGTCAAGAGG TA ACTCTAAGTCGGCCATTCCT 
AAAAAAACAAGACAGCCACA TA TTAGGGAGACTAGTTAGAAG 
ACTAGTTTCTGACTAGTTAT TA ACTAGTTGACAGGTTCCCTC 
CTGACTCCCCGTCGTGTAGA TA ACTACGATACGGGAGGGCTT 
GCACAACATGGGGGATCATG TA ACTCGCCTTGATCGTTGGGA 
TTGCAACTAATACTAGTTAG TA TCTAGTCTCCTATAACTCTG 
AAATCTAGTCAAGAACTAGA TA CTTAACCTTCATACTGCTTA 
GGCAGTGAGCGCAACGCAAT TA ATGTGAGTTAGCTCACTCAT 
CCTGCAGATTTTGACCTAGT TA ACAAGGCACATCATGCTATC 
TTGGACTTGGTGCTGCTATA TA TTAGCTAATACACTAGTTAG 
CTAACTAGTGTATTAGCTAA TA TATAGCAGCACCAAGTCCAA 
AGGTAAGCCCGCCACAAATA TA TATTTTTAACAAGATACCGT 
AAGCCCTCCCGTATCGTAGT TA TCTACACGACGGGGAGTCAG 
AATTAATAAGAGACTAATTA TA AACTAAACACACAAGCAAGC 
* CTAACTAGTGTATTAGCTAA TA TATAGCAGCACCAAGTCCAA 
CGGGCTTACCTACATCAAAT TA ATAAGAGACTAATTATAAAC 
AACTGATCTTCAGCATCTTT TA CTTTCACCAGCGTTTCTGGG 
ATAGGAGACTAGATACTAAC TA GTATTAGTTGCAACTAACCT 
GATAGCATGATGTGCCTTGT TA ACTAGGTCAAAATCTGCAGG 
CAGTCTAGTTGACAACTAGA TA GATTCTAGATTGAGGCCAAA 
AGTTATAGGAGACTAGATAC TA ACTAGTATTAGTTGCAACTA 
TTTTTCTAAATACATTCAAA TA TGTATCCGCTCATGAGACAA 
CTAACTAGTGTATTAGCTAA TA TATAGCAGCACCAAGTCCAA 
AAGCCCTCCCGTATCGTAGT TA TCTACACGACGGGGAGTCAG 
TATTTGTTTATTTTTCTAAA TA CATTCAAATATGTATCCGCT 
AGCGGATACATATTTGAATG TA TTTAGAAAAATAAACAAATA 
ATATCCAAACTCCAGGTACA TA ACTAGTCGAAATCTCTTTTA 
CCTGCAGATTTTGACCTAGT TA ACAAGGCACATCATGCTATC 
GACTAGTCAGTGACTAGCAA TA ACTAACAAGGTATTAACCTA 
TCCCAACGATCAAGGCGAGT TA CATGATCCCCCATGTTGTGC 
GCTCAGGGAATTTAGGGAGT TA TCTGCGACCACCGAGGAACG 
TAAAAGAGATTTCGACTAGT TA TGTACCTGGAGTTTGGATAT 
CTATGCGGCATCAGAGCAGA TT GTACTGAGAGTGCACCATAT 
* GTAAGTAGTTCGCCAGTTAA TA GTTTGCGCAACGTTGTTGCC 
CGACTAGCTTTAAGCCTAGT TA CTGACTAGTCCACAGGACGA 
CCTGTCGTGCCAGCTGCATT AA TGAATCGGCCAACGCGCGGG 
TGTCAGACCAAGTTTACTCA TA TATACTTTAGATTGATTTAA 
TTGGACTTGGTGCTGCTATA TA TTAGCTAATACACTAGTTAG 
TTGTCTCATGAGCGGATACA TA TTTGAATGTATTTAGAAAAA 
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Figure 5.5 Analysis of sequences flanking ISYIOO insertions isolated in vitro in this 
study. A) Alignment of sequences flanking target TA dinucleotides. All the assays used 
pH2 as target plasmid. Group I results are from in vitro transposition assay using supercoiled 
plasmid canying mini-ISYIOO as donor, group II and III results are from in vitro transposition 
assays using mini-ISYIOO excised from pXF153 by ISYIOO transposase (group II) or by 
Acul (group III). The orientation of the insertions were labelled as "+" or "_", indicating 
the orientation from IRL to IRR of insertions relative to the ampicillin resistance gene on 
pH2. Sequences marked with an asterisk (*) were flanked by TA at one side but only A at 
the other. B) Base frequencies of 5 nucleotides on either side of the target TA. Duplicated 
target sequences were removed so that each target sequence contributed only once to the 
analysis in any direction. C) Weblogo of independent target sequences from A). 
A) 
In vivo (from PCC6803 + Urasaki et al., 2002) 
-5 -4 -3 -2 -1 T A 2 3 4 5 
A 16 13 19 12 18 0 43 14 14 12 12 8 
C 8 9 2 5 2 0 0 8 6 5 6 10 
G 12 9 8 8 6 0 0 2 3 7 10 5 
T 7 12 14 18 17 43 0 19 20 19 15 20 
In vivo + in vitro (IRLIIRR transposon - this work) 
-5 -4 -3 -2 -1 T A 2 3 4 5 
A 14 12 37 21 25 57 20 13 11 25 9 
C 19 16 3 8 6 0 0 10 19 5 10 17 
G 20 8 0 17 8 0 0 6 6 6 11 18 
T 5 22 18 12 19 57 1 22 20 36 12 14 
All 
-5 -4 -3 -2 -1 T A 2 3 4 5 
A 30 25 56 33 43 10034 27 23 37 17 
C 27 25 5 13 8 0 0 18 25 10 16 27 
G 32 17 8 25 14 0 0 8 9 13 21 23 
T 12 34 32 30 36 100 1 41 40 55 27 34 
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F igure 5.6 Analysis of target sequences from independent ISYI OO insertion sites. 
Independent target sequences ofmini-ISYIOO with IRL and IRR from in vivo and in vitro 
transposition assays in this study and target sequences obtained from in vivo transposition 
assay done by Urasaki et al., 2002 together with the deduced target sequences oflSYlOO 
on the genomic DNA were analysed separately and in combination. A) Base frequency 
distribution of 5 nucleotides on either side of the target TA. B) Weblogo of the alignment 
of the independent target sequences. 
deduced. At position -3, A is present in 55% of targets and T is present in 32%, whereas at 
position +3, T is present in 55% of targets and A is present in 23%. At positions -1 and +1, 
either T or A is present in 74-78% of insertions and at positions -2 and +2, either T or A is 
present in 62-66% (Table 5.1). At position -2, G is present in 25% of target sites, whereas 
C is unfavourable. Conversely at position +2, C is present at 25% of target sites and G is 
unfavourable. 
The deduced consensus target sites of IRLlIRR insertions from this study as well as 
that deduced from all the published data, is palindromic. This is the expected result if there 
is no orientation preference for insertion at any site, even if the prefened sequence is not 
palindromic. This is because the targets are aligned according to the direction of ISY100 
insertions and a non-palindromic sequence, when averaged in both orientations will give a 
palindromic sequence. Multiple insertions were observed at several different sites, and 
both orientations were observed at these sites in approximately equal numbers, agreeing 
with the idea that there is no orientation preference for insertion (Table 5.2, Figure 5.7). 
This suggests that the left and right ends of the transposon are equivalent in the target 
search, as would be expected if the strand transfer complex is functionally 2-fold 
symmetric. Nevertheless, it is still possible that palindromic targets are prefened over non-
palindromic sequences. This question can be addressed by asking whether palindromic 
bases are more common than expected at minor positions. In other words, if an A is 
present at position -3, is there an increased probability of a T at position +3? Analysis of 
the frequency of palindromic bases at minor positions (Table 5.3) shows that palindromic 
bases do not occur at higher than expected frequency at minor positions in the 3 base pairs 
flanking the target T A. Thus there does not seem to be any inherent preference for 
palindromic targets. 
ANNTANNT (N = any base) was the simplest consensus target sequence deduced 
for ISYlOO (IRLlIRR) insertions. 31 out of 101 (30.7%) different insertion sites in this 
study and in PCC6803 genome and in the results of Urasaki et al. (2002) match this 
consensus sequence. Among these 31 sites, only 2 are fully palindromic over the 8 bp 
around the central TA, supporting the lack of preference for palindromic target sites. A 
total of 33 out of the 84 sequenced ISYlOO-IRLlIRR insertions into pH2 (39.3%), or 21 
out of the 58 different target sites (36.2%) match up to the consensus sequence 
ANNTANNT (Table 5.2, Figure 5.4A, 5.5A), and 15 out of the 36 available ANNTANNT 
sequences in pH2 (41.7%) have at least one insertion. Two out of the 14 ISYlOO-IRLlIRL 
and ISYlOO-IRRlIRR insertions were also into sites matching this consensus sequence 
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Table 5.1 Number and percentage occurrence of bases flanking duplicated target 
dinucleotides 
A) Independent target sequences used by IRL-IRR transposons in vivo and in vitro in this 
study (Figure 5.6A). 
Base 2ositions relative to target dinucleotides 
-3 -2 -1 +1 +2 +3 
37 21 25 20 13 11 
A (63.8%) (36.2%) (43.1%) (34.5%) (22.4%) (19.0%) 
3 8 6 10 19 5 
C (5.2%) (13.8%) (10.3%) (17.2%) (32.8%) (8.6%) 
0 17 8 6 6 6 
G (0%) (29.3%) (13.8%) (10.3%) (10.3%) (10.3%) 
18 12 19 22 20 36 
T (31.0%) (20.7%) (32.8%) (37.9%) (34.5%) (62.1%) 
B) Independent target sequences used by IRL-IRR transposons in this study, and the study 
of Urasaki et al. (2002) and in the PCC6803 genome (Figure 5.6A). 
Base 2ositions relative to target dinucleotides 
-3 -2 -1 +1 +2 +3 
56 33 43 34 27 23 
A (55.4%) (32.7%) (42.6%) (33.7%) (26.7%) (22.8%) 
5 13 8 18 25 10 
C (5%) (12.9%) (7.9%) (17.8%) (24.8%) (9.9%) 
8 25 14 8 9 13 
G (7.9%) (24.8%) (13.9%) (7.9%) (8.9%) (12.9%) 
32 30 36 41 40 55 
T (31.7%) (29.7%) (35.6%) (40.6%) (39.6%) (54.5%) 
Table 5.2 Distribution of ISYIOO insertions in pH2 from this study 
A) Insertion of ISYlOO IRLlIRR 
Position (bp) ANNTANNT Orientation 1 (+)(1) Orientation 2 (-)(1) Total in vivo in vitro in vivo in vitro 
16 1 1 
29 1 1 
64 Y 1 1 
66 Y 1 1 
68 Y 1 1 
97 1 1 
108 1 1 
114 1 1 
186 1 1 2 
232 1 1 
348 1 1 
429 Y 1 1 
484 1 1 
488 1 1 
491 1 1 
595 1 1 
619 1 1 
631 1 1 
937 Y 1 1 
1245 Y 2 2 
1537 1 1 
1539 1 3 8 12 
1794 1 1 
1830 1 1 
1955 1 1 
1985 1 1 
2023 1 1 
2182 2 2 
2224 Y 1 1 
2265 Y 2 1 1 4 
2345 Y 1 1 
2432 Y 1 1 2 
2620 1 2 3 
2908* 1 1 
3201 Y 1 1 2 
3211 Y 1 4 1 6 
3274 1 1 
3366 1 1 
3495 1 1 
3678 Y 2 2 
3744 Y 1 1 2 
3846 2 2 
3849 1 1 
4048 Y 2 4 6 
4157 2 2 
4176 1 1 
4996 1 1 
5122* 1 1 
5182 1 1 
Total 15 21 18 30 84 
B) Insertion of ISYlOO IRL/IRL (in vivo) 
Position (bp) ANNTANNT Orientation 1 (+)(1) Orientation 2 (-1(1) 
2545 1 
3861 Y 1 
4196 1 
Total 1 2 
C) Insertion ofISYlOO IRRlIRR (in vivo): 
Position (bp) ANNTANNT Orientation 1 (+)(1) Orientation 21-1(1) 
173 1 
527 1 
635 1 
1546 1 
1558 1 
2224 1 
2269 Y 1 
2876 1 
3495 2 
4176 1 
5227 1 
Total 4 8 
(1) "+" indicates that the insertion is in the same direction (from IRL to IRR) as the Ampf 
gene in pH2. For insertions with two identical IR sequences, "+" indicates that the Kad" 
gene in the mini-ISYlOO is in the same orientation as the Ampf gene of pH2. "-" indicates 
insertions in the opposite orientation. All insertions are into TA targets on pH2 except 
those labelled with an asterisk (*), which inserted into TT/AA dinucleotides instead. 
A) 
TA-rich sequence Amp Ori 
L-________________________ ~r-----_L ______ ~~~ ____ Ji---
B) 
In vivo 0.5 kb 
'+-~ § 41 I 
.0'- 2 § ~ 0 ..... lwllul..L1 __ ....I. ..... II'--___L. __ ....I.-__ L---'-....J1u...1 -U.11 .... 1 -'-.&...---1 __ -1. ...... 1 ---'---'-' __ ---lL ________ ...Io..----'--
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C) 
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~10 
~ 8 
'0 6 
<u 4 
.0 2 E ~ 0~'--~~----------'-----L.~-1.~'--'-----L.--~-'----~--~----------~ 
Z 
D) 
(J) 
512 
~10 
~ 8 
'+- 6 Total 0 
'- 4 Q) 
.0 2 E 
~ 0 
Z 
Figure 5.7 Distribution of insertions of mini-ISYIOO on pH2. A) Stmcture ofpH2. The 
length of the genes are drawn to scale. B), C) and D) show the distribution of insertions 
on pH2 from in vivo transposition assays, in vitro transposition assays and both assays. 
The position of insertion is shown along the X-axis and the number of insertions at each 
position is indicated by the height of the bar. Insertions in the "+" orientation are shown 
in red, those in the "_" insertion are shown in green (details in Table 5.1). 
Table 5.3 Absence of bias toward a palindromic sequence for ISYIOO insertion sites 
A) Independent target sequences used by IRL-IRR transposons in vivo and in vitro in this 
study. 
position in sequence +1 +2 +3 T A T C T A 
Percentage (and 37.9% 34.5% 34.5% 32.8% 62.1% 19.0% 
number) of occurrence (22/58) (20/58) (20/58) (19/58) (36/58) (11158) 
Percentage (and number) of base 
occurrence at the mirror positiona 
A 50.0% 30.0 % 58.3% (11122) (6120) (21/36) 
T 40% 9.1% (8120) (1111) 
G 42.1% (8/19) 
B) Independent target sequences used by IRL-IRR transposons in this study, Urasald et al. 
(2002) and in the PCC6803 genome. 
position in sequence +1 +2 +3 T A T A T A 
Percentage (and 
number) of occurrence 
40.6% 33.7% 39.6% 26.7% 54.5% 22.8% 
(411101) (34/101) (40/101) (27/101) (55/101) (23/101) 
Percentage (and number) of base 
occurrence at the mirror positiona 
41.5% 
A (17/41) 
T 35.3% (12/34) 
27.5 % 
(11/40) 
29.6% 
(8127) 
56.4% 
(31155) 
17.4% 
(4123) 
a The mirror positions for positions + 1, +2, +3 are positions -1, -2, -3 respectively. 
(Table 5.2). Thus the consensus sequence may have some use in predicting which sites will 
be used by ISYlOO. 
The impact of DNA structure, including DNA bending and flexibility, has been 
shown to be important for the target selection for several transposons (Kuduvalli et al., 
2001; Liu et al., 2005; Manna et al., 2004; Pribil and Haniford, 2003; Vigdal et al., 2002). 
In this study, ISYlOO preferentically inserted into some 'hot' target sites. The target that 
was used most frequently (at position 1539 bp on pH2) with 9 insertions in one 0l1entation 
and 3 insertions in the other, had the sequence AT ATA TT A, which does not fit the 
consensus sequence. Perhaps the very AT rich nature of this sequence gives this sequence 
structural features that make up for the lack of a T at position +3. However, more work is 
needed to investigate whether the local DNA structure has an effect on the target 
preference of ISYlOO insertion. 
For all of the transposition events where the donor was supercoiled plasmid DNA, 
whether the reaction was in vivo or in vitro, TA was used as target and duplicated in the 
reaction. However, when transposition was carried out in vitro using AcuI-cleaved mini-
ISYlOO, two insertions were isolated where TT (or AA) was used as a target instead of TA. 
In these cases the TT (AA) target sequence was duplicated after insertion (Figure 5.5 A-
lII). In two other cases, TA was used as a target but while the normal TA was found 
adjacent to the left end of the transposon, only A was found at the right end (Figure 5.5 A-
Il, III). It appears in these cases that the strand transfer reaction occuned at a TA but at 
positions staggered by 1 bp instead of the normal 2 bp. It seems that transposition 
following assembly of transposase onto the pre-cleaved transposon is in some way less 
precise than the normal reaction. Perhaps the excision reaction ensures that transposase 
assembles properly onto the transposon ends. 
5.3 Targeted transposition catalysed by transposase-zinc finger fusion 
proteins 
To find out whether ISYlOO could be used for targeted transposition, the zinc finger DNA-
binding domain of the mouse transcription factor Zif268 was fused to the C-terminus of 
transposase to create Z-transposase. Transposition catalysed by Z-transposases was then 
studied in vivo using a modification of the transposition assay described in chapter III. 
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5.3.1 Designs of chimeric Zif268-transposases and constructions of donor plasmids for 
in vivo transposition 
In experiments to alter the substrate specificity of Tn3 resolvase, Akopian et al. fused the 
DNA-binding domain of Zif268 to the C-terminus of the intact Tn3 resolvase, or to the C-
terminus of the N-terminal catalytic domain of resolvase (Akopian et al., 2003). The genes 
for the Zif268 DNA-binding domain with various N-terminallinkers were readily available 
from Aram Akopian as an EagI-KpnI restriction fragment. A transposon expression vector 
was therefore constructed with an EagI restriction site in the correct frame at the 3' end of 
the transposase gene and a KpnI site after the new transposase stop codon (Figure 5.8B). 
This expression vector encodes a protein with three extra amino acids (YGR) after the 
normal transposase C-terminus. Three different EagI-KpnI fragments were then inserted 
into this plasmid to make plasmids expressing ISYlOO transposase fused to the Zif268 
DNA-binding domain by three different protein linkers (Figure 5.8B). Two linkers were 
short repetitive glycine- and serine-rich peptides designed to be flexible ([GSGh and 
[GSG]4) (Figure 5.8B). The third linker consisted of the entire C-terminal DNA-binding 
domain (residues 141-185) of Tn3 resolvase and a few extra amino acids (Figure 5.8B). 
The genes for these three transposase-Zif268 fusion proteins ("Z-transposase": Tnp-
[GSGb-Zif268, Tnp-[GSG]4-Zif268, and Tnp-Tn3-Zif268) as well as the gene encoding 
transposase with three extra amino acids at the C-terminus (Tnp-YGR), were used to 
replace the wild-type transposase gene in the A-dv based transposon donor plasmid 
pXF116 (Figure 5.8A). These plasmids were then used for in vivo transposition assays with 
the target plasmids described below. 
5.3.2 Design of target plasmids for Z-transposase 
Zif268 binds asymmetrically to its binding site, with finger-l bound to the 3' end and 
finger-3 bound to the 5' end of the Zif268 binding site 5'- GCGTGGGCGT -3'. Z-
transposase bound to a target site by a C-terminal Zif268 DNA-binding domain will be 
tethered with a specific orientation, and might catalyse inseltions only to one side of the 
Zif268 binding site. Furthermore, the transposase might be constrained by Zif268 such that 
it can only catalyse insertions at a fixed distance from the Zif268 binding site, or on only 
one face of the DNA helix relative to the Zif268 binding site. Transposition into sites at the 
wrong distance, or on the wrong face of the DNA helix, would require unfavourable 
distortion of either the DNA or the protein. 
Target sites were therefore designed with potential TA target sites at all possible 
distances (from 1 bp to 36 bp) from both possible orientations of the Zif268 binding site. 
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A) 
B) 
Tnp-YGR 
Linker 1 
(GSG)3 
Linker 2 
(GSG)4 
Linker 3 
Tn3 DBD 
Zif268 
-DBD 
Zif268 site -N- TANN array 
( 5309 - 5354 bp) 
Donor plasmid 
8.3-8.4 kb 
AP 
JSY100 Tn 
BamHI 2651 bp 
Linker!: GSGGSGGSG 
Linker2: GSGGSGGSGGSG 
Linker3: Tn3 DNA-binding domain 
Ndel Eagl Kpnl BamHI 
r-----l r---l r---l r---l 
catATGGCTTACAGTTTAGATTTAAGG . .. ... TACTGTGGCGTTTACGGCCGTtagggtaccggatcc 
MAY S L D L R . .... . Y C G V Y G R * 
I 
Eagl Tnp Spel 
r---l r---l 
cggccgCAGGCGTGGCTCTGGCGGTTCCGGCGGCTCTGGTACTAGT 
G R R R G S G G S G G S G T S 
Eagl Spel 
r---l r---l 
cggccgCAGGCGTGGCTCTGGCGGTTCCGGCGGCTCTGGTGGCAGTGGTACTAGT 
G R R R G S G G S G G S G G S G T S 
Eagl 
r---l 
cggccgCAGGCGTACCGTGGACAGGAACGTCGTGCTGACGCTTCATCAGAAGGGCACTGGT 
G R R R T V 0 R N V V L T L H Q K G T G 
GCAACGGAAATTGCTCATCAGCTCAGTATTGCCCGCTCCACGGTTTATAAAATTCTTGAA 
ATE I A H Q LSI A R S T V Y K I L E 
Spel 
r---l 
GACGAAAGGGCGAGCTCAGACCCAACTTCACAGACTAGT 
o ERA S S D P T S Q T S 
Spel 
r---l 
actagtGAACGTCCGTATGCTTGTCCGGTTGAATCCTGTGACCGTCGTTTCTCGAGATCA 
T S E R PYA C P V ESC 0 R R F S R S 
GACGAACTGACCCGTCACATCCGTATCCACACCGGTCAGAAACCGTTCCAGTGCCGTATA 
DEL T R H I R I H T G Q K P F Q C R I 
TGCATGAGGAACTTCTCCAGATCTGACCACCTGACCACCCACATCCGTACGCACACTGGC 
C M R N F S R SOH L T T H I R T H T G 
GAAAAACCGTTCGCATGCGATATCTGCGGTCGTAAATTCGCGCGCTCTGATGAACGTAAA 
E K P F A COl C G R K FAR S 0 E R K 
Kpnl BamHI 
CGTCACACCAAAATCCACCTGCGTCAGAAAGATTCGAGCTCAtgag~gtac~~gatc~ 
R H T K I H L R Q K 0 S S S * 
C) GCGTGGGCGT 
N [TANN19 array 
ACGCCCACGC 
[TANNlg array 
Zif268 site -N- TANN array 
zif268 binding site: 5'-GCGTGGGCGT-3' 
N: No=None 
N1=C 
N2=CA 
N3=CAG 
10 20 30 
----:----1----:----1----:----1----:-
TANN-array: 5'-TAGATATCTAAGTAAATACGTATGTATGTATATAGA-3' 
1 2 3 4 567 8 9 
Figure 5.8 Donor and target plasmids used to assay for in vivo transposition catalysed 
by ISYIOO transposase-Zif268 fusion proteins. A) Map of the donor and targetplasmids. 
Donor plasmids are pXFll6-like plasmids, encoding transposase-Zif268 fusion proteins. 
Target plasmids are pH2 with target sequences, consisting of the Zif268 recognition 
sequence adjacent to a [TANNJ9 array. B) Sequences oftransposase-Zif268 fusion proteins. 
Restriction sites are indicated above the DNA sequences and the amino acid sequences 
of serine-rich glycine-rich linkers, Tn3 resolvase DNA-binding domain, and the Zif268 
DNA-binding domain are shown in bold and underlined. C) Structures and sequences of 
the Zif268- [TANNh target sites inserted into pH2. 
This was done by placing a repeated array of 9 copies of the sequence TANN (where N 
was a randomly chosen base) adjacent to the Zif268 binding site, at four different spacings 
(0, 1, 2 and 3 bp) (Figure 5.8C). The sequence [TANN]9 has the added advantage that all 
but the first and last TA dinucleotides have an A at the -3 and a T at the +3 position and 
therefore conform to the consensus preferred target site. A total of 8 different target 
sequences, with both possible orientations of the Zif268 binding site and four different 
spacings between the Zif268 binding site and the TA array, were inserted as double 
stranded oligos into pH2 to construct Ampr target plasmids (Figure 5.8A). These plasmids 
are referred to here as pZ±X where + or - indicates the orientation of the Zif268 binding 
site and X = 0, 1, 2, or 3 indicates the length of the spacer. All of these plasmids were 
based on pH2 so that transposition could either go into the TA array adjacent to the Zif268 
binding site, or the large TA-rich region of A. nidulans DNA in pH2. 
5.3.3 Z-transposases catalyse transposition to one side of the Zif268 binding site. 
In the first experiment (Experiment A, Table 5.4), 32 separate in vivo transposition assays 
were set up by co-transforming one A-dv-based donor plasmid and one target plasmid into 
DH5a. Eight different target plasmids were used, with both orientations of the Zif268 
binding site and 4 different spacings between the Zif268 binding site and the TA alTay. 
Four donor plasmids were used, differing only in the transposase gene. Three donor 
plasmids carried the three different Z-transposase genes, while the fourth carried 
transposase with three additional amino acids (Tnp-YGR) , but no Zif268 DNA-binding 
domain. A standard in vivo transposition assay was then carried out. 10 single colonies 
containing donor and target plasmids were pooled and grown for 18 hours in liquid culture, 
diluted 1 in 1000 and grown a further 18 hours. DNA was isolated from these cells and 
plasmid molecules in which the mini-ISY100 had jumped into the target plasmid were 
isolated by transformation into the A lysogen strain DS964 and selection for kanamycin 
resistance. Twenty colonies were picked from each transformation and checked for 
chloramphenicol resistance, and the transposition frequency was calculated in the usual 
way. Transposition catalysed by the control transposase (Tnp-YGR) occurred with a 
frequency ranging from 0.42- 4.00 x 10-3 (mean ± 1 standard deviation= 2.11 ± l.13x 10-3) 
into the 8 different substrates (Table 5.4A). Transposition catalysed by Tnp-(GSG)3-Zif268 
and Tnp-(GSG)4-Zif268 occurred with a reduced frequency (0.70 ± 0.38 x 10-3 and 0.76 ± 
0.35 x 10-3 respectively), while the transposition frequency obtained with Tnp-Tn3-Zif268 
(0.47 ± 0.35 x 10-3) was approximately 4-fold lower than that obtained with Tnp-YGR. 
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Table 5.4 In vivo transposition frequency (xlO·3) of Z-transposase 
Experiment A 
Target Transp_osases 
plasmid Tnp-YGR Tnp-(GSG)3- Tnp-(GSG)4- Tnp-Tn3-Zif268 Zif268 Zif268 
pZ+1 1.87 0.27 0.38 0.58 
pZ+2 0.42 0.11 0.80 0.13 
pZ+3 1.70 0.54 1.28 0.84 
pZ+4 2.17 0.85 1.08 1.13 
pZ-1 4.00 0.82 0.35 0.33 
pZ-2 2.98 1.22 0.98 0.33 
pZ-3 2.71 1.07 0.81 0.22 
pZ-4 1.03 0.69 0.41 0.19 
Average 
2.11 ± 1.13 0.70 ± 0.38 0.76 ± 0.35 0.47 ± 0.35 (± 1 SD) 
Experiment B 
Target Transposases Wild-type Tnp-(GSG)3- Tnp-(GSG)4-plasmid Tnp Zif268 Zif268 Tnp-Tn3-Zif268 
pZ+1 0.80 0.31 0.50 0.09 
pZ+2 1.08 0.34 0.76 0.06 
pZ+3 1.55 0.19 0.28 0.09 
pZ+4 1.46 0.27 1.34 0.06 
pZ-1 1.91 0.32 0.60 0.05 
pZ-2 5.77 0.34 0.61 0.09 
pZ-3 4.20 0.37 0.56 0.06 
pZ-4 1.75 0.27 0.48 0.04 
pH2 2.81 0.10 0.24 0.04 
Average 
2.37 ± 1.63 0.28 ± 0.09 0.60 ± 0.32 0.06 ± 0.02 (± 1 SD) 
In vivo transposition assays to test the transposition activity of chimeric transposases. 
Both experiments A and B were started from multiple (10) single colonies, catTying 
both donor and tat'get plasmid and were can-ied out as described in chapter II. In 
experiment A 1 f.,LI of plasmid DNA was electroporated into DS964, whereas m 
experiment B the DNA used in the electroporation was standardised to 100 ng. 
Thus fusing the Zif268 DNA-binding domain to ISYlOO transposase does not abolish 
transposition, although the linker consisting of the resolvase C-terminal domain 
substantially reduced the transposition frequency. 
To get a reasonable estimate of the frequency of insertions into the designed target 
adjacent to the Zif268 binding site, it was decided that 20 colonies should be examined for 
each transposition assay. The approximate location of mini-ISYlOO insertions catalysed by 
Z-transposases could be determined by restriction digestion of plasmids purified from 
individual DS964 transformants. However, to avoid purifying plasmid DNA from 640 
individual colonies, an initial PCR-based screen was carried out on transformant colonies. 
Twenty colonies from each transposition assay were picked and used directly as template 
for PCR as described in Chapter II. Two combinations of primers were used, to detect both 
possible orientations of the mini-ISYlOO in the TANN array of the target plasmids (Figure 
5.9A). PCR products of approximately 720 bp with primers Rev_308 and KanR, and 
approximately 530 bp with primers Rev _308 and KanL indicated insertions close to the 
Zif268 binding site. This process identified 143 plasmids out of the 640 screened, 
containing insertions close to the Zif268 binding site. DNA was prepared from these 143 
colonies, digested with BamHI and run on an agarose gel to verify the PCR results. The 
mini-ISYlOO used in this assay contains two BamID sites flanking the Kan f gene, 30 bp in 
from each end. The 5.4 kb target plasmids all contain a single BamHI site almost exactly 
2.7 kb away from the Zif268 binding site. Therefore plasmids with insertions close to the 
Zif268 binding site will give a 1.3 kb Kanf fragment and two co-migrating fragments of 2.7 
kb (Figure 5.10). Those plasmids giving this restriction pattern were sequenced using both 
KanL and KanR primers. Sequencing results showed that all the insertions were into TA 
targets and were flanked by TA at both sides. 121 out of the 143 plasmids, identified by 
PCR and BamID digestion as carrying insertions close to the Zif268 binding site, carried 
insertions in the [TANN]9 array. The other 22 carried insertions nearby, but outside the 
[TANN]9 array. 
The number of insertions into the TANN array differed for the different combinations 
of donor and target plasmids. For the control transposase (Tnp-YGR) , between 1 and 3 out 
of 20 insertions were into the [TANN]9 target (Table 5.5, 5.6). Thus the [TANN]9 array is 
used as target approximately 9% of the time, even in the absence of a Zif268 DNA-binding 
domain. Tnp-(GSG)3-Zif268 and Tnp-(GSG)4-Zif268 gave similar results, except that Tnp-
(GSG)4-Zif268 gave 10 out of 20 inserts into the TA target array of one substrate, pZ+ 1 
(Table 5.5, 5.6). Tnp-Tn3-Zif268 gave much more promising results. For the " " 
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Figure 5.9 Colony PCR to screen transposition events for insertions close to the Zif268 binding site. A) Diagram showing 
positions of primers on the target plasmid and mini-ISYI00. Primer Rev-308 is located upstream of the Zif268 binding site and 
TA array (white box). Primers KanL and KanR are located close to the ends ofthe mini-ISYI00. B) 1.2% agarose gel electrophoresis 
ofPCR products obtained from single DS964 transformant colonies. Lanes 1-20 of each gel show PCR products using 20 kanamycin 
resistant single colonies from in vivo transposition assays. The donor plasmid and target plasmid used are indicated above each gel. 
The PCR primers used are indicated to the side of each gel. Lane 21 shows a negative control PCR reaction. 
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Figure 5.10 BamHI digestion to screen potential target specific transposition. A) 
Diagram shows insertion of a mini-ISYI00 into the [TANN]9 array on the target plasmid. 
The relative positions of BamBI sites on the mini-ISYI00 and the target plasmid are 
shown. B) 1.2% agarose gel electrophoresis of the BamBI digestion products of candidate 
plasmids carrying an insertion ofmini-ISYI00 from an in vivo transposition assay with 
Tnp-(GSG)3-Zif268 and pZ-2.These plasmids were purified from Kanf Cms single colonies 
which gave PCR products close to the desired size. Lanes 1 - 6 correspond to lanes 4, 
5,6, 7, 9 and 15 respectively on Figure 5.9. 
Table 5.5 Target selection in transposition by Z-transposase 
(Experiment A) 
Number of insertions into TANN array 
Target plasmid Tnp-YGR Tnp-(GSG)3- Tnp-(GSG)4- Tnp-Tn3-Zif268 Zif268 Zif268 
pZ+1 1120 3/20 10120 11120 (P<0.05) (P<0.05) 
pZ+2 3/20 2120 2/20 7120 
pZ+3 2120 1120 0120 18120 (P<0.05) 
pZ+4 2120 2/20 1120 19/20 (P<0.05) 
pZ-1 3120 2120 4/20 4120 
pZ-2 2120 3/20 0120 1120 
pZ-3 1120 2120 4120 3120 
pZ-4 1120 3/20 3120 1120 
A chi-squared test was performed to compare the number of insertions into the 
[TANN]9 array mediated by chimeric proteins with the number mediated by Tnp-
YGR. Those giving P<0.05 are indicated in the table. 
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Table 5.6 Details of the in vivo transposition of Z-transposases 
(Experiment A) 
No. of insertions into TA array 
Ampf Transposition Target Kad' Total No. 
colonies frequency No. of insertions into plasmid (xl04) colonies (x 10-3) in the 20 specific TA (1) general 
insertions (No.: position of TA) 
pZ+l 177 3308 1.87 1120 1 : 2nd TA 
pZ+2 314 1320 0.42 3120 2: ihTA 1:7th TA(+) 
pZ+3 187 3184 1.70 2120 
1: 4thTA 
1: 8th TA 
5000 2120 1 : 6
th TA (+) pZ+4 230 2.17 1: 8th TA 
1: 3fd TA 
pZ-l 110 4400 4.00 3120 1 : 4thTA 
1: ihTA (+) 
pZ-2 83 2476 2.98 2120 2: 7th TA (+) 
pZ-3 79 2140 2.71 1120 1: 9th TA 
pZ-4 102 1052 1.03 1120 1 : 4thTA 
pZ+l 240 647 0.27 3 3 : 4th TA 
1: 2nd TA 
pZ+2 139 156 0.11 2120 1: 6th TA 
pZ+3 171 921 0.54 1120 1: 7th TA 
pZ+4 101 863 0.85 2/20 2: 2nd TA 
pZ-l 87 717 0.82 2/20 2: 7th TA 
1 : 2na TA pZ-2 80 973 1.22 3/20 2: 5th TA 
1 : 7th TA (+) 
pZ-3 84 895 1.07 2120 1: 7th TA 
1: 4thTA (+) 
pZ-4 69 474 0.69 3120 1: 6th TA 
1 : i h TA (+) 
(Continued on next page) 
No. of insertions into T A alTay 
Ampr Transposition Target Kad Total No. Tnp colonies frequency No. of insertions into plasmid (x 104) colonies (x 10-3) in the 20 specific TA (1) general 
insertions (No.: position ofTA) 
1 : 2no TA 
pZ+l 132 500 0.38 10120 3:4
th TA 
5: ihTA 
1 : 7th TA (+) 
pZ+2 92 738 0.80 2120 1: 2
no TA 
1 : 2nd TA (+) 
>-3 
::l pZ+3 68 870 1.28 0120 "d -
I 
~ 
1 : 2nd TA Cl pZ+4 122 1315 1.08 1120 CI:l 
Cl 3:2nd TA '-' pZ-l 114 394 0.35 4120 .,. 1: 8th TA I N 
..... 
l::3 pZ-2 98 959 0.98 0120 -0\ 
00 
2: 2no TA 
pZ-3 74 601 0.81 4120 1:4th TA(+) 
1 : 7th TA (+) 
1 : 5th TA (+) 
pZ-4 37 151 0.41 3120 1: 6th TA 
1 : 7thTA 
1 : 3rd TA (+) 
2: 4thTA 
pZ+l 59 343 0.58 11120 2: 6th TA (+) 
5: ih TA 
1:7th TA(+) 
pZ+2 75 97 0.13 7/20 5: 5
th TA 
2: 7thTA 
>-3 11 :2no TA ::l 
"d 
4: 2nd TA(+) I pZ+3 92 770 0.84 18/20 >-3 
::l 3: 7th TA w 
I 
10: 2no TA N ..... 
l::3 pZ+4 69 780 1.13 19120 7: 2nd TA (+) 0\ 
00 2: ihTA 
pZ-l 61 204 0.33 4120 3: 2
nd TA (+) 
1: 7thTA 
pZ-2 28 91 0.33 1120 1: 7thTA 
pZ-3 72 160 0.22 3120 3: ihTA(+) 
pZ-4 216 410 0.19 1120 1: ihTA 
(1): (+) indicates that the mini-ISY100 is inserted with the Kanr gene in the same 
orientation as the Ampf gene on the target plasmid. All other insertions have the 
opposite orientation. 
orientation of the Zif268 binding site, the [TANN]9 target was used approximately 11 % of 
the time, roughly the same frequency as in the absence of the Zif268 DNA-binding 
domain. However, for the "+" Olientation, 18 out of 20 insertions into pZ+3 and 19 out of 
20 insertions into pZ+4 were in the [T ANN]9, while 11 out of 20 and 7 out of 20 insertions 
into pZ+1 and pZ+2 were in the [TANN]9 array. Thus it appears that Tnp-Tn3-Zif268 
fusion protein catalyses insertions with increased frequency only at one side of the Zif268 
binding site (Table 5.5, 5.6). 
Next, the exact locations of insertions into the [TANN]9 arrays were analysed. The 
locations of insertions catalysed by the four different transposases into the eight different 
target sites are shown in Table 5.6 and summarised graphically in Figure 5.11. Analysing 
the 15 different insertions catalysed by Tnp-YGR, the TA closest to the Zif268 binding site 
was never used, and nor was the fifth, while the seventh TA was used six times. If all of 
the insertions where there was no increase in insertion into the [TANN]9 array are added 
into this analysis, it can be seen that the second, fourth and seventh TA from the Zif268 
binding site are preferred sites of integration. Perhaps the flanking sequences of these TAs 
have sequence or structural features that make them preferred targets for normal 
transposase. The first TA is never used as a target, perhaps because it does not have an A at 
the -3 position andlor because it is too close to the GC-rich Zif268 binding site. Z-
transposase might also block integration into this site by binding to the Zif268 binding site. 
When insertions catalysed by Tnp-Tn3-Zif268 into targets adjacent to the Zif268 binding 
site in the "+" orientation are examined, it appears that different TAs are favoured in the 
different substrates. The second TA was used for 15/18 and 17119 insertions for pZ+3 and 
pZ+4 respectively, with the seventh TA used for the other insertions. The fifth TA in pZ+2 
and the seventh T A in pZ+ 1 were also preferred. This suggests that insertions might be 
favoured at certain fixed distances from the Zif268 binding site possibly on one face of the 
DNA helix, though this needs to be verified by further repeats of this experiment. 
To avoid the large number of PCRs and plasmid purifications described above, an 
alternative method was used to display the distribution of insertions catalysed by Z-
transposases. After transfOlmation into DS964, all of the colonies should contain different 
ISYlOO insertions into the target plasmid. Colonies were therefore washed off the 
transformation plates and plasmid DNA was purified from these pooled colonies. This 
DNA was cleaved with BamHI and run on an agarose gel. All of the plasmid molecules in 
these pools should give a 1.3 kb Kanl' fragment from the mini-ISYlOO. Plasmids with an 
insertion adjacent to the Zif268 binding site will give two bands of the same size at 2.7 kb, 
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Figure 5.11 Distribution ofinsertions in the [TANN19 array from in vivo Z-transposition 
assays. Histogram to show number of insertions into each TA in the target sites. 
while all of the other plasmids will give two bands, one larger than 2.7 kb and the other 
smaller. The mixture will therefore give a ladder of different sized fragments, with the 
relative intensity of the band at 2.7 kb position indicating the proportion of insertions in, or 
close to, the TANN array. The results of this analysis from the same in vivo transposition 
assays described above (Experiment A) are shown in Figure 5.12. As expected, a ladder of 
bands representing insertions at different locations is seen in all of the lanes. Tnp-YGR, 
Tnp-(GSG)3-Zif268 and Tnp-(GSG)4-Zif268 give complex ladders of bands, with the 2.7 
kb band making up approximately 10-20% of this ladder. Thus only 10-20% of the plasmid 
molecules in these mixtures contain insertions in or close to the TANN designed target. 
Tnp-Tn3-Zif268 gave less complex ladders of bands, perhaps correlating with the low 
transposition frequency and a smaller total number of transform ant colonies in the pools. 
For the targets with the Zif268 binding site in the "+" orientation, but not for those with 
this site in the "-" orientation, the 2.7 kb band makes up a large proportion of the total 
amount of DNA, consistent with the results shown in Table 5.6. This technique therefore 
gives a good idea of the proportion of insertions into the designed target, and the results are 
generally consistent with those obtained by purifying large numbers of individual 
plasmids. 
Another thing that can be noted in Figure 5.12 is that a high proportion of molecules 
can sometimes contain insertions into a single site. For instance in the DNA purified from 
the transposition reaction with Tnp-(GSG)4-Zif268 and pZ+2 (Figure 5.12A, lane 12), two 
very bright bands of approximately 2.3 and 3.0 kb, probably representing a single insertion 
into one site on pZ+2, are present. This result presumably reflects an early transposition 
event into this site in the original strain carrying both target and donor plasmid in DH5a. 
The best way to distinguish between a genuine target preference and an early 
fortuitous transposition event giving multiple copies of the same insertion, is to carry out 
multiple independent repeats of the transposition assay. As a first step toward confirming 
the target specificity of the different Z-transposases, a second set of in vivo transposition 
assays (Experiment B) was carried out. This experiment used the same three Z-transposase 
donor plasmids and a control plasmid carrying the wild-type transposase (pXF116). As a 
control, pH2 was also used as a target for all 4 donor plasmids, so that a total of 36 assays 
were carried out. A standard in vivo transposition assay was carried out as before, giving 
similar transposition frequencies (Table 5.7). DNA was then prepared from pooled 
kanamycin resistant colonies, cut with BamHI and run on an agarose gel (Figure 5.13). The 
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Figure 5.12 Electrophoretic display of insertions catalysed by Z-transposases. Plasmid 
DNA was purified from pooled Kanr colonies from each individual transposition assay 
in experiment A. DNA was cleaved with BamHI and separated on a 1.2% agarose/TAE 
gel. The transposase and target plasmid used are indicated above each lane. Lane 1 of each 
gel contains BamHI-digested pZ+2. Lane 2 of each gel contains a transposition product 
with a single insertion in the [TANN]9 array. 
Table 5.7 Details of the in vivo transposition of Z-transposases 
(Experiment B) 
Target Ampr Kanr Transposition frequency plasrnids (x 104) (x 10-3) 
1 pZ+l 169 1360 0.80 
2 pZ+2 145 1560 1.08 
~ 3 pZ+3 110 1710 1.55 
-. 4 pZ+4 110 1610 1.46 
--
p,. 
1 Mean ± ISD: ....... 5 '< pZ-l 117 2240 1.91 
"d 2.37 ± 1.63 (1) 
~ 6 pZ-2 137 7910 5.77 
,g 7 pZ-3 41 1720 4.20 
8 pZ-4 68 1190 1.75 
Co pH2 77 2167 2.81 
17 pZ+l 130 401 0.31 
18 pZ+2 188 646 0.34 
~ 
,g 
1 
19 pZ+3 203 391 0.19 
,-... 
20 pZ+4 187 508 0.27 0 
C/.l Mean ± ISD: 0 21 pZ-l 228 732 0.32 
'--" 0.28 ± 0.09 w 1 22 pZ-2 147 494 0.34 N 
-. t:3 23 pZ-3 267 976 0.37 0\ 
00 
24 pZ-4 300 815 0.27 
C2 pH2 160 154 0.10 
9 pZ+l 118 586 0.50 
10 pZ+2 108 817 0.76 
~ 11 pZ+3 88 248 0.28 "d 
1 
,-... 
12 pZ+4 72 963 1.34 0 
C/.l Mean ± ISD: 0 13 pZ-l 94 566 0.60 
'--" 0.60 ± 0.32 
"'" 1 14 pZ-2 85 515 0.61 N 
-. t:3 15 pZ-3 152 850 0.56 0\ 
00 
16 pZ-4 111 535 0.48 
C1 pH2 143 349 0.24 
25 pZ+l 208 182 0.09 
26 pZ+2 402 229 0.06 
~ 27 pZ+3 251 232 0.09 :::s 
"d 28 pZ+4 323 190 0.06 1 ~ 
:::s 29 pZ-l 309 159 0.05 Mean ± ISD: VJ 1 0.06 ± 0.02 N 
-. 30 pZ-2 272 256 0.09 t:3 
0\ 31 pZ-3 141 88 0.06 00 
32 pZ-4 221 88 0.04 
C3 pH2 172 71 0.04 
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Figure 5.13 Electrophoretic display of insertions catalysed by Z-transposases. Plasmid 
DNA was purified from pooled Kanr colonies from each individual transposition assay 
in experiment B.DNA was cleaved with BamHI and separated on a 1.2% agarose/TAE 
gel. The transposase and target plasmid used are indicated above each lane. Lane 1 of each 
gel contains BamHI-digested pZ+2. Lane 2 of each gel contains a transposition product 
with a single insertion in the [TANN]9 array. 
sizes of these pools range from 1190-7910 colonies for wild-type transposase, to 71-256 
colonies for Tnp-Tn3-Zif268. With the wild-type transposase, it can be seen that adding 
the TANN array increases transposition to this area of all eight target plasmids. However, 
there is clear evidence for targeted transposition by Tnp-Tn3-Zif268, with a much brighter 
band at 2.7 kb for all of the substrates with the Zif268 binding site in the "+" orientation 
compared to the wild-type transposase. BamID digestion of a randomly selected 20 Kanf 
single colonies from the assays employing Tnp-Tn3-Zif268 together with target plasmid 
pZ+3 or pZ+4 suggested more than half (60% and 55% respectively) of the insertions were 
in the designed target array adjacent to the Zif268 binding site (Figure 5.14), although the 
exact target sites need to be further identified by sequencing. There was no evidence for a 
high level of targeting by either Tnp-(GSG)3-Zif268 or Tnp-(GSG)4-Zif268 in these assays. 
5.4 Discussion 
In this chapter, the target preference of ISY100 outside the duplicated target TA was first 
investigated based on the deduced target sites used by ISY100 in vivo and in vitro in this 
study, in the study of Urasaki et al. (2002) and the insertions in the sequenced genome of 
Synechocystis sp. PC6803. The consensus target sequences ADWTAWHT (where W = A 
or T, D = not C and H = not G) or more generally ANNTANNT (where N = any base), 
with the duplicated target TA at the centre, was deduced from these data. The strongest 
preference was for T and A at +1-3, with a weaker preference for AT-rich sequence at 
positions ±1 and ±2 relative to the central TA. 
Although the insertion sites might be biased by selection against insertions into 
essential genes in the genome, or by the relatively small number of available targets in the 
plasmids used, the single biggest limitation in this study was probably the small number of 
insertions studied. Only about 100 different insertion sites were analysed in this study, in 
contrast to more than 800 different sites for Tel and Tc3 in the studies of Preclin et al. 
(2003). 
The deduced consensus target sequence (ANNT ANNT) was adapted and used in the 
design of [TANN]9 target sites that could be placed next to the binding site for Zif268 to 
investigate the target specificity of ISYI00 transposase-Zif268 fusion proteins. These 
arrays were placed at 4 different positions so that transposition into T A target sites could 
be studied at all possible distances from 1 to 36 bp from the Zif268 binding site. 
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Figure 5.14 BamHI digests of transposition products catalysed by Tnp-Tn3-Zif268 
into pZ+3 and pZ+4. DNA from 20 randomly selected individual KanT transformants of 
DS964 from experiment B with Tnp-Tn3-Zif268 and either pZ+3 or pZ+4 was cleaved 
with BamBI and run on a 1.2% agarose/TAE gel. 
Transposition was studied in vivo rather than in vitro because the in vivo assay is easy 
to carry out and there is no need to purify the Z-transposase. The in vivo assay set up could 
also be adapted to screen for mutants of Z-transposase that have increased activity or target 
specificity. 
It was decided to fuse the Zif268 DNA-binding domain (Zif268-DBD) to the C-
terminus of ISY100 transposase partly due to the ease with which expression plasmids 
could be constructed. Another consideration was that addition of a His-tag to the N-
terminus of IS630 transposase inactivated the transposase in vivo, whereas a C-terminal 
His-tag led to an increase in activity (my unpublished data). It was therefore thought that a 
C-terminal fusion was less likely to inactivate ISY100 transposase than an N-terminal 
fusion. In similar experiments carried out in other labs, the zinc finger domains of Zif268 
and E2C have been fused to both the N-terminus and the C-terminus of mv integrase 
without loss of activity (Bushman and Miller, 1997; Tan et aI., 2004). A recent in vivo 
study on the IS630/Tcllmariner superfamily transposase Sleeping Beauty suggested that 
attaching another Cys2His2 zinc finger protein (Sp 1) to the C-terminus of Sleeping Beauty 
transposase abolished transposase activity, while the addition of Sp1 or zinc fingers 3-8 of 
the human zinc finger protein ZNF202 to the N-terminus of SB did not (Wilson et al., 
2005). However, no alteration of target selectivity was observed in this study. It is 
therefore possible that N-terminal fusions of zinc finger DNA-binding domains to ISY100 
transposase might also be active. 
Preliminary evidence strongly suggested that fusing the Zif268 DNA-binding domain 
to ISY100 transposase via the C-terminal DNA-binding domain of Tn3 resolvase led to 
targeted transposition on just one side of the Zif268 recognition site. Whether the 
preference for TAs at certain distances from the Zif268 binding site is due to tethering of 
transposase in a fixed configuration with respect to the Zif268 binding site, or is caused by 
the different flanking sequences of the TAs in the TANN array, requires further 
investigation. The role of the Tn3 resolvase DNA-binding domain is also unclear. It may 
function simply as a non-specific linker protein to allow the Zif268 DNA-binding domain 
to reach the target site while the transposase is bound in the integration complex. 
Alternatively, it may play some more specific role, for instance by binding to the DNA 
between the Zif268 binding site and the target site. However, there is no evidence that it is 
influencing target choice by binding to res site-related sequences. 
The Zif268 binding site is 9-10 bp long, with each "finger" recognising 3-4 bp. 
Together with the TA target specificity of ISY100 transposase, the chimeric transposase 
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can potentially recognise a specific 11 - 12 bp sequence. In theory this sequence will occur 
only once in every 4 Mbp of random sequence, equivalent to one site in the genome of E. 
coli. To increase this specificity, more zinc finger domains can be added onto the zinc 
finger DNA-binding domain (Beerli and Barbas, 2002). Another possibility is to construct 
a transposase that is targeted to a T A flanked by two Zif268 binding sites in indirect repeat. 
Because of the expected 2-fold symmetry of the integration complex, this should 
efficiently target transposition to the central T A. A preliminary experiment to set up such a 
system has been carried out by Marko Prorocic, with some limited success. The distance 
between the inverted repeat Zif268 recognition sites was chosen based on the distance 
between a single Zif268 binding site and the prefened target TA found in my studies. Such 
a transposase could potentially recognise a sequence of 22 bp in length, which should 
occur once in 1012 bp, and is long enough to specify a unique site in a mammalian genome. 
Other systems have been set up that take advantage of the ability of two zinc finger 
DNA-binding domains to specify a unique site in a large genome. Zinc finger nucleases, 
based on the resttiction enzyme FokI, require two zinc finger target sites in inverted repeat 
(Mani et al., 2005). These nucleases have been engineered to recognise several different 
sites in the human genome, and have been used to initiate homologous gene replacement of 
medically important genes in human cells (Durai et al., 2005). Tn3 resolvase has been 
fused to Zif268 to produce Z-resolvases. Recombination requires two Zif268 recognition 
sites flanking the res site I central region in inverted repeat (Akopian et al., 2003). 
More work is needed, first to confirm the target-specific transposition reported in this 
chapter, and then to increase the specificity and efficiency of transposition. One of the 
problems with the targeted transposition reported here is that there is still a relatively high 
level of transposition into random sites. It seems possible that mutant transposases could be 
isolated that cannot bind tightly enough to target DNA to allow transposition. These 
mutants might be rescued by the zinc finger DNA-binding domain, in which case 
transposition would only occur adjacent to the zinc finger binding site. The in vivo 
transposition assays developed in this work could perhaps be modified to allow selection 
of such mutants, and also of hyperactive Z-transposase mutants that bring about 
transposition with a higher frequency. 
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Chapter VI 
Concluding remarks 
The main objectives of this project were to increase our understanding of the transposition 
mechanism of ISYlOO, and to investigate the potential to develop ISYlOO into a target-
specific transposition tool. The results presented here demonstrate that ISYlOO transposes 
via a cut-and-paste mechanism, and that ISYlOO transposase is the only protein required 
for transposition. Transposase binds transposon ends via its N-terminal helix-turn-helix 
domains, and then cleaves the transposon exactly at its 3' ends, and two nucleotides inside 
the transposon at its 5' ends. Transposase integrates the excised transposon into target TA 
sites, which are duplicated after transposition. 
Double-stranded breaks at the ISYlOO ends occur in a defined order. The non-
transferred strand is always cleaved first, and the transferred strand can only be cleaved 
once the non-transferred strand has been cleaved. This result is consistent with previous 
observations on the cleavage of Masl mariner, a eukaryotic member from the same 
supelfamily (Dawson and Finnegan, 2003). For some transposons, such as Tn5 and TnlO, 
transposase cleaves the second strand via a hairpin intermediate, and this accounts for the 
defined order of strand cleavage for these elements. However, all of the evidence suggests 
that Masl does not cleave via a hairpin intermediate. Instead, it seems that the non-
transferred strands are cleaved independently at each end. Only when first strands have 
been cleaved can the two ends come together to form a paired end complex (PEC). Second 
strand cleavage occurs within the PEC, possibly by a domain swapping mechanism in 
which the transposase bound to one end cleaves the transferred strand of the other end. No 
hairpin structures were seen at ISYlOO ends, consistent with the results for Masl. 
Although there was no direct evidence for PEC formation for ISYlOO, second strand 
cleavage appeared to be coordinated at the two ends, suggesting formation of some sort of 
synaptic complex. More experiments are needed to identify the mechanism responsible for 
the defined order of cleavage by ISYlOO transposase and the nature of any PEC. Fmther 
work is also needed to show whether the lack of observable PECs might be due to an 
unstable synaptic complex and whether this might account for the low level of coordinated 
insertion of transposon ends in the in vitra system. 
Fusion of the Zif268 DNA-binding domain to the C-terminus of ISYlOO transposase, 
with the Tn3 DNA-binding domain as a spacer, resulted in a chimelic Z-transposase that 
mediated transposition mostly into target sites adjacent to the Zif268 recognition site. This 
suggested that Z-transposase could be developed into a useful genetic tool. However, many 
more expeliments need to be done to investigate and develop this system. For instance, 
transposition assays with different sequences adjacent to the Zif268 recognition sites could 
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be carried out to verify whether targeting of specific TAs adjacent to the Zif268 site was a 
consequence of the local DNA sequence surrounding the TA targets, or tethering of 
transposase to the Zif268 site such that transposition could only occur at fixed distances 
from the Zif268 recognition site. Similar fusion proteins containing shorter linkers between 
transposase and Zif268 failed to give site-specific transposition. No obvious Tn3 resolvase 
recognition sites were present close to the Zif268 recognition site. Experiments employing 
protein spacers with different lengths and sequence are required to investigate whether the 
Tn3 resolvase DNA-binding domain contributes in some structure-specific manner to 
targeted transposition, or is simply providing a protein linker of the correct length and 
geometry. To investigate whether this system could be used to target transposition to 
different target sites, the transposase could be fused to zinc fingers with different DNA-
binding specificities. Experiments employing chimeric proteins with more zinc finger 
motifs, or with binding sites flanking the target TA in inverted repeat, are needed to see if 
transposition could be targeted to longer sites, expected to occur only once in a large 
eukaryotic genome. 
Results from this study suggested that improvements in specificity might be obtained 
by decreasing the transposition frequency into random sites without reducing transposition 
into specific target sites. A protein that had lower target binding affinity, and was therefore 
dependent on the zinc finger DNA binding domain for target binding, would have the 
desired properties. A papillation assay has been established in E. coli in this lab since work 
on this thesis was completed (S. Colloms, personal communication), to facilitate screening 
for hyperactive transposase mutants. Further assays are being set up to screen for mutants 
with increased target specificity. 
ISY100 transposase is the only protein required for transposition in vitro, suggesting 
ISY100 might be functional in wide-range hosts. Zinc finger proteins are common 
eukaryotic transcription factors, and should work well in eukaryotic hosts. However, wild-
type ISY100 transposase and ISY100-based Z-transposases have yet to be tested in 
eukaryotic cells, and this is a priority for future development of this system. One possible 
problem is the lack of a nuclear localisation signal (NLS) in the prokaryotic ISY100 
transposase. A region between the N-terminal DNA binding domain and the catalytic DDE 
domain, consisting of two basic residues followed by a 10 amino acid spacer and a cluster 
of 5 amino acids, of which three are basic, has been identified as a NLS in many 
transposases of the Tc1/mariner family (Ivics et al., 1996). ISY100 transposase has a 
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similar basic region that might also function as a NLS in eukaryotes, but this has yet to be 
tested. 
The in vivo reversibility of transposition can be problematic when it is desirable to 
obtain stable mutations or insertions. This problem can be minimized in several ways. The 
main strategy that has been used is to control expression of the transposase protein, so that 
it is only supplied transiently. For instance, the transposase gene can be carried on a vector 
that cannot replicate in the host cell, or the transposase can be supplied as mRNA which is 
quickly degraded. Another possibility is to introduce pre-assembled transpososomes, 
catalytically competent synaptic complexes of transposase and excised transposon, into the 
cell (Goryshin et al., 2000). Recent experiments have demonstrated that E. coli can be 
electroporated with transpososomes assembled from ISYlOO transposase and pre-excised 
transposon (my unpublished results). This yielded Kanf colonies that presumably reflect 
transposase-catalysed integration of the transposon into E. coli chromosomal DNA. This 
may function, and be useful, in other cell types. 
Results from this study showed that the cleavage activity of ISYlOO transposase was 
affected by the sequence of the dinucleotides flanking the donor transposon. The maximum 
cleavage activity was obtained with the wild-type TA dinucleotide, and the activity was 
dramatically reduced in the presence of alternative flanking dinucleotides. The work 
presented in this thesis demonstrated that the dinucleotides flanking new insertions are 
produced by duplication of the target site. Furthermore, pre-excised transposon DNA is an 
efficient substrate for integration. Therefore, ISYlOO transposase mutants with changes in 
preference for either the donor cleavage site or the target site (but not both) could possibly 
be useful for preventing further events after the initial transposon insertion. Finding 
transposase mutants with alternative target site specificity may also be necessary for 
extending the range of sequences available for targeting by Z-transposases. 
As yet little is known about when and how members of the IS630/Tcl/mariner 
family capture target DNA during transposition. Transposons Tn7 and Mu have separate 
proteins responsible for target binding and strand-transfer, and target site selection is done 
before cleavage. For TnlO, where transposition is catalysed by a single transposon-
encoded protein, target capture occurs only after transposon excision (Sakai and Kleckner, 
1997). Since excision and strand transfer reactions are carried out by a single catalytic site, 
it seems likely that the target site is recognized by same patt of the transposase complex 
that binds the donor flank in the excision reaction. In this study, transposase mediated 
transposition of pre-excised ISYI00 in vitro into TT (AA) dinucleotide instead of TA at an 
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elevated frequency. This suggests that target site selection may depend on the 
conformation of the complex formed by transposase and the two transposon ends. Studies 
of target capture by ISY100 transposase may be facilitated by Z-transposase, which can 
mediate transposition to a specific target site in a DNA molecule. For instance, it might be 
possible to obtain a crystal structure (or failing that, other structural information) of Z-
transposase bound to transposon ends and target DNA in a target capture complex. This 
sort of study could also aid in the development and refinement of Z-transposase as a 
genetic tool. 
Although much work remains to be done, ISYIOO transposase and Z-transposase 
hold much promise, and may form a useful tool in the armoury presently being developed 
in laboratories throughout the world to manipulate complex genomes in a controlled 
fashion. 
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